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The Hedgehog (Hh) and canonical Wnt/β-catenin signaling pathways are 
involved in various embryonic processes, and when aberrantly activated after birth in 
certain cell types or settings, are associated with the development of neoplasia.  Although 
the Hh and Wnt pathways can be activated concurrently during tumorigenesis, the 
functional significance of signaling crosstalk in tumor initiation and progression has not 
been established. 
Constitutive Hh signaling underlies several human tumors, including basal cell 
carcinoma (BCC) and basaloid follicular hamartoma in skin.  Intriguingly, superficial 
BCCs arise as de novo epithelial buds resembling embryonic hair germs, collections of 
epidermal cells whose development is regulated by canonical Wnt/β-catenin signaling.  
Similar to embryonic hair germs, human BCC buds exhibited increased levels of 
cytoplasmic and nuclear β-catenin, a marker of canonical Wnt/β-catenin signaling, and 
expressed early hair follicle lineage markers.  We also detected canonical Wnt/β-catenin 
signaling in epithelial buds and hamartomas from mice expressing an oncogene, M2SMO, 
leading to constitutive Hh signaling in skin.  Conditional overexpression of the Wnt 
pathway antagonist Dkk1 in M2SMO-expressing mice potently inhibited epithelial bud 
and hamartoma development without affecting Hh signaling, indicating pathologic Hh 
signaling brings about these changes indirectly, via canonical Wnt/β-catenin pathway.  
My findings uncover a previously unknown requirement for ligand-driven, canonical 
Wnt/β-catenin signaling for Hh-driven tumorigenesis, identify Wnt ligands as potential 
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pharmacological target for these neoplasms, and establish the molecular basis for the 
well-known similarity between early BCCs and embryonic hair germs. 
I also describe my preliminary findings showing that epithelium-specific 
activation of Hh signaling is sufficient to reactivate growth of resting hair follicles, a 
process which is normally controlled by the Wnt/β-catenin pathway.  In addition, I show 
that epithelial Hh signaling leads to robust activation of melanogenesis, and this can be 
blocked by inhibiting Wnt ligand function with Dkk1.  Taken together, these studies 
establish that a variety of responses to deregulated Hh signaling in skin, involving both 
epithelial cells and melanocytes, are strictly dependent on canonical Wnt/β-catenin 
signaling.  Moreover, they set the stage for studies further examining the biology and 







The Hedgehog (Hh) and Wnt/β-catenin signaling pathways play essential 
regulatory roles in a vast array of developmental and biological processes during both 
embryogenesis and adult life, and when deregulated, contribute to the tumorigenesis of 
many organs.  Similar to other organs, hair follicle development is dependent upon the 
coordinated and complementary functions of multiple signaling pathways in both the 
epidermal and mesenchymal compartments, including the Hh and Wnt/β-catenin 
signaling pathways.  Wnt signals are believed to be necessary and sufficient for the initial 
stages of hair follicle development, including the formation of epithelial buds, while Hh 
signaling subsequently promotes the rapid proliferation of follicle epithelium needed to 
assemble a mature follicle.  Interestingly, skin cancers driven by uncontrolled Hh 
signaling, superficial basal cell carcinomas (BCC), arise as de novo epithelial buds 
resembling embryonic hair germs, collections of epidermal cells whose development is 
regulated by Wnt/β-catenin signaling.  This intriguing morphological similarity was first 
observed by pathologists nearly 80 years ago, but the molecular basis for this 
phenomenon has been lacking.   
For my thesis project, my objective was to gain further molecular insights into the 
functions of the Hh and Wnt embryonic signaling pathways in cell fate decisions and 
cancer, using the skin as a model system.  Based on the morphological similarities 
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between Hh-driven ectopic epithelial buds and canonical Wnt-driven embryonic hair 
buds, I hypothesized that cross-talk between Hh and Wnt pathways plays important roles 
during Hh-driven skin tumorigenesis.  In this thesis, I describe the experimental designs 
and scientific methods I undertook to test my hypothesis, utilizing transgenic mouse 
models in which the functions of Hh and Wnt pathways, in skin, had been genetically 
altered.  Utilizing these mouse models, I demonstrate that over-expressing M2SMO, an 
oncogenic mutant of the Hh effector protein Smoothened (Smo) resulting in constitutive 
Hh signaling in the skin, leads to the development of de novo epithelial buds and skin 
tumors called follicular hamartomas.  I report the evidence of β-catenin-dependent Wnt 
pathway activation in these Hh-induced lesions, including upregulation of genes 
encoding multiple Wnt ligands, nuclear and cytoplasmic localization of β-catenin, and 
expression of several endogenous Wnt target genes.  Remarkably, I also demonstrate that 
transgenic conditional over-expression of the Wnt pathway antagonist Dkk1 in M2SMO 
skin potently inhibited M2SMO-driven epithelial bud and follicular hamartoma 
development without affecting Hh signaling.  The work described here uncovers a novel 
requirement for ligand-driven, canonical Wnt/β-catenin signaling for Hh pathway-driven 
tumorigenesis in skin; identifies Wnt ligands as potential pharmacological targets for 
neoplasms with deregulated Hh signaling; and establishes the molecular basis for the 
well-known similarity between early BCCs and embryonic hair germs.  Furthermore, 
these studies raise the possibility that Wnt signaling may be similarly important in other 
neoplasms associated with deregulated Hh signaling. 
Although ectopic Hh signaling drives the formation of epithelial buds resembling 
hair germs these do not go on to form mature hair follicles, probably because of the 
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absence of a mesenchymal component required for follicle development.  Utilizing a 
mouse model that expresses a stabilized, truncated β-catenin mutant that results in 
constitutive activation of Wnt/β-catenin signaling, I also demonstrate that M2SMO-
driven follicular hamartomas retain the capacity to differentiate and express multiple late-
stage hair follicle lineage markers.  Furthermore, I demonstrate that activation of this 
stabilized β-catenin mutant is sufficient to induce de novo formation of mature hair 
follicles and sebaceous glands even in hairless volar skin of adult mice, demonstrating 
that forced canonical Wnt/β-catenin signaling can reprogram even mature epidermis to 
form hair follicles.  
Finally, I also describe my preliminary findings which suggest that activation of 
Hh signaling in the epithelium of quiescent, resting hair follicles is sufficient to trigger 
new follicle growth.  In addition, I show that constitutive activation of Hh signaling in 
skin results in ectopic pigment accumulation, with an increase in the number of 
melanocytes and their progenitors as well as upregulation of multiple melanocytic 
markers, possibly by an indirect mechanism via activation of canonical Wnt/β-catenin 
signaling.   
 
Morphogenesis of the Hair Follicle: Wnt and Hh Pathways Play Sequential and 
Distinct Roles 
The hair follicle is the most prominent miniorgan of the skin, and the epidermis 
and its appendages play many critical roles in homeostasis and sustainment of life, 
including providing an essential protective barrier from a constant array of assaults and 
damages from ultraviolet radiation from sun exposure and microbes; wound healing; 
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keeping body fluids in; and helping maintain a constant body temperature against ever-
fluctuating environmental conditions (Fuchs, 2007).  During embryogenesis, the 
epidermis and early hair follicles develop from pluripotent progenitor cells (Millar, 2002) 
(Figure 1-1).  While the embryonic surface ectoderm stratifies to form the epidermis, a 
subset of surface ectodermal cells develops into hair follicles and other ectoderm-derived 
appendages (Mikkola and Millar, 2006).  It is believed that the initial signal to drive hair 
follicle development originates from the dermis, which then induces the formation of 
local thickenings (placodes) of epithelial cells, called hair buds, that grow and proliferate 
into the underlying dermis (Hardy, 1992).  It is not clear whether the initiating dermal 
signal is uniform throughout the developing epidermis, or produced individually by early 
dermal condensates to influence the development of each hair bud , but the final location 
of hair buds appears to be influenced by reaction-diffusion mechanisms involving 
competing epithelial signals (Jiang et al., 2004; Sick et al., 2006).  In mice, different 
types of hair follicles form at different stages during embryogenesis, and the molecular 
interactions among the competing signals result in the formation of a hexagonal array of 
primary hair buds that appears at approximately embryonic day 14.5 (E14.5).  These 
primary hair buds give rise to the large guard hairs, and subsequently secondary hair buds 
are initiated in several waves between E15.5 and birth, and develop into hair follicles that 
produce three morphologically distinct types of hairs, designated awl, auchene, and 
zigzag (Schmidt-Ullrich and Paus, 2005).   
 Like other organs, hair follicle development is orchestrated by a series of precise 
molecular signals traveling between overlying epithelial follicle progenitor cells and 
underlying mesenchymal condensate, which together ultimately give rise to a mature hair 
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follicle (Fuchs, 2007).  The presence of these molecular inductive signals that travel 
between the epidermis and dermis was established by pioneering studies performed 
nearly 60 years ago, with mesenchymal-epithelial tissue recombination studies using 
chick and mouse skin at different stages of embryonic development [reviewed in (Hardy, 
1992; Olivera-Martinez et al., 2004)].  More recently, the molecular identities of some of 
these signals has been established, and include the bone morphogenic proteins (BMPs) 
and their inhibitors, which negatively regulate hair bud formation and compete with Eda 
in establishing a regularly patterned placodal array; Tumor Necrosis Factor (TNF)-family 
member ectodysplasin-A (Eda), which signals via its receptor EdaR and NFκB to 
regulate primary hair bud formation; transforming growth factors-β; fibroblast growth 
factors; Wnt/β-catenin; and Sonic hedgehog (Shh) [reviewed in (Schmidt-Ullrich and 
Paus, 2005; Fuchs, 2007).  In this thesis, the roles of Wnt and Hh pathways during hair 
follicle development and tumorigenesis will be the major focus.   
Canonical Wnt/β-catenin signaling is both necessary and sufficient for the initial 
stages of hair follicle development (Gat et al., 1998; Huelsken et al., 2001; Andl et al., 
2002; Lo Celso et al., 2004), including the formation of the hair buds (Figure 1-1).  The 
hair bud, once formed, then transmits a signal of epithelial origin to the underlying 
dermis to form a mesenchymal condensate, which eventually develops into the dermal 
papilla.  Subsequently, Hh signaling promotes the massive proliferation of follicle 
epithelium needed to assemble a mature follicle, and the proliferating epithelial cells in 
the follicle epithelium envelop the developing dermal papilla to form the follicle bulb (St-
Jacques et al., 1998; Chiang et al., 1999).  Wnt signals then again play an important role 
in the differentiation of committed epithelial progenitors in the hair bulb to form late-
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stage hair follicle lineages to give rise to the seven distinct concentric layers of terminally 
differentiating cells in the mature hair follicle (Fuchs, 2007; Millar, 2002; DasGupta and 
Fuchs, 1999).  These studies demonstrate that while both canonical Wnt/β-catenin and 
Hh signaling pathways play essential roles during hair follicle development, they serve 
largely distinct, non-overlapping and sequential roles.  
Numerous studies have demonstrated the central roles of Wnt and Hh signaling 
during hair follicle development.  The developing embryonic hair buds and mesenchymal 
condensate express multiple Wnt ligands, including Wnts 10a and 10b, and also exhibit 
nuclear and cytoplasmic β-catenin localization, an indication of activated canonical 
Wnt/β-catenin signaling (DasGupta and Fuchs, 1999; Noramly et al., 1999; Reddy et al., 
2001).  Furthermore, embryonic hair buds and dermal papillae show positive β-
galactosidase expression of the Wnt reporter gene TOPgal (TCF/Lef Optimal Promoter 
β-galactosidase), where β-galactosidase expression is under the control of enhancer 
composed of multimerized TCF/Lef1 binding sites (DasGupta and Fuchs, 1999).  In 
addition, Huelsken et al. showed that skin-specific deletion of β-catenin results in a 
complete lack of hair bud formation in mice (Huelsken et al., 2001).  Similarly, Andl et al. 
showed that the constitutive over-expression of the secreted canonical Wnt inhibitor 
Dkk1 (see below for details) in skin prevents hair follicle morphogenesis from the earliest 
stages (Andl et al., 2002), and reduced hair follicle morphogenesis was also observed in 
Lef1 knockout mice (van Genderen et al., 1994), further suggesting that canonical Wnt/β-
catenin signaling is required for hair bud development in skin.  Conversely, Gat et al. 
showed that transgenic mice expressing a truncated, constitutively activated form of β-
catenin that lack the critical phosphorylation sites on the N-terminus that are needed for 
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its degradation in skin develop numerous de novo hair follicles (Gat et al., 1998).  
Similarly, Lo Celso et al. showed that the conditional over-expression of N-terminally 
truncated, stabilized β-catenin in postnatal epidermis is sufficient to drive de novo hair 
follicle morphogenesis (Lo Celso et al., 2004).   
During embryonic development, Sonic hedgehog (Shh) is produced and secreted 
by the developing hair bud.  Initial studies that mapped the expression patterns of Hh 
target genes reveal that Shh signals to both the epithelial and mesenchymal components 
of the developing hair follicle (Mill et al., 2003; Oro et al., 1997; St Jacques et al., 1998; 
Chiang et al., 1999).  Analysis of Shh-deleted skin revealed that while the initial bud 
development was not impaired in Shh-/- skin, these buds failed to proliferate and grow to 
form mature hair follicles (Chiang et al., 1999; St-Jacques et al., 1998), demonstrating the 
critical role of Hh signaling in promoting the proliferation of the growing follicle 
epithelium.  Taken together, these studies show that Wnt and Hh signaling pathways play 
essential but sequential roles during normal hair follicle development, with the Wnt 
pathway being necessary and sufficient for initiation of hair bud development.  
Hair follicles grow and proliferate at an angle to the skin, pointing from anterior 
to posterior.  Interestingly, a body of evidence also suggests a role for canonical Wnt and 
Hh signaling pathways in regulating the polarity of hair follicles.  Shh expression in hair 
and feather follicles exhibits an asymmetric pattern of localization (Gat et al., 1998; 
Morgan et al., 1998), and overexpression of Shh in embryonic chick skin causes the 
formation of feather buds that have lost their normal orientation (Ting-Berreth and 
Chuong, 1996).  Similarly, over-expression of Wnt7a, or stabilized β-catenin mutant in 
embryonic chick skin, and over-expression of Lef1 or stabilized β-catenin in transgenic 
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mouse skin resulted in altered follicular polarity (Zhou et al., 1995; Gat et al., 1998; 
Noramly et al., 1999; Widelitz et al., 1999; Widelitz et al., 2000), including the loss of 
asymmetrical Shh expression, suggesting that canonical Wnt/β-catenin signaling lies 
upstream of Shh in controlling polarity.   
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Figure 1-1.  Model for hair follicle morphogenesis.  Hair follicle morphogenesis occurs 
during embryogenesis and is initiated by the formation of hair bud, a localized collection 
of epidermal cells.  Canonical Wnt/β-catenin signaling plays an essential role during the 
initial hair bud development (see text).  Subsequently, Hh signaling plays a pivotal role in 
driving the proliferation and downgrowth needed to assemble a mature follicle.  The 
dermal condensate is enveloped by the invading epithelial cells and forms the dermal 
papilla.  Canonical Wnt/β-catenin signaling mediates the differentiation of distinct hair 
follicle cell types in the newly formed follicle, and the sebaceous gland develops 
concurrently.  Melanocytes arising from the neural crest populate the matrix and produce 
melanin to generate pigmented hair shaft.  The bulge region of the mature follicle serves 
as the stem cell niche for the follicle.  Adapted from SE Millar, 2002. 
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The Hair Cycle 
Hair follicle morphogenesis occurs during embryogenesis, and once formed, the 
number of hair follicles at birth remains constant throughout adult life (Hardy, 1992).  
The hair follicle is one of few organs that undergoes cyclic transformations for its entire 
life, from periods of regeneration and rapid growth (anagen), where key aspects of its 
embryonic development are recapitulated, to periods of massive regression via apoptotic 
mechanisms (catagen), followed by periods of rest and quiescence (telogen)  [reviewed in 
(Stenn and Paus, 2001; Paus and Cotsarelis, 1999) and (Figure 1-2)].   
These unique and remarkable features of the hair follicle, in addition to its relative 
abundance and easy accessibility, make it an extremely attractive model system.  In mice, 
hair cycling is synchronized in the dorsal skin for the first 2-3 months of life, and the 
postnatal hair cycle during the synchronized period is well characterized in C57/BL6 
mice (Paus et al., 1999b) (Figure 1-2).  During each new hair growth cycle, molecular 
events that occur during embryonic hair follicle morphogenesis are recapitulated, 
including the interplay between inductive signals that travel between the follicular 
epidermal and dermal cells.  Wnts 10a and 10b are expressed in follicle epithelial cells 
adjacent to the dermal papilla at anagen onset (Reddy et al., 2001), and the Wnt-reporter 
TOPgal gene expression is also seen in the bulge region of hair follicles at anagen onset 
(DasGupta and Fuchs, 1999).  In addition, activation of canonical Wnt signaling in 
telogen skin by expressing a 4-hydroxytamoxifen (4-OHT)-inducible stabilized, truncated 
β-catenin mutant is sufficient to trigger a new hair growth cycle (Lo Celso et al., 2004; 
Van Mater et al., 2003).  Conversely, onset of the first postnatal anagen did not occur in 
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mice that progressively lose β-catenin from the skin and hair follicles (Huelsken et al., 
2001), suggesting that canonical Wnt/β-catenin signaling plays an important role in 
providing the initiating signal to trigger anagen.  Intriguingly, adenovirus-mediated 
ectopic expression of Shh (Sato et al., 1999; Wang et al., 2000b), as well as topical 
application of synthetic Hh agonist (Paladini et al., 2005) were also sufficient to induce 
resting telogen hair follicles to re-enter anagen, suggesting that activation of the Hh 
pathway in resting hair follicles is also sufficient to induce new hair growth.  Similar to 
the growing epithelium during embryogenesis, once a new hair cycle is initiated by 
Wnt/β-catenin signaling, Hh signaling again plays an indispensable role in driving the 
proliferation of follicle epithelium (St-Jacques et al., 1998; Sato et al., 1999; Wang et al., 












Figure 1-2.  The hair cycle.  Once formed, postnatal hair follicles cycle through periods 
of rest (telogen), growth (anagen), and regression (catagen).  In mice, hair follicles reside 
in telogen for a variable amount of time, anagen for 19-21 days, and catagen for 1-2 days 
(Schmidt-Ullrich and Paus, 2005).  At the beginning of each new cycle, a signal from the 
dermal papilla activates the stem cells in the bulge (green).  This leads to rapid 
proliferation of the follicle epithelium and invagination into the dermis.  The deepest 
portion of the new growing anagen follicle contains highly proliferative matrix cells (red) 
which give rise to multiple cell lineages in the inner root sheath and hair shaft.  During 
catagen, proliferation ceases, and there is massive apoptosis, leaving behind a relatively 
small number of non-proliferative epithelial cells surround the telogen hair shaft.  It is 
within this residual epithelial cell compartment (green), that stem cells capable of giving 
rise to all cell lineages in the hair follicle, sebaceous gland, and epidermis, reside.  
Adapted from Fuchs 2007. 
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Hair Follicle Bulge: The Stem Cell Compartment 
Hair follicles contain a population of epithelial stem cells in a region known as the 
bulge (Cotsarelis et al., 1990; Taylor et al., 2000; Blanpain et al., 2004; Tumbar et al., 
2004; Morris et al., 2004) (Figure 1-2).  Stem cells in the hair follicle are needed for skin 
homeostasis, wound-healing, cyclic postnatal follicle growth, and are the likely 
progenitor cells for a variety of skin tumors.  The cells in the bulge region divide less 
frequently than other epithelial cells in the hair follicle, but are activated at each anagen 
onset to produce a population of rapidly-dividing transit-amplifying cells (Cotsarelis et al., 
1990).  The dermal papilla is believed to play a critical role in triggering new anagen by 
directly signaling to the bulge region (Stenn and Paus, 2001), due to its proximity to the 
bulge in the telogen hair follicle.  This process of bulge-cell activation has been proposed 
to also recapitulate many of the signaling pathways during embryonic hair follicle 
development.  However, despite many similarities, there also seem to be differences, and 
an area of active research in the field is in trying to gain a deeper insight into the 
relationships between the embryonic hair bud and the adult bulge.  Recently, an 
exploding body of new knowledge from multiple laboratories has shed new light on the 
complex properties of the hair follicle stem cell compartment.  Microarray profiling 
analysis studies have revealed a distinct set of genes that are preferentially expressed in 
the bulge (Blanpain et al., 2004; Tumbar et al., 2004; Morris et al., 2004), compared to 
other epithelial cells of the hair follicle.  Interestingly, while many of the bulge cells 
express TCF3, TCF4, and several Frizzled proteins, thus suggesting that many Wnt-
responsive genes are expressed in the bulge cells, they also express proteins that are 
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associated with inhibition, not activation, of Wnt signaling (Tumbar et al., 2004; Nguyen 
et al., 2006).  Additional studies have demonstrated that TCF3 can function as a repressor 
of Wnt signaling in the absence of β-catenin (Merrill et al., 2001; Nguyen et al., 2006).  
Studies have demonstrated that in their quiescent resting stage, there is an active 
suppression of the Wnt/β-catenin signaling in the bulge cells to maintain their 
undifferentiated state, and subsequently upon a Wnt activation signal, stem cells are 
activated and a new hair growth cycle is induced (Lo Celso et al., 2004; Van Mater et al., 
2003; Lowry et al., 2005).  Taken together, current data suggest that the activated β-
catenin/TCF/Lef1 in the early hair germ persists in the hair bulb (Figure 1-2) of the 
mature follicle throughout anagen, and the close proximity and interaction of this follicle 
epithelium with the neighboring dermal papilla is critical for the proper initiation of 
anagen and proliferation of epithelial cells known as the matrix cells.  As the follicle 
epithelium rapidly proliferates, the dermal papilla moves away from the bulge, and the 
rapidly proliferating matrix cells in the follicle base near the dermal papilla then undergo 
terminal differentiation to give rise to the late stage hair follicle lineages.  While there 
remain many unanswered questions on the biology and mechanism of bulge stem cell 
activation, these intriguing findings may have profound clinical applications and 
significance, as it was recently observed that human bulge stem cells share highly similar 
properties as mouse bulge stem cells (Ohyama et al., 2006).  It is likely that better 
understanding of follicle stem cell biology from mouse models may yield new therapeutic 




Canonical Wnt Signaling 
 
The Wnt family of secreted glycoproteins mediates cell-cell interactions during 
cell growth and differentiation in both embryos and adults by binding to receptors on the 
cell surface to mediate signaling transduction events to the cytoplasm and nucleus 
(Willert et al., 2003).  To date, genome sequencing has revealed 20 distinct Wnt proteins 
in vertebrates.  Wnt signaling is involved in a variety of processes throughout the body 
such as generation of cell polarity and specification of cell fate, and when deregulated, 
contributes to tumorigenesis in several organs (Clevers, 2006; Cadigan and Liu, 2006; 
Hoppler and Kavanagh, 2007).  It is now known that different Wnt ligands may 
participate in distinct signaling pathways, with the main ones broadly classified as 
“canonical” and “non-canonical” Wnt signaling pathways.  The “canonical” Wnt 
signaling pathway is a major focus of this thesis and will be discussed in detail.     
Activation of the canonical Wnt signaling pathway results when a subset of 
secreted Wnt proteins bind to Frizzled receptors and essential low-density lipoprotein 
receptor-related protein (LRP) co-receptors (Cadigan and Liu, 2006).  β-catenin is the 
key mediator of the canonical Wnt pathway, and has dual, non-overlapping functions in 
cell-cell adhesion and signal transduction (Brembeck et al., 2006).  There exist two main 
pools of β-catenin in epithelial cells: one pool forms a stable complex with the 
cytoplasmic domain of E-cadherin at cell-cell borders and tethers it to the actin 
cytoskeleton via α-catenin, and the other pool of β-catenin is found within the cytoplasm 
and/or nucleus.  In the absence of Wnt ligands, “free” cytoplasmic β-catenin is 
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phosphorylated by a multi-protein complex known as β-catenin destruction complex 
comprised of glycogen synthase kinase 3 (GSK-3β), adenomatous polyposis coli protein 
(APC), Axin, and Casein Kinase Iα (CKIα).  Under basal conditions, β-Transducin 
Repeat Containing Protein (β−TRCP) interacts with phosphorylated β-catenin, which is 
then ubiquitinated by E3 ubiquitin ligase complex and targeted for rapid proteasome-
mediated degradation mediated by 26S proteosome machinery (Aberle et al., 1997).   
Upon the binding of Wnt ligands to their Frizzled and LRP 5/6 co-receptors, a 
number of changes in the intracellular signaling machinery of responding cells take place.  
First, the cytoplasmic protein Dishevelled is phosphorylated and function of the GSK-
3β/APC/Axin/CKIα destruction complex is inhibited, leading to inhibition of β-catenin 
phosphorylation and its subsequent stabilization.  Several studies have suggested that 
Dishevelled inhibits the activities of β-catenin destruction complex by interacting with 
Frequently Rearranged in Advanced T-cell Lymphomas (FRAT)/GSK-3β Binding 
Protein (GBP) (Li et al., 1999; Farr, III et al., 2000; Salic et al., 2000).  Once stabilized in 
the cytoplasm, β-catenin then translocates into the nucleus, where it complexes with 
members of the T-Cell Factor/Lymphoid Enhancer Factors (TCF/LEF) family of DNA 
binding factors to regulate the transcription of Wnt target genes (Figure 1-3).  While 
multiple genes regulated by canonical Wnt/β-catenin signaling have been identified, 
Axin2 (Jho et al., 2002) and Sp5 (Weidinger et al., 2005) appear to be faithful target genes 
that are reliable markers of canonical Wnt signaling activaty.  In mammals, there exist 4 
members of the TCF/LEF family of transcription factors: TCF1, TCF2 (also known as 
LEF1), TCF3, and TCF4 (Clevers, 2006).  Intriguingly, when β-catenin is not present in 
the nucleus, TCF/LEF transcription factors bind to transcriptional repressors such as 
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Groucho to inhibit the transcription of Wnt target genes (Roose et al., 1998; Cavallo et al., 
1998).   
While it is clear that the canonical Wnt signaling pathway is tightly regulated via 
an elaborate and extensive intracellular regulatory machinery outlined above, a variety of 
extracellular proteins have also been identified that bind to the secreted Wnt ligands 
and/or receptors to regulate canonical Wnt signaling.  One such family of Wnt ligand 
binding proteins are the secreted frizzled-related proteins (sFRPs), which are extracellular 
factors that bind to the Wnt ligands to modulate their association with Frizzled/LRP 5/6 
co-receptors (Rattner et al., 1997).  Five sFRP genes have been discovered in verterbrates, 
named sFRP1-5; interestingly, sFRPs seem to be able to both inhibit and potentiate 
canonical Wnt signaling depending on the concentration and individual sFRP protein 
(Kawano and Kypta, 2003).  For example, while Sfrp1 has been shown to primarily 
inhibit Wnt signaling at high concentrations, in certain contexts Sfrp1 is capable of 
potentiating Wnt signaling at low concentrations (Uren et al., 2000).   
Another family of secreted proteins that regulate Wnt signaling extracellularly is 
the Dickkopf (Dkk) proteins.  Dkk1, originally identified as an inducer of head formation 
in Xenopus embryos (Glinka et al., 1998), is a potent and specific endogenous secreted 
Wnt inhibitor (Bafico et al., 2001; Mao et al., 2001; Semenov et al., 2001; Niehrs, 2006).  
How does Dkk1 inhibit canonical Wnt signaling?  It was found that Dkk1 inhibits 
canonical Wnt signaling by binding to the LRP co-receptors required for activation of 
canonical Wnt signaling, and the inhibition of Wnt signaling by Dkk1 also requires 
Kremen1 and Kremen2, transmembrane proteins that form a ternary complex with Dkk1 
and LRP 5/6 co-receptors (Mao et al., 2002).  The formation of the Dkk1-LRP5/6-
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Kremen ternary complex rapidly induces internalization and depletion of cell-surface 
LRP5/6 co-receptors and blockade of canonical Wnt signaling (Figure 1-4) (Mao et al., 
2002).  As mentioned previously, over-expression of Dkk1 in the basal layer of mouse 
epidermis effectively inhibited canonical Wnt signaling and blocked hair follicle 
morphogenesis (Andl et al., 2002).   In this mouse model, since Dkk1 is a secreted 
protein, it is likely that Dkk1 expressed in the basal cells also blocked canonical Wnt 
signaling in adjacent dermal cells in addition to the cells in the epidermis.   
 While the crucial role of LRP 5/6 co-receptors in canonical Wnt signaling has 
been established, the function of each Frizzled receptor, as well as each individual Wnt 
ligand in the canonical Wnt signaling pathway, has not been elucidated in full detail.  
Establishing the functions of each molecule in Wnt signaling is no trivial task, as a large 
number signaling components exist in vertebrates, including 20 Wnts, 10 Frizzled 
receptors, 2 LRP co-receptors, 5 Sfrp genes, 4 Dkk genes, as well as several other 
modifiers.  Furthermore, multiple Wnt ligands seem to be capable of binding to and 
interacting with multiple Frizzled receptors (Bhanot et al., 1996), and these promiscuous 
ligand-receptor interactions also add to the complexity of the Wnt signaling pathway.   
Furthermore, some of the Wnt ligands may signal through alternate “non-
canonical” pathways involving Frizzled receptors but not LRP co-receptors, β-catenin, or 
TCF/LEF factors [reviewed in (Katoh, 2005; Kohn and Moon, 2005), and may even have 
antagonistic effects on canonical Wnt signaling, adding another layer to the complex 
nature of Wnt signaling pathway.  An excellent web-based online database of Wnt 




Figure 1-3.  The canonical Wnt signaling pathway.  In the absence of a Wnt signal 
(left), free cytoplasmic β-catenin is rapidly phosphorylated by a complex of proteins 
composed of GSK-3β, APC, Axin, and CKIα.  This facilitates binding of the β-TRCP, 
which subsequently mediates the ubiquitinylation and proteosomal degradation of β-
catenin.  In the absence of β-catenin, TCF/LEF transcription factors bind to 
transcriptional repressor Groucho to repress target gene transcription.  Interaction of a 
Wnt ligand (right) with Frizzled and LRP5/6 co-receptors triggers the activation of 
Dishevelled (Dvl) which results in the inactivation of the β-catenin destruction complex.  
β-catenin is no longer phosphorylated, and this allows unphosphorylated, stabilized β-
catenin to accumulate and enter the nucleus, where it interacts with members of the 








Figure 1-4.  Dkk1 and Kremen inhibit canonical Wnt/β-catenin signaling by 
removing LRP6 from the cell surface.  A model for Dkk1/Kremen action.  LRP5/6 act 
as co-receptors for the canonical Wnt/β-catenin pathway, and the binding of a Wnt ligand 
by Frizzled and LRP5/6 co-receptors activates the canonical Wnt/β-catenin pathway (left).  
Dkk1, LRP5/6 and Kremen form a ternary complex that triggers rapid internalization and 






First identified in genetic studies of embryonic segmentation and imaginal disk 
specification in Drosophila melanogaster, Hh proteins are expressed in many tissue types 
during development and influence patterning through their effects on proliferation, cell 
death, and lineage selection in Drosophila and higher organisms [reviewed in (Lee et al., 
1992; McMahon et al., 2003; Ingham and Placzek, 2006)].  Proper Hh signaling is 
required for normal embryonic development, as fetuses with defects in Hh signaling, 
specifically involving Shh, fail to survive, and exhibit dramatic birth defects such as 
cyclopia, which is a form of holopropsencephaly (Chiang et al., 1996; Belloni et al., 
1996; Roessler et al., 1996).  The development of various other structures and tissues is 
also severely impaired in mice with Shh deficiency (Litingtung et al., 1998; St-Jacques et 
al., 1998; Chiang et al., 1999; Ramalho-Santos et al., 2000; Dassule et al., 2000; Pepicelli 
et al., 1998).   Hh proteins are secreted morphogens with different amounts of signal 
causing the recipient cells to adopt distinct cell fates.  Hh signaling is highly conserved 
from insects to vertebrates, and vertebrates have multiple homologues of a number of 
components of the pathway, including three Hh proteins in mammals: Shh, mentioned 
earlier, Indian hedgehog (Ihh), and desert hedgehog (Dhh) (Hooper and Scott, 2005).  Of 
the three, Shh is the most potent in biossays (Pathi et al., 2001) and most broadly 
expressed in embryonic and adult tissues (Altaba et al., 2002b; Altaba et al., 2002a), and 
will be the focus of discussion here.   
Shh protein undergoes extensive auto-processing and post-translational 
modifications which are essential for proper function and full activation of Hh pathway 
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(Porter et al., 1995; Porter et al., 1996).  Shh protein, initially synthesized as a 45kD 
precursor protein, is autocleaved to generate a 19kD N-terminal signaling peptide and a 
25 kD C-terminal fragment (Porter et al., 1995). The N-terminal signaling peptide is 
further processed and results in the palmitoylation of its N-terminus and covalent 
attachment of a cholesterol moiety at the C terminus (Shh-N) (Mann and Beachy, 2004).  
The fully processed, activated Shh protein is highly hydrophobic, and subsequently 
diffuses out to establish gradients of signaling via several mechanisms, including 
participating in long range signaling by multimerizing at lipid rafts with the lipid adducts 
sequestered at the centers (Zeng et al., 2001).  An alternative mechanism to control the 
extracellular transport of Shh by diffusion is via interactions with heparin sulphate 
proteoglycans (Rubin et al., 2002).  Because of these diffusion properties of Shh protein, 
in many tissues during development the cells that synthesize Shh are distinct from cells 
that respond to the signal, and while the responding cells may be adjacent to the cells 
producing the signal, they could also be a significant distance away.   
Secreted Hh ligands frequently act as paracrine signaling effectors, altering the 
functions of responsive target cells by a highly conserved signaling pathway which is 
normally maintained in an “off” state by the Hh receptor Ptch1, a 12-span transmembrane 
protein (Ingham and Placzek, 2006).  In the absence of Hh ligand, Ptch1 represses Smo, a 
7-span transmembrane, G-protein-coupled receptor (GPCR)-like protein that is an 
obligatory transducer of Hh signaling in target cells (van den and Ingham, 1996; Alcedo 
et al., 1996).  Although the exact mechanism is not yet fully clear, it is hypothesized that 
Ptch1 represses Smo by preventing Smo to localize to the cell surface [reviewed in 
(Rohatgi and Scott, 2007)].  Binding of Shh ligand to its receptor Ptch1 blocks the latter’s 
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function, thus resulting in the de-repression of Smo which ultimately leads to an altered 
pattern of gene expression in the nucleus mediated by zinc-finger proteins of the Gli 
family via actions of several intracellular proteins.  While multiple Hh/Gli target genes 
have been described, Gli1 and Ptch1 are considered ‘classical’ Hh target genes whose 
expression is consistently upregulated in response to Hh signaling, making them reliable 
markers for Hh pathway activation (McMahon et al., 2003).   
While significant insight into the molecular mechanisms regulating Hh signaling 
have been achieved in recent years, many aspects of Hh signaling are still not well 
understood.  For example, it is still not fully clear how the binding of Shh to Ptch1 de-
represses Smo, although increasing evidence shows that Ptch1 functions to inhibit Smo 
via transport of a small molecule intermediate (Bijlsma et al., 2006; Corcoran and Scott, 
2006).  The indirect interaction between Ptch1 and Smo to regulate Hh signaling has 
gained further evidence by several studies that examined the role of cholesterol 
metabolites in Hh signaling.  Bijlsma et al. showed that Ptch1 induces the secretion of 
(Pro-) Vitamin D3 from cells, and both (Pro-) Vitamin D3 and Vitamin D3 can inhibit 
Smo directly (Bijlsma et al., 2006).  Corcoran et al. showed that oxysterols, which lie 
downstream of (Pro-) Vitamin D3 in the cholesterol synthesis pathway, can activate Smo 
(Corcoran and Scott, 2006).  Several small molecules exist that modulate Smo activity, 
including purmorphamine, a Hh agonist (Sinha and Chen, 2006) and cyclopamine, a Hh 
antagonist (Chen et al., 2002). While these in vitro studies need to be confirmed in a 
more vigorous in vivo setting, these data suggest that in the absence of Shh, high levels of 
Vitamin D3 and low levels of oxysterol inhibit Smo, whereas when Shh binds Ptch1, 
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reduced transport of Vitamin D3, and increased synthesis/transport of oxysterols activate 
Smo.   
In addition, the exact molecular mechanism of how Smo signals through to the 
Gli transcription factors to mediate the activation of Hh signaling is not fully understood.  
In Drosophila, Costal-2, a kinesin-like protein, directly interacts with Smo and recruits 
downstream regulators as well as the transcription factor Cubitus interruptus (Ci) to 
mediate signal transduction (Robbins et al., 1997; Sisson et al., 1997).  However, the role 
of Kif7 and Kif27, homologs of Drosophila Costal-2, in vertebrate Hh signaling is more 
controversial.  A study by Varjosalo et al. showed that in marked contrast to Drosophila, 
major Costal-2-like functions are lost in mammalian cells; instead, Suppressor of Fused 
(SuFu), a negative regulator of the pathway that interacts with Gli proteins, plays an 
essential role in signal transduction by mediating Gli2 and Gli3 localization (Varjosalo et 
al., 2006).  Other negative regulators of Gli protein include protein kinase A (PKA) 
which phosphorylates Gli3, leading to proteosomal-mediated cleavage of Gli3 to a 
truncated form (Wang et al., 2000a; Chen et al., 1998; Hammerschmidt et al., 1996).  Hh 
signaling is also regulated via extracellular mechanisms, as the amount of Shh available 
to bind Ptch1 is tightly regulated by Hh-binding proteins, such as Hh-interacting protein 
(Hip), which sequester Hh (Chuang and McMahon, 1999).   
If the Costal-2 homolog sKif2 and Kif27 do not play essential roles in vertebrates, 
then what else could be mediating Hh signaling transduction from the plasma membrane 
to the cytoplasm?  Several studies have suggested the critical role of the primary cilium 
in vertebrate Hh signaling (Corbit et al., 2005; Haycraft et al., 2005; Huangfu and 
Anderson, 2005; Huangfu et al., 2003; Liu et al., 2005).  Cilia are microtubule-based cell-
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surface extensions built from the basal body through an intra-flagellar transport (IFT) 
assembly process.  Interestingly, initial IFT knockout studies in mice showed that these 
mice exhibited Hh-signaling-related phenotypes: for example, in the limb, where 
antagonism of Gli3 repressor plays a predominant role in digit specification, extra digit 
formation was seen in IFT mutants, but in contrast, ventral cell identities within the 
neural tube that require Gli1 activator forms were absent in IFT-defective mice (Haycraft 
et al., 2005; Huangfu and Anderson, 2005; Huangfu et al., 2003; Liu et al., 2005).  In 
addition, almost all of Hh signal transduction seem to require IFT machinery, as epistatic 
analyses studies have shown that IFT proteins act downstream of Smo and upstream or at 
the level of Gli proteins (Huangfu and Anderson, 2005; Liu et al., 2005).  Strikingly, Smo, 
Gli1/2/3 and SuFu proteins are localized to primary cilia, and it was shown that their 
accumulation in this organelle is responsive to Hh stimulation (Corbit et al., 2005; 
Haycraft et al., 2005).  Taken together, evidence gained so far suggests the primary cilia 
are of critical importance for mediating vertebrate Hh signaling, and may provide a 
function analogous to that of Costal-2 in vertebrates, linking Smo to the modulation of 
Gli factors.   
In vertebrate Hh signaling, Gli-interacting protein SuFu also appears to be 
critically important, as SuFu null mutant mouse embryos died at embryonic day E9.5 
with a gain-of-function phenotype comparable to that of Ptch1 null embryos (Varjosalo et 
al., 2006; Cooper et al., 2005).  Furthermore, it was shown that SuFu+/- mice develop 
spontaneous skin tumors, as observed in Ptch+/- mice (Svard et al., 2006).  Interestingly, 
while SuFu plays an essential role in mediating vertebrate Hh signaling, Fused (Fu) 
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mutants are essentially normal and do not exhibit obvious Hh-related phenotypes in mice 
(Chen et al., 2005; Merchant et al., 2005).  
To mediate physiological Hh signaling, Gli transcription factors undergo post-
translational processing and ultimately translocate into the nucleus where they can bind to 
their promoter recognition sites to activate transcription by direct association with a 
consensus binding site (5’-TGGGTGGTC-3’) located in the promoter region of target 
genes.  While the signaling events downstream of Smo and the exact mechanism of Gli 
activation are not fully understood, the regulation of Gli activation likely requires 
multiple proteins, as has been shown with SuFu which acts as a negative regulator by 
binding to Gli to prevent the activation of Hh target genes (Kogerman et al., 1999).  In 
Drosophila, PKA was shown to induce proteosome-mediated cleavage of Gli to a 
truncated form by phosphorylating Ci (Chen et al., 1998), and Wang et al showed that 
PKA-dependent processing of vertebrate Gli3 in developing limb similarly generates a 
potent repressor in a manner antagonized by apparent long-range signaling from 
posteriorly localized Shh protein (Wang et al., 2000a).   In mammalian cells, there exist 
three zinc finger family transcription factors, Gli1, Gli2, and Gli3.  Gli1 and Gli2 are 
thought to serve mainly as positive transcriptional activators whereas Gli3 acts as a 
transcriptional repressor (Ingham and McMahon, 2001). Interestingly, Gli1 deficient 
mice are essentially normal, suggesting that Gli1 function is dispensable in the presence 
of normal Gli2 expression (Park et al., 2000; Bai et al., 2002).  Gli3 contains both 
activation and repression domains, but in most settings where Hh ligand is not present, 
acts as a transcriptional repressor.  For example, genetic studies using Gli3-/- mice have 
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showed that loss of Gli3 can partially or completely rescue neural and limb development 
defects in Shh-/- mice (Litingtung and Chiang, 2000; Rallu et al., 2002).   
The primary activating effector of mammalian Hh signaling is Gli2.  Gli2-/- mice 
exhibit significant developmental anomalies in multiple organs, including the central 
nervous system, skeletal system, and the hair follicle (Mo et al., 1997; Matise et al., 1998; 
Mill et al., 2003), reminiscent of Hh deficiency.  These findings suggest that Gli2 is the 
primary transcriptional effector mediating physiologic responses to Shh and other Hh 
ligands.  How is Gli2 transcriptional activity regulated?  Recent studies suggest that Gli2 
exists primarily in a full length activator form, rather than a processed repressor form, 
and PKA/CKI-driven phosphorylation of C-terminal serine residues in Gli2 allows Gli2 
to directly interact with β-TrCP, resulting in ubiquitination and proteosomal degradation 
of Gli2 (Bhatia et al., 2006; Pan et al., 2006).  In addition, it has been shown that Sufu 
regulates vertebrate Gli protein subcellular distribution and transcriptional activity 
(Kogerman et al., 1999; Cheng and Bishop, 2002; Dunaeva et al., 2003; Ding et al., 1999), 
and the actin-binding protein Missing in Metastasis (MIM)/BCC_enriched gene 4 
(BEG4) has also shown to be a regulator of Gli transcription by binding to Sufu and Gli 
to potentiate Gli-dependent transcription (Callahan et al., 2004). 
Interestingly, while Wnt and Hh pathways clearly exhibit distinct roles and 
features, the two pathways share a number of similarities and signaling components, 
suggesting that certain aspects of the two pathways could have a common evolutionary 
origin (Nusse, 2003).  For example, both Wnt and Hh ligands require palmitoylation by 
acyl transferases (Wnt proteins by Porcupine and Hh proteins by Skinny Hh), and both 
require heparin-sulphate-modified proteoglycans for transport to their respective 
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receptors Fz and Ptch (Takei et al., 2004).  Smo and Fz are both 7 transmembrane 
receptors and have considerable amino-acid sequence similarity.  Furthermore, each 
pathway is mediated by a cytoplasmic complex that can be scaffolded to bring it together 
with Smo or Fz.  These complexes regulate phosphorylation, degradation and nuclear 
access of a transcriptional regulator (Ci/Gli for Hh, β-catenin for Wnt).  In each case, 
GSK3β and CKI target the transcriptional regulator for ubiquitination by Slimb; a crucial 
step for blocking signaling in the absence of ligand.  Furthermore, SuFu is found in 
complexes with β-catenin as well as Gli, and functions as a negative regulator in both 
pathways (Meng et al., 2001), further suggesting the similarity between canonical Wnt 







Figure 1-5.  The Hedgehog signaling pathway.  In the absence of Hh ligand, the Hh 
pathway is maintained in an “off” state by the inhibitory effects of Ptch1 on Smo.  Sufu 
either binds to Gli proteins, sequestering them in the cytoplasm, or binds to Gli-
responsive promoter elements, inhibiting transcription, or both.  PKA phosphorylates Gli 
proteins, leading to βTrCP-mediated uniquitination and proteosomal degradation.  In the 
presence of Hh ligand, the binding of Shh to Hh receptor Ptch1 results in the de-
repression of Smo, leading to translocation of Smo to the primary cilium.  Smo then 
associates with β-arrestin2 to be endocytosed.  Smo-mediated activation of Gli proteins 
results in translocation of the active forms of Gli1 or Gli2 to the nucleus, resulting in 
transcription of Hh target genes.  In physiologic Hh signaling, this process is reversible. 
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Wnt Signaling in Disease 
Both the Hh and Wnt pathways, with such crucial functions in regulating cell 
proliferation and differentiation programs, have been implicated in the pathogenesis of 
several types of tumors when mutated or otherwise deregulated.  The initial data implying 
Wnt signaling in tumorigenesis was the discovery of Wnt1 (originally termed int1) as an 
oncogene that can transform mouse mammary epithelial cells (Nusse and Varmus, 1982).  
Subsequently, the association of aberrant Wnt signaling with human cancer, particularly 
colorectal cancer has been extensively established.  In the early 1990s, the adenomatous 
polyposis coli (APC) gene was discovered in a hereditary cancer syndrome called 
familial adenomatous polyposis (FAP) (Kinzler et al., 1991; Nishisho et al., 1991), and 
subsequently it was determined that a germline APC mutation is the genetic cause of FAP.  
FAP patients are born with one defective APC allele, and develop a large number of 
colon adenomas, or polyps starting from early adulthood.  The polyps in FAP patients are 
benign, clonal outgrowths of epithelial cells in which the second APC allele has been 
inactivated, and eventually progress into malignant adenocarcinomas.  A majority of 
malignant colon cancers exhibit the loss of both APC alleles (Kinzler and Vogelstein, 
1996) and subsequent inappropriate activation of β-catenin.  Korinek and colleagues 
showed that TCF reporter constructs, which are normally transcribed only upon Wnt 
signaling activation, are aberrantly transcribed in APC mutant cancer cells through the 
action of both β-catenin and TCF4 (Korinek et al., 1997), further linking colon cancer 
with aberrant Wnt signaling activation.  Furthermore, a number of colorectal cancers 
were found to contain mutations in Axin2 (Liu et al., 2000), and patients with hereditary 
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Axin2 mutations display a predisposition to colon cancer (Lammi et al., 2004).  In 
addition, activating, stabilizing point mutations in β-catenin have been implicated in 
colorectal tumorigenesis (Morin et al., 1997), again illustrating that an ‘activating’ defect 
at any of multiple levels of the Wnt signaling transduction pathway may lead to colon 
cancer development.    
Mounting evidence also indicates the role of aberrant Wnt signaling in the 
pathogenesis of several other types of tumors, including hair follicle-derived tumors.  In 
the hair follicle, the transient-amplifying (TA) cells in the hair matrix compartment 
appear to be the target for neoplastic transformation by aberrant activation of canonical 
Wnt signaling.  Expression of constitutively active, oncogenic β-catenin in mice led to 
the development of hair follicle-derived trichofolliculomas and pilomatricoma-like 
lesions (Gat et al., 1998; Lo Celso et al., 2004).  In addition, Chan et al. reported that 
most human spontaneous pilomatricomas carry activating mutations in β-catenin (Chan et 
al., 1999).  In another study, Lo Celso et al. showed that expression of tamoxifen-
inducible, activated β-catenin mutant in adult mouse skin again induced 
trichofolliculomas (Lo Celso et al., 2004).  In contrast to hair follicle-derived tumors, 
approximately one-third of a series of human sebaceous tumors carry LEF1 mutations, 
impairing LEF1 binding to β-catenin and subsequent transcriptional activation (Takeda et 
al., 2006).  This observation suggests that in the absence of Wnt signaling to induce early 
progenitors cells into a hair follicle fate, progenitors may be erroneously redirected 
toward a sebocyte lineage.  During embryonic hair follicle development, sebocytes are 
derived from cells within the superficial hair follicle, and are the final differentiated cells 
to appear in the developing follicle (Figure 1-1 and (Paus et al., 1999a)).  Before birth, 
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oil-rich sebocytes form a gland located outside of the hair follicle and release their 
contents into the hair canal.  Interestingly, a recent report by Malanchi et al. demonstrated 
the critical role of Wnt/β-catenin signaling in squamous cell carcinoma, another type of 
epithelial skin cancer which expresses lineage markers of interfollicular epidermis 
(Malanchi et al., 2008).   
Activating canonical Wnt pathway mutations have been also detected in a variety 
of other cancers [reviewed in (Reya and Clevers, 2005; Clevers, 2006)] .  Loss-of-
function mutations in Axin have been detected in hepatocellular carcinomas (Satoh et al., 
2000), and aberrant Wnt signaling activation has been reported in hematological 
malignancies such as chronic myelogenous leukemia (Jamieson et al., 2004), and 
neuronal tumors such as a subset of medulloblastoma (Guessous et al., 2008; Eberhart et 
al., 2000; Koch et al., 2001).   
Interestingly, it has also been shown that several cancers feature elevated levels of 
nuclear/cytoplasmic β-catenin, a hallmark of activated canonical Wnt signaling, but in 
the absence of detectable APC, β-catenin, or Axin mutations.  How is this possible?  
Increasing evidence suggests that this may occur via epigenetic silencing of genes 
encoding natural Wnt pathway inhibitors such as sFRP (Fukui et al., 2005; Lee et al., 
2004; Liu et al., 2006) and Wnt Inhibitory Factor (WIF) (Ai et al., 2006; Batra et al., 
2006; Wissmann et al., 2003), or increased expression of pathway components such as 
Wnt ligands (Clement et al., 2006; Katoh et al., 2001; Milovanovic et al., 2004; Rhee et 
al., 2002; Sen et al., 2001), FZD receptors (To et al., 2001; Kirikoshi et al., 2001), and 
Dvl family members (Uematsu et al., 2003a; Uematsu et al., 2003b).   
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It is clear that aberrant activation of canonical Wnt signaling plays a major role in 
the pathogenesis of a broad spectrum of human cancers and diseases, and further insight 
into the molecular pathogenesis will enable the discovery of novel drugs and therapies for 
clinical use. 
 
Hh Signaling in Disease 
In addition to the critical role Hh signaling plays during embryonic development 
[reviewed in (McMahon et al., 2003)], Hh signaling also directs the formation or the 
persistence of certain stem- and precursor-cell populations in adults (Ahn and Joyner, 
2005; Baron, 2003; Machold et al., 2003; Palma and Altaba, 2004; Adolphe et al., 2004).  
Mutations in Hh pathway involving multiple key components have been implicated in 
several human anomalies, including holoprosencephaly and the nevoid basal cell 
carcinoma syndrome (NBCCS) [reviewed in (Mullor et al., 2002b)].  Furthermore, 
aberrant, constitutive activation of Hh pathway can contribute to tumorigenesis in 
multiple organs, including basal cell carcinoma (BCC) and basaloid follicular hamartoma 
in skin, medulloblastoma in brain, and embryonal rhabdosarcoma in muscle (Altaba et al., 
2002b; Altaba et al., 2002a; Mullor et al., 2002a; Wetmore, 2003).  Moreover, Hh 
pathway has also been implicated in tumors arising in the lungs, digestive and urogenital 
tracts, and hematopoietic system (Berman et al., 2003; Karhadkar et al., 2004; Thayer et 
al., 2003; Watkins et al., 2003; Dierks et al., 2007), further demonstrating that the Hh 
pathway exerts its effects in a wide variety of tissues and organs, and its deregulation 
plays a critical role in the pathogenesis of multiple tumor types.  Several Hh target genes, 
such as Bcl2, Cyclins D1 and D2, and FoxM1 are directly involved in cell cycle 
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regulation and cell survival, and it is conceivable that the activation of these genes 
directly contributes to the initiation and proliferation of Hh pathway-associated tumors. 
BCC is the most common type of cancer in light-skinned individuals with more 
than a million new cases diagnosed in the US each year, and although it rarely 
metastasizes, BCC can cause significant morbidity due to local invasion (Tang et al., 
2007).  A predisposition to skin cancer is associated with several genetic disorders 
including albinism, xeroderma pigmentosum and the NBCCS, also known as the Gorlin 
syndrome (ya-Grosjean and Couve-Privat, 2005).  Gorlin syndrome, inherited in an 
autosomal dominant manner, is characterized by multiple developmental anomalies and 
predisposition to several cancers (Gorlin, 1995).  Clinical features include odontogenic 
keratocysts, facial dysmorphism with macrocephaly, skeletal abnormalities, basal cell 
nevi, ovarian fibromas, medulloblastomas, neuroectodermal tumors and BCCs in skin 
(Manfredi et al., 2004).  Analysis of Gorlin syndrome patients helped establish the 
molecular basis of BCC tumorigenesis.  Linkage analysis revealed the locus for the tumor 
suppressor gene PTCH1, the human homologue of Drosophila Ptc located on 
chromosome 9q22-31, was implicated in Gorlin syndrome  (Farndon et al., 1992; Gailani 
et al., 1992).  Germline mutations of PTCH1 observed in Gorlin patients (Hahn et al., 
1996; Johnson et al., 1996) as well as frequent loss of heterozygosity at 9q22 found in 
other Gorlin syndrome-associated tumors (Vorechovsky et al., 1997b; Vorechovsky et al., 
1997a) clearly linked aberrant Hh pathway with BCC tumorigenesis.  Furthermore, 
mutations affecting several genes leading to aberrant Hh pathway activation have been 
identified in sporadic BCCs, including loss-of-function mutations in PTCH1 and gain-of-
function mutations in SMO (Hahn et al., 1996; Johnson et al., 1996; Xie et al., 1998).  
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Moreover, nearly all human BCCs exhibit evidence of elevated Hh signaling activity, 
further implicating the obligatory role of activated Hh signaling in BCC development and 
maintenance, regardless of the underlying genetic defect.    
Genetically engineered mice have been essential and invaluable scientific tools 
for dissecting out the molecular mechanisms of disease. Not surprisingly, both gain-of-
function as well as loss-of-function genetic studies utilizing transgenic mouse models 
with targeted manipulation of Hh signaling mediators at multiple levels – Shh, Ptch, Smo 
and Gli – have uncovered important insights into the role of Hh signaling in skin diseases, 
and these animal models support the notion that uncontrolled Hh pathway activation is 
sufficient to drive BCC- or BCC-like tumorigenesis in mice (Oro et al., 1997; Xie et al., 
1998; Aszterbaum et al., 1999; Grachtchouk et al., 2000; Nilsson et al., 2000; 
Grachtchouk et al., 2003; Hutchin et al., 2005).  Oro and his colleagues showed that over-
expression of Shh in the skin of transgenic mice using a keratin 14 (K14) promoter 
induced the development of early BCC-like tumors (Oro et al., 1997).  However, K14-
Shh mice die shortly after birth, and it is unclear whether these early BCC-like tumors 
can progress to form full-blown BCCs in adult life, or whether activation of Shh 
expression in postnatal adult skin is also sufficient to drive BCC-like tumor development.  
Fan et al. showed that the regenerated human skin transgenic for Shh when grafted onto 
immune deficient mice displayed abnormal BCC-like tumors (Fan et al., 1997).  In 
addition, Xie et al. showed that the expression of M2SMO under the 5.2 kb keratin 5 
(K5) promoter was sufficient to induce development of BCC-like tumors in newborn skin 
(Xie et al., 1998), although these mice also failed to survive after birth. Work from 
several laboratories has also shown that over-expression of Gli1 or Gli2 in transgenic 
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mouse skin is sufficient to drive BCC or BCC-like tumor development, implicating Gli 
transcription factors as mediators of oncogenic Hh signaling.  Mice expressing Gli2 
driven by a K5 promoter develop numerous BCCs on their skin within 3 months of age 
(Grachtchouk et al., 2000).  K5-Gli2 BCCs share similar gross and histological 
appearances with human BCCs, and also exhibit a high level of Hh pathway activation as 
assessed by robust Gli1 and Ptch1 expression (Grachtchouk et al., 2000).  Similarly, 
Nilsson and colleagues showed that expression of human GLI1 in mice under K5 
promoter induced development of a variety of skin tumors, incuding trichoepitheliomas 
and, rarely, BCCs (Nilsson et al., 2000).   
Interestingly, analysis of adult transgenic mice expressing a constitutively 
activated mutant form of Smo, M2SMO, revealed that these mice did not develop BCC, 
but rather developed benign follicular hamartoma, a benign, slow-growing, and relatively 
undifferentiated skin tumor that expresses BCC protein markers and expands into the 
underlying dermis (Grachtchouk et al., 2003).  The lack of BCC development in 
M2SMO-expressing mice may be explained by the lower level of Hh signaling activation 
in mice expressing M2SMO relative to mice expressing Gli2, as assessed by relatively 





Figure 1-6.  Models of Hh pathway activation in human cancers.. (a) HH ligand 
overexpression is associated with esophageal, gastric, pancreatic, breast, prostate, small-
cell lung cancer, and B cell neoplasms.  (b) Loss of function mutations in PTCH1 are 
seen in basal cell carcinoma and medulloblastoma.  (c) Pathway-activating SMO 
mutations have been found in basal cell carcinomas and medulloblastomas, as well.  
These mutations render SMO insensitive to PTCH1 inhibition, irrespective of HH ligand 
status.  (d) GLI2 amplification has been reported in squamous cell carcinoma (Snijders et 
al., 2005).  (e) Loss of function mutations of SUFU are seen in medulloblastoma and 




BCC is classified histologically according to morphology, and includes nodular, 
micronodular, infiltrative and superficial forms (Sexton et al., 1990; Fuchs, 2008).  In 
particular, superficial BCC is characterized by epithelial buds of proliferating basal cells 
that grow down from the epidermis into the superficial dermis, maintaining their 
attachment to the basal cell layer.  Intriguingly, these Hh-driven superficial BCC share a 
striking morphological similarity with embryonic Wnt-driven hair germs (Lever, 1948; 
Montgomery, 1935; Sellheyer and Krahl, 2008; El-Bahrawy et al., 2003; Kumakiri and 
Hashimoto, 1978), but the molecular basis for this similarity is not known.  Do 
superficial BCCs resemble embryonic hair buds because similar pathways are utilized 
during BCC development and early stages of hair follicle morphogenesis?  Is the Hh-
driven ectopic bud development a direct effect of Hh signaling, or is it indirect?  With 
two distinct signaling pathways giving rise to similar-appearing epithelial structures, it is 
conceivable that ectopic Hh pathway activation drives de novo bud development 
indirectly, via the canonical Wnt pathway.  This possibility is strengthened by a previous 
report in Xenopus showing that Gli proteins activate expression of Wnt ligands (Mullor et 
al., 2001).  Does Hh signaling similarly influence expression of Wnt genes and canonical 
Wnt signaling in skin?  Perhaps most importantly, is canonical Wnt signaling required for 
Hh-mediated development of epithelial hair buds, follicular hamartomas, or BCCs that 
arise from constitutive Hh signaling in skin?  What are the effects of heightened Hh or 
canonical Wnt signaling on hairless epidermis?   I was in a unique position to address 
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these questions utilizing the powerful genetic mouse models in which the functions of Hh 
and canonical Wnt signaling pathways have been altered.  
In addition, while previous reports have found that canonical Wnt activation in 
resting telogen hair follicles is sufficient to trigger a new hair follicle growth cycle (Van 
Mater et al., 2003; Lo Celso et al., 2004), other studies have indicated that ‘unscheduled’ 
Hh pathway activation is also sufficient to induce a new hair growth cycle in mice (Sato 
et al., 1999; Paladini et al., 2005).  However, in these studies, Hh activation was likely 
induced in both the epidermal and dermal cells, and it is unclear in which cell population 
Hh signaling must be activated to trigger the anagen growth phase.  Several important 
questions remain to be answered stemming from these observations.  What is the 
molecular explanation for this phenomenon?  Could Hh activation be triggering a new 
growth cycle indirectly by stimulating Wnt signaling pathway in resting hair follicles?  
Does Shh act directly on hair follicle stem cells to reactivate growth and trigger a new 
growth phase?  Is epithelial-specific Hh signaling sufficient to initiate new follicle 
formation?  Utilizing novel mouse models that allow precise spatial and temporal control 
of Hh signaling activity in the cutaneous epithelium, I describe results that address these 
questions and provide new insights into hair follicle biology. 
 
Summary 
The Hh and canonical Wnt/β-catenin signaling pathways play pivotal roles in a 
variety of developmental and biological processes during embryogenesis and adult life, 
and when deregulated, contribute to the pathogenesis of many tumors.  In this thesis, I 
address the aforementioned questions utilizing constitutive as well as inducible transgenic 
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mouse models in which I have modulated the Hh and Wnt signaling pathways.  In 
Chapter II, I describe our findings as we investigated the potential involvement of Wnt 
signaling in superficial human BCCs and a mouse model expressing the Hh pathway 
effector, M2SMO.  I show that similar to embryonic human hair germs, BCC buds 
exhibited elevated levels of nuclear and cytoplasmic β-catenin, a marker of canonical 
Wnt signaling, and expressed the early hair follicle lineage markers Sox9, K17, and 
CCAAT displacement protein (CDP).  Similar changes, along with expression of multiple 
Wnt genes, Tcf4, activated β-catenin, and the Wnt target genes Axin2 and Sp5, were 
detected in M2SMO-expressing mouse skin containing epithelial buds and follicular 
hamartomas.  I also show that by selectively blocking canonical Wnt signaling by 
conditional over-expression of the potent Wnt inhibitor Dkk1, epithelial bud and 
hamartoma development in M2SMO mice was blocked, despite continued Hh signaling.  
Thus, I demonstrate an essential function for the canonical Wnt pathway downstream of 
pathologic Hh signaling in skin.   
In Chapter 3, I show that forced activation of canonical Wnt signaling is sufficient 
to drive advanced hair follicle differentiation in both normal and M2SMO-skin by taking 
advantage of Cre-inducible Ctnnb1(Ex3)fl/fl transgenic mice (Harada et al., 1999). 
Ctnnb1(Ex3)fl/fl mice express a stabilized, mutant β-catenin that lacks the critical 
phosphorylation sites on exon 3 necessary for its degradation when crossed with a 
taxomifen-inducible, skin-specific Cre-driver K5-CreERT2 (Indra et al., 1999) mice.  
Utilizing doxycycline-inducible K5-rtTA (Diamond et al., 2000);TRE-SmoA1 (developed 
by fellow MSTP student Evan Michael in the Dlugosz laboratory) bitransgenic mice, I 
also show that epithelial-specific Hh activation in quiescent resting telogen follicles is 
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sufficient to trigger new anagen growth cycle (Chapter 4).  Finally, I also present data 
showing that ectopic Hh signaling in murine skin leads to de novo melanogenesis and 
accumulation of pigment, and that this process may be mediated indirectly by activation 
of the canonical Wnt signaling pathway (Chapter 5).   
By examining the complex interactions between Hh and Wnt pathways during 
pathogenesis of skin tumors driven by ectopic Hh signaling, my thesis work uncovers a 
novel requirement for canonical Wnt signaling downstream of pathologic Hh signaling in 
skin.  The results described in this thesis provide novel insights into how the precisely-
regulated interactions between the Hh and canonical Wnt pathways are perturbed in 
pathology, and provides exciting relevance for investigating the potential Hh-Wnt 
crosstalk in other neoplasms.     
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Pathological responses to oncogenic Hedgehog signaling in skin are dependent on 
canonical Wnt/β-catenin signaling∗ 
Summary 
Constitutive Hh signaling underlies several human tumors (Rubin and de Sauvage, 
2006), including basal cell carcinoma (BCC) and basaloid follicular hamartoma in skin 
(Grachtchouk et al., 2003; ya-Grosjean and Couve-Privat, 2005).  Intriguingly, superficial 
BCCs arise as de novo epithelial buds resembling embryonic hair germs (Lever, 1948; 
Montgomery, 1935; Sellheyer and Krahl, 2008), collections of epidermal cells whose 
development is regulated by canonical Wnt/β-catenin signaling (Andl et al., 2002; 
Huelsken et al., 2001).  Similar to embryonic hair germs, human BCC buds exhibited 
increased levels of cytoplasmic and nuclear β-catenin, and expressed early hair follicle 
lineage markers.  We also detected canonical Wnt/β-catenin signaling in epithelial buds 
and hamartomas from mice expressing an oncogene, M2SMO (Xie et al., 1998), leading 
to constitutive Hh signaling in skin.  Conditional overexpression of the Wnt pathway 
antagonist Dkk1 in M2SMO-expressing mice potently inhibited epithelial bud and 
hamartoma development without affecting Hh signaling.  Our findings uncover a hitherto 
unknown requirement for ligand-driven, canonical Wnt/β-catenin signaling for Hh 
                                                          
∗ Most of this chapter represents a subset of the data from a published manuscript: Yang, S.H., et al. (2008). 
“Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/β-
catenin signaling.” Nat Genet (in press). 
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pathway-driven tumorigenesis, identify a new pharmacological target for these neoplasms, 
and establish the molecular basis for the well-known similarity between early BCCs and 
embryonic hair germs. 
 
Introduction 
As described in Chapter I, hair follicle development is orchestrated by a series of 
inductive signals involving epithelial and mesenchymal hair follicle progenitors and their 
progeny, and includes the BMPs and their inhibitors, transforming growth factors-β, 
fibroblast growth factors, and the Wnt, Eda/Edar, and Hedgehog (Hh) pathways (Fuchs, 
2007).  Canonical Wnt signaling is both necessary and sufficient for the initial stages of 
hair follicle development (Andl et al., 2002; Gat et al., 1998; Huelsken et al., 2001; Lo 
Celso et al., 2004), including the formation of embryonic hair buds, while Hh signaling 
subsequently promotes the massive proliferation of follicle epithelium needed to 
assemble a mature follicle (Chiang et al., 1999; St-Jacques et al., 1998).  Wnt signals then 
play an important role in the differentiation of committed epithelial progenitors to form 
late-stage hair follicle lineages (DasGupta and Fuchs, 1999; Fuchs, 2007;Millar, 2002).  
In addition to its functions in hair follicle development, Wnt signaling is involved 
in multiple other processes throughout the body, and when deregulated, contributes to 
tumorigenesis in several organs (Cadigan and Liu, 2006; Clevers, 2006; Hoppler and 
Kavanagh, 2007).  Binding of a subset of secreted Wnt proteins to Frizzled receptors and 
low-density lipoprotein receptor-related protein (LRP) co-receptors activates a conserved 
“canonical” Wnt signaling pathway (Cadigan and Liu, 2006).  β-catenin is a critical 
mediator of the canonical Wnt pathway, a protein that has dual, non-overlapping 
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functions: cell-cell adhesion and signal transduction (Brembeck et al., 2006).  There exist 
two main pools of β-catenin in epithelial cells: one pool forms a stable complex with the 
cytoplasmic domain of E-cadherin at cell-cell borders, and the other pool is within the 
cytoplasm and/or nucleus.  In the absence of Wnt ligands, “free” cytoplasmic β-catenin is 
phosphorylated by glycogen synthase kinase 3 (GSK-3β), which is complexed with 
adenomatous polyposis coli protein (APC), and Axin.  Under basal conditions, βTrCP 
interacts with phosphorylated β-catenin, which is ubiquitinated and targeted for rapid 
proteasome-mediated degradation.  When Wnt proteins bind to their Frizzled/LRP co-
receptors, the cytoplasmic protein Dishevelled is phosphorylated and function of the 
GSK-3β/APC/Axin destruction complex is inhibited, leading to inhibition of β-catenin 
phosphorylation and its stabilization.  In the nucleus, β-catenin complexes with members 
of the LEF/TCF family of DNA binding factors to regulate transcription of Wnt target 
genes.  While multiple canonical Wnt target genes exist, Axin2 (Jho et al., 2002) and Sp5 
(Weidinger et al., 2005) have shown to be faithful target genes, and along with 
nuclear/cytoplasmic β-catenin localization, may be used as reliable markers for canonical 
Wnt pathway activation.  
A number of extracellular proteins have been identified that bind to the secreted 
Wnt ligands and/or receptors to regulate canonical Wnt signaling, including Dkk1.  Dkk1, 
originally identified as an inducer of head formation in Xenopus embryos, is a potent and 
specific endogenous secreted Wnt inhibitor, and inhibits canonical Wnt signaling by 
binding to the LRP co-receptors required for activation of canonical Wnt signaling 
(Bafico et al., 2001; Mao et al., 2001).  The inhibition of Wnt signaling by Dkk1 also 
requires Kremen1 and Kremen2, transmembrane proteins that form a ternary complex 
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with Dkk1 and LRP 5/6 co-receptors (Mao et al., 2002).  The formation of the Dkk1-
LRP5/6-Kremen ternary complex rapidly induces internalization and depletion of cell-
surface LRP5/6 co-receptors and blockade of canonical Wnt signaling (Mao et al., 2002). 
Hh ligands are expressed in many embryonic tissues and influence patterning 
through their effects on proliferation, cell death, and lineage selection (Ingham and 
Placzek, 2006; Rubin and de Sauvage, 2006).  After birth, proper Hh signaling is required 
to maintain normal cell proliferation and survival in adult tissues, and deregulated Hh 
signaling is associated with the development of several types of neoplasms (Roessler et 
al., 1996).  Secreted Hh ligands frequently act as  paracrine signaling effectors, altering 
the function of responsive target cells by a highly conserved signaling pathway which is 
normally maintained in an “off” state by the Hh receptor Ptch1 (Ingham and Placzek, 
2006).  In the absence of Hh ligand, Ptch1 represses Smoothened (Smo), an obligatory 
transducer of Hh signaling in target cells.  Binding of Hh ligand to Ptch1 blocks its 
function, resulting in derepression of Smo which ultimately leads to an altered pattern of 
gene expression mediated by zinc-finger proteins of the Gli family (Gli1, Gli2, and Gli3) 
(ya-Grosjean and Couve-Privat, 2005).  Gli1 and Ptch1 are considered ‘classical’ Hh 
target genes whose expression is consistently upregulated in response to Hh signaling, 
making them reliable markers for Hh pathway activation (McMahon et al., 2003).  
In hair follicles, Hh pathway plays an indispensable role in driving proliferation 
of follicle epithelium during development and the postnatal hair cycle (Altaba et al., 
2002; Sato et al., 1999; St-Jacques et al., 1998; Wang et al., 2000), which include phases 
of growth (anagen), regression (catagen), and rest (telogen).  Normally, Hh signaling in 
hair follicle epithelium is tightly regulated and restricted to the initial development of the 
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follicle, and the growth phase of the hair cycle after birth.  In contrast, sustained Hh 
signaling is associated with the development of several types of ‘follicular’ tumors, 
including BCC, trichoepithelioma, and basaloid follicular hamartoma.   
BCC is the most common type of cancer in light-skinned individuals with more 
than a million new cases diagnosed in the US each year, and although it rarely 
metastasizes, BCC can cause significant morbidity due to local invasion (Tang et al., 
2007).  Mutations affecting several genes leading to aberrant Hh pathway activation have 
been identified in BCC, including loss-of-function mutations in PTCH1 and gain-of-
function mutations in SMO (Hahn et al., 1996; Johnson et al., 1996; Xie et al., 1998).  
Moreover, nearly all human BCCs exhibit evidence of elevated Hh signaling activity, and 
several animal  models support the notion that uncontrolled Hh pathway activation is 
sufficient to drive BCC- or BCC-like tumorigenesis in mice (Aszterbaum et al., 1999; 
Grachtchouk et al., 2000; Grachtchouk et al., 2003; Hutchin et al., 2005; Nilsson et al., 
2000; Oro et al., 1997; Xie et al., 1998).  
BCC is classified histologically according to morphology, and includes nodular, 
micronodular, infiltrative and superficial forms (Sexton et al., 1990).  In superficial BCC, 
epithelial buds of proliferating basal cells grow down from the epidermis into the 
superficial dermis, maintaining their attachment to the basal cell layer.  Pathologists have 
long noted the morphological similarity between focal epidermal downgrowths in BCC 
and embryonic hair germs (El-Bahrawy et al., 2003; Kumakiri and Hashimoto, 1978; 
Lever, 1948; Montgomery, 1935), raising the possibility that: A) similar pathways are 
utilized during BCC development and early stages of hair follicle morphogenesis; and B) 
canonical Wnt signaling is involved indirectly in pathologic responses to deregulated Hh 
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signaling in skin.  While some prior studies have identified coordinate changes in the Hh 
and canonical Wnt pathways in BCCs and other neoplasms (El-Bahrawy et al., 2003; Li 
et al., 2007; Mullor et al., 2001; Pasca di Magliano et al., 2007; Saldanha et al., 2004; 
Taipale and Beachy, 2001; Yamazaki et al., 2001), direct evidence establishing the 
functional significance of Wnt signaling in Hh pathway-driven pathology in vivo is 
lacking. 
Using M2SMO-expressing transgenic mice as a model system, we tested whether 
pathological Hh signaling in skin leads to the formation of hair-bud like structures 
indirectly, via canonical Wnt signaling, the physiological stimulus for hair bud formation 
in embryos.  We show upregulation of multiple canonical Wnt genes, nuclear and 
cytoplasmic redistribution of β-catenin, and upregulation of endogenous Wnt target genes 
Axin2 and Sp5 in M2SMO-expressing mouse skin.  Moreover, using a doxycycline-
regulated transgenic mouse expressing the canonical Wnt inhibitor Dkk1, we show that 
ectopic bud formation and expansion require canonical Wnt signaling activity.  Our 
findings establish a pivotal role of Hh-Wnt interactions in the pathogenesis of a epithelial 
buds and hamartomas driven by aberrant Hh signaling, and provide a molecular 
explanation for the morphological and biochemical similarity between early BCC and 
embryonic hair germs. 
 
Materials and Methods 
Transgenic mice and conditional transgene activation.   
To focally activate Hh signaling in skin, we crossed K5-flxGFP-M2SMO mice 
(Allen et al., 2003), which harbor a Cre-inducible M2SMO allele, with tamoxifen-
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inducible K5-CreERT2 (Indra et al., 1999) mice (provided by Pierre Chambon and Daniel 
Metzger).  Low level (“leaky”) recombinase activity of CreERT2, in the absence of 
tamoxifen, resulted in ectopic expression of M2SMO in skin (Allen et al., 2003).  To 
generate triple transgenic mice with epithelial expression of M2SMO and doxycycline-
inducible Dkk1 expression, ΔK5-M2SMO mice (Grachtchouk et al., 2003) were first 
crossed with K5-rtTA (Diamond et al., 2000) mice.  ΔK5-M2SMO;K5-rtTA mice were 
then crossed with TRE-Dkk1 (Chu et al., 2004) mice, to generate ΔK5-M2SMO;K5-
rtTA;TRE-Dkk1 mice, designated M2SMO+Dkk1 when treated with doxycycline to 
induce Dkk1 expression.  To induce Dkk1 expression in M2SMO+Dkk1 mice, 
doxycycline (20 mg/ml) was administered in drinking water with 5% sucrose, and in 
doxycycline-containing chow (Bio-serve, 200 mg/kg).  After three days, mice were 
maintained on doxycycline-containing chow but received normal drinking water.  All 
mice were housed and maintained according to University of Michigan institutional 
guidelines, as stipulated by the University Committee on the Use and Care of Animals. 
 
Tissue harvesting and wholemount preparation.   
Human superficial BCCs were obtained from the Cutaneous Surgery and 
Oncology Unit, Department of Dermatology, University of Michigan Medical School, 
according to an IRB-approved protocol (IRBMED 2000-0015).  Embryonic human skin 
was obtained from Advanced Bioscience Resources.  For hematoxylin and eosin (H&E) 
staining and immunohistochemistry, human and mouse skin samples were fixed in 
neutral-buffered formalin (NBF) overnight, transferred to 70% ethanol, processed, and 
embedded in paraffin.  Mouse skin was also embedded in OCT Compound (Tissue-Tek) 
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for frozen sections.  To prepare whole-mounts of volar skin, mice were euthanized and 
ventral hind limb skin was removed.  Volar skin was microdissected and whole-mount 
preparation was performed essentially as described previously for tail skin (Braun et al., 
2003).  Transilluminated whole mount images were captured with a digital camera 
(Diagnostic Instruments Spot RT3) mounted on a dissecting stereomicroscope (Leica 
MZFL3), using Spot Software Version 4.6 (Diagnostic Instruments).   
 
Immunostaining.   
The following primary antibodies were used for immunostaining: K1 (rabbit 
polyclonal, 1:1,000, Covance); K5 (rabbit polyclonal, 1:2,000, Covance); K17 (rabbit 
polyclonal, 1:4,000, gift from P. Coulombe); β-catenin (mouse monoclonal, 1:1,000, 
Sigma); Sox9 (rabbit polyclonal, 1:1,000, Chemicon); CDP (rabbit polyclonal, 1:100, 
Santa Cruz); Ki67 (rabbit polyclonal, 1:500, Vector Laboratories);  AE13 (1:10, gift from 
Henry Sun); AE15 (1:50, gift from Henry Sun); P-cadherin (rat monoclonal, 1:500, 
Zymed); E-cadherin (rat monoclonal, 1:1,000, Zymed); Cyclin D1 (rabbit polyclonal, 
1:1,000, Neomarkers).  For immunohistochemistry, 8 μm sections were cut in a 
parasagittal plane.  For all antibodies except for AE13, AE15, P- and E-cadherin, 
immunoreactivity of antigens was restored by immersing slides in boiling 0.01 M citrate 
buffer, pH ~6, for 10 min.  Blocking was performed using 1.5% normal goat serum in 
phosphate-buffered saline (PBS), and tissue sections were incubated with primary 
antibodies diluted in PBS containing 1% bovine serum albumin, typically for 1-3 h at 
room temperature (21-23 ºC).  Subsequent immunostaining procedures were performed 
using peroxidase Vectastain ABC kit (Vector Laboratories) and 3,3’-diaminobenzidine 
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(DAB) as a substrate, according to the manufacturer’s protocol.  A M.O.M. kit (Vector 
Laboratories) was used for immunostaining with mouse primary monoclonal antibodies 
according to the manufacturer’s protocol.  Sections were counter-stained with 
hematoxylin and mounted using Permount (Fisher Scientific).  For immunofluorescence 
staining, sections were cut from OCT-embedded blocks and fixed in cold acetone for 10 
minutes.  FITC-conjugated secondary antibodies (Jackson ImmunoResearch) were used 
at 1:75 dilution, and 100 ng/ml 4-diamidino-2-phenylindole (DAPI, Merck) was used for 
nuclear counterstaining.  Endogenous alkaline phosphatase activity was visualized using 
Alkaline Phosphatase Substrate Kit I (Vector Laboratories) and incubating tissue sections 
with substrate solution for 2-4 h at room temperature.  
 
Immunoblotting.   
Tissue was homogenized in RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% 
Triton X-100, 0.5 mM EDTA, 1 mM sodium orthovanadate, 200 mM sodium fluoride) 
using tissue microgrinder (Kontes 749520), vortexed vigorously, cleared by 
centrifugation for 15 min at 12,000 x g, and denatured by heating at 98 ºC for 5 min.  10 
μl of protein extract was resolved on a 10% (w/v) denaturing SDS poly-acrylamide gel 
(BioRad) and transferred to nitrocellulose membrane.  “Activated” β-catenin was 
detected by probing with α-activated β-catenin (αABC) antibody (mouse monoclonal, 
1:1,000, Upstate).  Pan-actin antibody (mouse monoclonal, 1:1,000, Labvision) was used 
to detect actin for loading control.  Peroxidase-conjugated secondary antibodies were 




RNA isolation and semiquantitative RT-PCR.   
Volar, tail, and postnatal day 8 dorsal skin were homogenized in Trizol 
(Invitrogen) using a mechanical grinder (PowerGen700, Fisher Scientific), and lysates 
stored at -80°C until further processing.  RNA isolation, first strand cDNA synthesis, and 
RT-PCR were performed as described previously, with minor modifications(Allen et al., 
2003).  Primer sequences are listed in Supplementary Table 1. 
 





Gene Forward Primer Reverse Primer Size (bp)
Actin(Walterhouse 




GTCGGAAGTCCTATTCACGC CAGTCTGCTCTCTTCCCTGC 364 
Ptch1(Takabatake 
et al., 1997) AACAAAAATTCAACCAAACCTC TGTCTTCATTCCAGTTGATGTG 243 
Tcf4 CAGCTCAAAGCATCAGGACTC CTGTTGATCAAGGCCAAAGCGC 338
Axin2(Kim et al., 
2005) CAGGAGCCTCACCCTTCG ACGCCGAGGTGCTTGCCC 402 
Sp5  ACACCAGGGTACTTGCCATC AATCGGGCCTAGCAAAAACT 305 
Cyclin 
D1(Berman et al., 
2002) 
CTCTGGCTCTGTGCCTTTCT CCGGAGACTCAGAGCAAATC 646 
Wnt2(Liu et al., 
2003) CGGCCTTTGTTTACGCCATC TGAATACAGTAGTCTGGAGAA 496 
Wnt3(Liu et al., 
2003) GCCGACTTCGGGGTGCTGGT CTTGAAGAGCGCGTACTTAG 320 
Wnt4(Liu et al., 
2003) TGTACCTGGCCAAGCTGTCAT TCCGGTCACAGCCACACTT 330 
Wnt5a(Liu et al., 
2003) TCCTATGAGAGCGCACGCAT CAGCTTGCCCCGGCTGTTGA 230 
Wnt7b(Liu et al., 
2003) ACCGTCTTCGGGCAAGAACT CCTGGCGTTCTTTTTGATCT 260 
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Wnt10a(Liu et al., 
2003) AAAGTCCCCTACGAGAGCCC CAGCTTCCGACGGAAAGCTT 180 
Wnt10b(Liu et al., 
2003) CGGCTGCCGCACCACAGCGC CAGCTTGGCTCTAAGCCGGT 180 
Wnt11(Liu et al., 
2003) GCCATGAAGGCCTGCCGTAG GATGGTGTGACTGATGGTGG 160 
Wnt13(Liu et al., 





Expression of similar lineage markers in human superficial BCCs and embryonic 
hair buds 
Both human superficial BCCs and embryonic hair buds, comprised a focal 
grouping of epidermal cells protruding into the underlying dermis (Figure 2-1), and 
expressed early-stage follicle lineage markers, including the outer root sheath markers 
K17 (Jih et al., 2003) and Sox9 (Oseroff et al., 2005), and the hair matrix/inner root 
sheath marker CDP (Callahan et al., 2004) (Figure 2-1c,d,g-j).  However, in contrast to 
the non-overlapping distribution of cells expressing Sox9 and CDP in embryonic hair 
buds (brackets in Figure 2-1h,j), these lineage markers appeared to be co-expressed in 
cells of human superficial BCC (Figure 2-1g,i).   Epithelial cells in both the superficial 
BCCs and embryonic hair buds were more proliferative, based on Ki67-immunostaining, 
than adjacent epidermis (Figure 2-1k,l) and did not express the epidermal differentiation 
marker K1 (Figure 2-1e,f).  In contrast to embryonic hair buds (Figure 2-1b, arrowhead), 
superficial BCCs did not exhibit a morphologically recognizable mesenchymal papilla 






Figure 2-1.  Human superficial basal cell carcinoma expresses hair bud lineage 
markers.  (a,b) H&E-stained sections of early human superficial BCC and embryonic 
hair buds.  Dashed line in (b) indicates epithelial component of embryonic hair follicle, 
with adjacent mesenchymal condensate marked with an arrowhead.  Note absence of 
morphologically recognizable mesenchymal condensate near superficial BCC.  (c,d) Hair 
placode marker K17 is expressed in superficial BCC and hair bud.  At this stage of 
embryonic development, surrounding epidermis (d) also expresses this marker.  (e,f) The 
suprabasal cell marker K1 is not expressed in superficial BCC or in hair bud.  (g-j) Outer 
root sheath marker Sox9 and hair matrix/inner root sheath marker CDP are expressed in 
superficial BCC and hair bud.  Note largely non-overlapping expression patterns of Sox9 
and CDP in hair bud (brackets in h,j), compared to overlapping expression in superficial 
BCC.  (k,l) Increased proliferation in superficial BCC and hair bud relative to adjacent 
epidermis, assessed by Ki67 staining.  
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Ectopic Hh signaling in mouse epidermis produces superficial BCC-like 
downgrowths resembling embryonic hair buds 
De novo epidermal downgrowths have been noted in several mouse models with 
deregulated Hh signaling activity in skin (Allen et al., 2003; Grachtchouk et al., 2003; 
Nilsson et al., 2000; Oro et al., 1997; Vidal et al., 2005).  We examined epithelial bud 
development in greater detail in mice expressing a gain-of-function SMO allele (M2SMO) 
following Cre-mediated recombination (Allen et al., 2003).  We then examined epithelial 
bud development in mice with focally-activated Hh signaling in skin, achieved using the 
M2SMO oncogene (Xie et al., 1998).  We restricted much of our analysis to a triangular 
region of volar skin completely devoid of follicles or other skin appendages, enabling us 
to study the effects of deregulated Hh signaling in a morphogenetically naive epidermis 
(Figure 2-2).  Constitutive activation of Hh signaling using M2SMO resulted in de novo 
epithelial bud initiation in this normally hairless region (Figure 2-3a-d).  Similar to 
human BCC (Figure 2-1), the M2SMO-induced buds expressed several lineage markers 
seen in embryonic mouse hair buds (Figure 2-5), including the outer root sheath markers 
K17 and Sox9, and the hair matrix/inner root sheath marker CDP (Figure 2-4 and 2-6).  
In addition, M2SMO-induced ectopic buds expressed Epcam (Figure 2-4c), 38kD 
glycoprotein that is specifically expressed in embryonic hair buds, as well as secondary 
hair germs in telogen hair follicles and BCC (Klein et al., 1990).  Similar to human 
superficial BCC, epithelial cells in M2SMO-induced buds co-expressed Sox9 and CDP, 
while embryonic hair buds showed non-overlapping distribution of cells expressing these 
markers (brackets in Figure 2-6f,h).  Expression of the suprabasal marker K1 was not 
seen in M2SMO buds or embryonic hair buds (Figure 2-6i,j), whereas proliferation 
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(Ki67-immunostaining) (Figure 2-6k,l) and P-cadherin expression (Figure 2-6m,n) were 
both increased relative to adjacent epidermis.  Notably, down-regulation of E-cadherin, a 
characteristic alteration in embryonic hair buds that may contribute to a shift from 
membrane-bound to cytoplasmic and nuclear β-catenin (Mullor et al., 2002), was not 
apparent in M2SMO-induced buds (Figure 2-6o,p), arguing that changes in E-cadherin 
expression levels are not required for ectopic hair bud development in this setting.  As in 
human BCC buds, M2SMO-induced ectopic buds were not associated with a 
morphologically-detectable mesenchymal component (Figure 2-6a,b) or expression of the 
mesenchymal condensate/papilla marker alkaline phosphatase (Figure 2-3e,f).  Ectopic, 
cell-autonomous activation of Hh signaling in mouse epidermis thus mimics early stages 
of human superficial BCC development by reprogramming epidermis to form epithelial 
invaginations similar to embryonic hair buds, with the notable absence of an associated 
mesenchymal component and impaired segregation of epithelial cells into distinct Sox9- 







Figure 2-2.  Hairless region of mouse volar skin. Whole-mount view of control skin 
from ventral aspect of mouse hind limb, with H&E-stained sections from indicated 
regions.  Triangle outlines a region completely devoid of hair follicles or other skin 
appendages (b’), compared to eccrine glands in the footpad region (a’) and hair follicles 





Figure 2-3.  Ectopic Hh signaling in M2SMO-expressing hairless mouse skin drives 
superficial BCC-like downgrowths resembling hair buds.  Histology, marker 
expression and increased proliferation rate of ectopic epithelial buds in volar skin from 
M2SMO-expressing mice and hair bud from E16.5 mouse embryo. (a,b) Wholemount 
view of hairless control (WT) and M2SMO transgenic volar skin.  Activation of Hh 
signaling using M2SMO results in the appearance of scattered buds and 
hyperpigmentation in hairless skin (b).  (c,d) H&E-stained sections showing distribution 
of buds in M2SMO volar skin (d).  (e,f) Endogenous alkaline phosphatase, a marker for 
follicle-associated mesenchymal condensates, is not detected in control or M2SMO volar 
skin. Inset in (f) shows alkaline phosphatase-positive (red) dermal papillae in hair 








Figure 2-4.  Ectopic Hh-induced buds in hairless volar skin express hair bud 
markers K17 and Epcam.  (a,b) Wholemount K17 immunoflourescence staining 
reveals K17-positive ectopic buds in M2SMO volar skin at a slightly later developmental 
time period than M2SMO volar skin shown in Figure 2-3.  Note only occasional K17-
positive cells are seen in control volar skin.  (c) M2SMO-induced buds express Epcam, 
hair bud specific marker (Klein et al., 1990).  (d) DAPI immunoflourescence image of (c) 













Figure 2-5.  Mouse hair bud cellular compartments and epithelial lineage markers.  
Cartoon illustrating early embryonic mouse hair bud compartments and epithelial lineage 
markers.  Red dashed line indicates Keratin 17 (hair bud marker) expression, green 
dashed line indicates Sox9 (outer root sheath marker) expression, and blue dashed line 
indicates CDP (matrix/inner root sheath) expression.  Note that Sox9 and CDP expression 







Figure 2-6.  M2SMO-induced ectopic epithelial buds express hair bud lineage 
markers.  (a,b) H&E-stained sections of de novo epithelial bud in M2SMO volar skin 
and embryonic mouse hair bud.  The mesenchymal condensate neighboring normal hair 
buds [arrowhead in (b)] is not detected in association with the M2SMO-induced bud (a).  
Immunostaining revealed expression of hair follicle outer root sheath markers K17 and 
Sox9 (c-f), and the hair matrix/inner root sheath marker CDP (g,h) in ectopic buds and 
embryonic hair buds.  Note non-overlapping expression of Sox9 and CDP in hair buds 
(brackets in f,h), compared to M2SMO-induced bud.  (i,j) The suprabasal marker K1 is 
not expressed in M2SMO-induced buds or embryonic hair buds, while proliferation (k,l) 
is increased in both.  (m,n) The hair bud marker P-cadherin is up-regulated in both 
M2SMO and embryonic hair buds, whereas down-regulation of E-cadherin is detected 
only in hair buds (o,p).  White dotted line shows epidermal-dermal junction.  
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Canonical Wnt signaling in human and murine Hh pathway-driven epithelial buds 
The formation of de novo epithelial buds in response to ectopic Hh signaling in 
epidermis was intriguing, given the compelling evidence pointing to the canonical Wnt 
pathway as the initiator of skin appendage development (Andl et al., 2002; Gat et al., 
1998; Huelsken et al., 2001; Ito et al., 2007; Lo Celso et al., 2004).  We therefore 
determined whether pathological Hh signaling in this setting was associated with 
activation of the canonical/β-catenin-dependent Wnt pathway.  Increased levels of β-
catenin in the cytoplasm and nucleus were seen in human embryonic hair buds (Figure 2-
7b), consistent with the notion that β-catenin-dependent Wnt signaling is activated during 
early stages of human follicle development, as previously shown in mouse hair follicles 
(Figure 2-7d).  We also detected increased levels of β-catenin in the cytoplasm and 
nucleus of neoplastic cells in human superficial BCCs and in M2SMO-induced mouse 
epithelial buds (Figure 2-7a,c), suggesting activation of the canonical Wnt pathway in 
response to ectopic Hh signaling.  Furthermore, non-phosphorylated (active) β-catenin 
was detected in lysates from M2SMO transgenic mouse skin by immunoblotting, with 
little or no expression in control, non-transgenic volar skin (Figure 2-7e).  Although 
nuclear β-catenin was seen in clusters of mesenchymal cells associated with human and 
murine embryonic hair follicles (Figure 2-7b,d), there was no detectable β-catenin in 
mesenchymal cells adjacent to human or murine epithelial buds driven by aberrant Hh 
signaling (Figure 2-7a,c). 
To determine if aberrant Hh signaling may be influencing the canonical Wnt/β-
catenin pathway through alterations in Wnt ligand expression, we performed 
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semiquantitative RT-PCR on RNA isolated from volar skin of M2SMO-expressing mice 
and controls (Figure 2-8).  As expected, mRNA encoding the Hh target genes Gli1 and 
Ptch1, indicating Hh pathway activation, was detected in samples from M2SMO volar 
skin, with negligible levels in controls.  In addition, transcripts encoding multiple Wnt 
ligands (Wnt3, 4, 5a, 7b, 10a and 10b), and the transcriptional coactivator Tcf4, were 
coordinately induced in M2SMO volar skin.  Expression of endogenous Wnt target genes 
(Clevers, 2006) Axin2 and Sp5, and the indirect target Cyclin D1, was also upregulated in 
M2SMO-expressing skin, indicating activation of a transcriptional program associated 
with canonical Wnt signaling.  
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Figure 2-7  Canonical Wnt signaling is activated in human superficial BCC and 
epithelial buds in M2SMO-expressing hairless mouse skin.  (a,b) β-catenin 
immunostaining reveals nuclear/cytoplasmic β-catenin localization in human superficial 
BCC and hair bud, consistent with activation of canonical Wnt signaling.  Note intense 
nuclear staining in mesenchymal cells adjacent to hair bud [arrowhead in (b)] but not 
BCC (a).  Adjacent epidermis (*) exhibits β-catenin localized to the cell membrane.  
(c,d) Similarly, β-catenin immunostaining reveals nuclear/cytoplasmic localization in 
mouse M2SMO bud cells arising from hairless volar skin and E16.5 mouse embryonic 
hair bud, with stained mesenchymal cells also noted adjacent to the hair bud (arrowhead).  
(e) Immunoblotting using mABC antibody showing presence of non-phosphorylated 
(active) β-catenin in lysates from M2SMO volar skin, but not hairless control volar skin.  
Skin lysate from postnatal day 8 mouse with actively-growing hair follicles (hf) was used 




Figure 2-8.  Multiple Wnt ligands, Tcf4, and Wnt target genes Axin2, Sp5 and Cyclin 
D1 are expressed in M2SMO volar skin.  Semiquantitative RT-PCR was performed on 
RNA isolated from control volar skin (Ctrl), early bud-stage M2SMO transgenic volar 
skin (M2SMO Bud), and later, basaloid follicular hamartoma-containing M2SMO volar 
skin (M2SMO BFH), with postnatal day 8 skin as a positive control (hf).  Upregulation of 
Gli1 and Ptch1 expression in M2SMO skin confirms activation of Hh signaling.  
M2SMO-expressing skin expresses multiple Wnt genes, Tcf4, and endogenous Wnt target 
genes Axin2, Sp5, and Cyclin D1.  In control volar skin, there is negligible expression of 
Gli1, Ptch1, and Wnt pathway-associated genes. 
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SMO*-induced hair buds form follicular hamartomas instead of hair follicles 
In contrast to embryonic hair buds, M2SMO-driven de novo buds did not develop 
into mature hair follicles, which express distinct markers in each of its seven cell lineages 
(Figure 2-9).  Instead, they formed undifferentiated basaloid follicular hamartomas 
(Grachtchouk et al., 2003) which contained two of the seven cell lineages present in 
normal mature hair follicles (Figure 2-10).  M2SMO-driven hamartomas expressed the 
outer root sheath markers K17 (McGowan and Coulombe, 1998) and Sox9 (Vidal et al., 
2005) (Figure 2-11a,c) and the hair matrix/inner root sheath marker CDP (Ellis et al., 
2001) (Figure 2-11e).  In this setting, since an inner root sheath is not present, CDP 
expression likely reflects a hair matrix-like differentiation program.  While the majority 
of epithelial cells comprising M2SMO-induced buds initially co-expressed Sox9 and 
CDP (Figure 2-6e,g) and exhibited nuclear and cytoplasmic localization of β-catenin 
(Figure 2-7c), expression of lineage markers and β-catenin was compartmentalized in 
hamartomas (Figure 2-11a,c,e,g,i,k).  The majority of cells in hamartomas expressed K17, 
with cells at the lesion periphery frequently expressing reduced levels of Sox9 (Figure 2-
11c).  In contrast, cells expressing CDP were in most cases restricted to the periphery of 
these lesions (Figure 2-11e).  Unlike normal hair follicles, M2SMO-driven hamartomas 
did not express late stage follicle markers specific for inner root sheath (trichohyalin, 
detected with AE15 antibody (O'Guin et al., 1992) or hair shaft (type I hair keratins, 
detected using AE13 antibody (Lynch et al., 1986)) (Figure 2-11m,o).  Thus, the bulk of 
cells in follicular hamartomas expressed outer root sheath hair follicle markers while cells 
at the periphery of these lesions exhibited some features analogous to hair matrix cells.  
These undifferentiated tumors are thus distinct from the well-differentiated hair follicle 
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tumors, trichofolliculomas and pilomatricomas, that arise in mice expressing stabilized 
forms of β-catenin (Gat et al., 1998; Lo Celso et al., 2004), and human pilomatricomas 
associated with CTNNB1 mutations (Chan et al., 1999).  Potential explanations for the 
lack of late-stage follicle lineage markers in M2SMO-induced hamartomas may include 
an insufficiently high level of canonical Wnt/β-catenin signaling for trichogenic 
differentiation, absence of an inductive mesenchyme/dermal condensates/dermal papillae, 
which may provide an essential maturation signal for follicular epithelium, or expansion 
of restricted progenitor cells with limited developmental potential, in response to 
M2SMO. 
Immunostaining for Ki67 revealed that in many of the hamartomas, proliferating 
cells were concentrated at the periphery where cells expressing the matrix marker CDP 
were located (Figure 2-11e,g).  Similarly, immunostaining for β-catenin showed 
cytoplasmic and nuclear accumulation preferentially in these outer-most cells, compared 
with cells in more central regions of the hamartomas (Figure 2-11i), and Cyclin D1 was 
also localized to the hamartoma periphery (Figure 2-11k).  Since Cyclin D1 is a Wnt 
target (Tetsu and McCormick, 1999), it may provide the link between compartmentalized 
expression of cytoplasmic/nuclear β-catenin, and increased proliferation, seen at the 
periphery of follicular hamartomas.   
Semiquantitative RT-PCR was used to examine alterations in gene expression 
associated with progression from M2SMO-induced hair buds to follicular hamartomas.  
Expression of Hh target genes Gli1 and Ptch1 was increased in volar skin with 
hamartomas (M2SMO BFH) relative to hair buds (M2SMO Bud, Figure 2-8), likely 
reflecting an expansion of the transgene-expressing population of cells with activated Hh 
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signaling.  The levels of Wnt5a and Tcf4, previously shown to be Hh-responsive (Pasca di 
Magliano et al., 2007; Reddy et al., 2001), were increased further in hamartomas, 
whereas expression of Wnts 3, 4, 7b, and 10a was essentially unaltered, and Wnt 10b 
levels appeared slightly reduced (Figure 2-8).  Interestingly, relatively low-level 
expression of transcripts for Wnts 2, 11, and 13 was detected in follicular hamartomas but 
not epithelial buds (Figure 2-8): the presence of Wnt11 in hamartomas mimics the 
relatively late appearance of this Wnt in maturing hair follicles (Reddy et al., 2001).  The 
expression level of Wnt target genes Axin2 (Jho et al., 2002) and Sp5 (Weidinger et al., 
2005) was not appreciably different in volar skin with hair buds versus hamartomas 
(Figure 2-8).  Thus, the evolution from hair buds to follicular hamartomas is associated 
with continued or newly-induced expression of transcripts encoding several Wnt ligands 
and Wnt target genes, and expansion of a population of undifferentiated, proliferative, 
matrix-like epithelial cells at the tumor periphery, expressing cytoplasmic/nuclear-









Figure 2-9.  Hair follicle cell lineages.  Cartoon showing follicle cellular compartments 







Figure 2-10.  Hh-induced epithelial buds expand to form basaloid follicular 
hamartomas with sustained Wnt signaling. (a,b) H&E-stained sections of early-stage 
M2SMO bud arising from hairless volar skin, and embryonic hair bud.  (c,d) M2SMO 
skin from mice 3 weeks of age and older contains basaloid follicular hamartomas, 







Figure 2-11  Marker expression of basaloid follicular hamartomas in 
M2SMO-expressing mice.  (a-d) Follicular hamartomas and anagen hair follicles 
express hair follicle outer root sheath markers K17 and Sox9, with cells at the periphery 
of hamartomas frequently expressing reduced levels of Sox9.  (e,f) The majority of cells 
expressing the hair matrix/inner root sheath marker CDP in hamartomas are restricted to 
the periphery of these lesions.  The peripheral cells in hamartomas are also more 
proliferative (g,h), exhibit nuclear/cytoplasmic localization of β-catenin (i,j), and express 
higher levels of the Wnt target Cyclin D1 (k,l) than cells in the central regions of 
hamartomas.  (m-p) In contrast to hair follicles, hamartomas do not express late-stage 
follicle differentiation markers trichohyalin, detected using AE15 antibody, or hair-
specific keratin, detected with AE13 antibody.  
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Development of M2SMO-induced epithelial buds and hamartomas is blocked by 
Dkk1 
Using a transgenic mouse model where doxycycline-regulated activation of the 
secreted Wnt inhibitor Dkk1 could be achieved in skin (Chu et al., 2004), we next tested 
whether canonical Wnt signaling was required for development of epithelial buds and 
their expansion to form hamartomas.  For these experiments, we combined M2SMO-
expressing transgenic mice [(ΔK5-M2SMO) (Grachtchouk et al., 2003)], keratin 5-
targeted reverse-tetracycline transactivator mice [(K5-rtTA) (Diamond et al., 2000)], and 
mice carrying a doxycycline-regulated transgene [TRE-Dkk1, (Chu et al., 2004)], 
enabling expression of a secreted inhibitor of canonical Wnt signaling, Dkk1.  We 
designated these triple-transgenic mice (ΔK5-M2SMO;K5-rtTA;TRE-Dkk1) 
M2SMO+Dkk1, for the sake of brevity.  In M2SMO+Dkk1 mice, Dkk1 expression could 
be induced by administration of the tetracycline analog doxycycline, leading to inhibition 
of canonical Wnt signaling at different time points during the development of ectopic 
buds and follicular hamartomas.            
We first induced Dkk1 in M2SMO-expressing mice (M2SMO+Dkk1) during 
embryogenesis, by administering doxycycline to pregnant dams at embryonic day 16.5. 
(Figure 2-12a).  Blockade of canonical Wnt signaling at this stage led to nearly complete 
inhibition of M2SMO-driven ectopic bud development in volar skin, as assessed by 
whole-mount analysis and histology (Figure 2-12b) of skin on postnatal day 7 (P7).  
Dkk1 induction at P1 (Figure 2-13a) also led to a dramatic inhibition of M2SMO-
mediated hair bud development, and a profound suppression of follicular hamartoma 
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formation, both in volar (Figure 2-13b and 2-16d) and tail (Figure 2-13c and 2-16b) skin 
examined at P35.  Interestingly, the strikingly increased pigmentation in M2SMO volar 
and tail skin was also blocked in M2SMO+Dkk1 mice (For further discussion see 
Chapter V).  Although expression of Wnt genes was similarly elevated in M2SMO and 
M2SMO+Dkk1 skin (Figure 2-14b), translocation of β-catenin to the cytoplasm and 
nucleus was suppressed in M2SMO+Dkk1 mice (Figure 2-14a), and expression of the 
Wnt target genes Axin2 and Sp5 was negligible, indicating effective blockade of 
canonical Wnt signaling by Dkk1 (Figure 2-14b).  In contrast, expression of the Hh target 
genes Gli1 and Ptch1 was similar in M2SMO and M2SMO+Dkk1 skin, indicating that 
M2SMO-driven constitutive Hh signaling was unaffected by Wnt pathway inhibition 
(Figure 2-14b).  Similarly, ectopic expression of the Hh-responsive keratin, K17 
(Callahan et al., 2004), was seen in both M2SMO and M2SMO+Dkk1 volar skin (Figure 
2-15b,c), whereas expression of hair bud and follicular hamartoma markers Sox9 and 
CDP, and increased cell proliferation, were no longer detected in M2SMO+Dkk1 mice 
(Figure 2-15f,i,l).  The profound blockade of M2SMO-induced hair bud and follicular 
hamartoma development, by Dkk1, establishes that biological responses to ectopic Hh 
signaling in skin are largely mediated indirectly, via the canonical Wnt/β-catenin 
signaling pathway.   
Notably, buds and hamartomas also developed in dorsal skin of M2SMO mice, 
but in this location they were not suppressed in M2SMO+Dkk1 mice, and β-catenin 
remained localized to the nucleus, suggesting that Dkk1 was not effectively inhibiting 
canonical Wnt signaling at this site.  This may be due to insufficiently high expression of 
Dkk1 in dorsal skin or a relative deficiency in the level of Kremens 1/2 (Mao et al., 2002), 
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which facilitate Dkk1’s ability to block Wnt signaling.  Bud and hamartoma development 
was also not inhibited in small regions of volar skin near footpads (arrowhead in Figure 
2-13b and 2-16d), and here again the presence of nuclear β-catenin indicated inefficient 
blockade of canonical Wnt signaling (Figure 2-16d and insets).  These results further 
underscore the tight correlation between inhibition of canonical Wnt/β-catenin signaling 






Figure 2-12.  Inhibition of canonical Wnt signaling with Dkk1 blocks M2SMO-
induced development of epithelial buds.  (a) Experimental time-line for induction of 
Dkk1 expression in M2SMO+Dkk1 mice during embryogenesis (E16.5) with analysis at 
postnatal day 7.  (b) Expression of Dkk1 blocks development of de novo buds seen in 










Figure 2-13.  Inhibition of canonical Wnt signaling with Dkk1 blocks M2SMO-
induced development of epithelial buds and follicular hamartomas.  (a) Experimental 
time-line for Dkk1 induction at postnatal day 1 with analysis at postnatal day 35 to assess 
effects on hamartoma development. (b) Gross view and H&E-stained sections of volar 
skin from control, M2SMO, and M2SMO+Dkk1 mice.  Note increased pigmentation and 
hamartoma development in M2SMO skin, compared to control.  The M2SMO-induced 
phenotype is dramatically inhibited by coexpression of Dkk1.  Foci of hyperpigmentation 
were sometimes detected in M2SMO+Dkk1 volar skin near footpads (arrowhead in b), 
and histology in these regions revealed buds and/or hamartomas with nuclear β-catenin 
(not shown), indicating incomplete blockade of canonical Wnt signaling in these regions.  
(c) Gross view and H&E-stained sections of tail skin from control, M2SMO, and 
M2SMO+Dkk1 mice.  Note disrupted hair formation, increased pigmentation, and 
hamartomas in M2SMO skin, compared to control.  The M2SMO-induced phenotype is 





Figure 2-14.  Conditional Dkk1 overexpression inhibits canonical Wnt/b-catenin 
signaling without affecting Hh signaling.  (a) Immunoflourescence for β-catenin in 
volar skin.  Cells with nuclear β-catenin in M2SMO skin, indicating activation of 
canonical Wnt signaling, are marked with arrowheads.  Inhibition of nuclear β-catenin 
localization in M2SMO+Dkk1 mice, indicating effective blockade of canonical Wnt 
signaling.  White dotted lines represent epidermal-dermal junction.  (b) Semiquantitative 
RT-PCR using RNA from control, M2SMO and M2SMO+Dkk1 tail skin reveals down-
regulation of Axin2 and Sp5 in M2SMO+Dkk1 volar skin, confirming blockade of 
canonical Wnt signaling.  In contrast, expression of Hh target genes Gli1 and Ptch1, as 







Figure 2-15.  Hh-responsive keratin K17 is expressed in both M2SMO and 
M2SMO+Dkk1 skin, but bud lineage marker Sox9 and CDP expression, as well as 
proliferation are lost in M2SMO+Dkk1 skin.  (a-c) The Hh-responsive keratin, K17, is 
not detected in control volar skin, but ectopically expressed in both M2SMO and 
M2SMO+Dkk1 volar skin, in keeping with sustained activation of Hh signaling in these 
mice.  (d-l) M2SMO-associated expression of Sox9, CDP, and Ki67 are blocked or 






Figure 2-16.  Inhibition of M2SMO-induced epithelial bud and hamartoma 
development by Dkk1 is uniform in tail skin, but not in volar skin.  (a) H&E-stained 
section of low magnification view of tail skin in M2SMO mice at postnatal day 35.  Note 
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extensive hamartoma development in M2SMO tail skin.  (b) The M2SMO-induced 
phenotype is dramatically inhibited in M2SMO+Dkk1 tail skin, and the inhibition of 
hamartoma development is uniform throughout the tail skin.  Nuclear and/or cytoplasmic 
β-catenin localization was not detected (not shown).  (c) H&E-stained sections of low 
magnification view of volar skin in M2SMO mice at postnatal day 35. Note extensive 
pigmentation and hamartoma development in M2SMO volar skin.  (d) Blockade of 
M2SMO-phenotype and canonical Wnt signaling by Dkk1 is incomplete and non-
uniform in the volar skin of M2SMO+Dkk1 mice, as a small foci of hyperpigmentation 
and hamartoma development is visible adjacent to regions with dramatic M2SMO-
phenotype inhibition.  β-catenin immunostaining revealed nuclear β-catenin localization 
in these small regions (lower right box), indicating incomplete blockade of canonical Wnt 




The histological resemblance of superficial BCCs to embryonic hair germs had 
been reported as early as 1913 (El-Bahrawy et al., 2003; Kumakiri and Hashimoto, 1978; 
Lever, 1948; Montgomery, 1935).  Here, we show that human BCC buds, similar to 
embryonic hair germs, exhibit nuclear and cytoplasmic β-catenin and express early hair 
follicle lineage markers.  We describe analogous changes in mouse epidermis with 
ectopically activated Hh signaling activity, along with elevated expression of multiple 
Wnt genes, Tcf4, and Wnt target genes Axin2 and Sp5.  Furthermore, we show that 
selective blockade of canonical Wnt signaling with Dkk1 dramatically inhibits epithelial 
bud and hamartoma development in M2SMO mice, indicating that pathologic Hh 
signaling brings about these changes indirectly, via the canonical Wnt pathway.  Our 
findings identify the canonical Wnt pathway as a mediator of pathological responses in 
skin previously attributed to the Hh pathway, help elucidate how ‘follicular’ tumors may 
arise from interfollicular epidermis, and provide a molecular explanation for the 
morphological and biochemical similarity between BCC buds and hair germs. 
Under normal conditions, Wnt/β-catenin signaling initiates hair bud development 
while Hh signaling is required for subsequent proliferation of follicle epithelium leading 
to formation of hair matrix and multiple cell lineages comprising the mature follicle 
(DasGupta and Fuchs, 1999; Fuchs, 2007; Millar, 2002).  Activation of canonical Wnt 
signaling in skin ultimately leads to induction of Hh signaling, whereas Wnt pathway 
blockade impairs physiological Hh signaling (Andl et al., 2002; Gat et al., 1998; 
Huelsken et al., 2001; Lo Celso et al., 2004).  These data place Hh downstream of the 
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initiating Wnt signal in follicle development, but since a direct effect on expression of Hh 
ligand(s) or other Hh pathway components has not been demonstrated, this may merely 
reflect the fact that Hh signaling is part of the biochemical program of hair matrix cells.  
Our data indicate that this relationship is reversed in the setting of Hh-driven pathology in 
skin, where the initial, aberrant activation of Hh signaling in epidermis leads to canonical 
Wnt signaling and formation of de novo epithelial buds and hamartomas.  In light of our 
findings in the setting of pathologically-activated Hh signaling in skin, it will be 
interesting to determine whether the Hh pathway contributes to Wnt signaling under 
physiological conditions, as has been proposed in other organs [e.g., (Hu et al., 2005; 
Madison et al., 2005)].  Since Hh signaling is activated in hair matrix cells in the 
maturing follicle, it may play a role in the robust activation of Wnt signaling in 
neighboring hair shaft progenitors.  
Previous reports have documented positive interactions between the Hh and Wnt 
signaling pathways in several cell types and tissues and in different species, but a 
requirement for Wnt signaling in a Hh-driven pathological process has not previously 
been demonstrated in vivo.  For example, in Drosophila imaginal discs, the Wnt 
orthologue wingless is directly regulated by the Gli orthologue Ci (Von and Hooper, 
1997).  Expression of Wnt5A, 7B, 7C, 8, 8B, and 11 has been reported in Xenopus animal 
cap explants injected with Gli2 and Gli3 mRNA, and blockade of Wnt signaling inhibits 
the morphogenetic response to Gli2 in this system (Mullor et al., 2001).  Also, in E1A-
immortalized RK3E rat kidney cells, expression of Wnt2b, Wnt4, and Wnt7 was induced 
by GLI1, and dominant-negative TCF4 inhibited GLI1-mediated focus formation in cell 
culture (Li et al., 2007).  While these data demonstrate that Hh-Wnt crosstalk is necessary 
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for an embryonic process and in vitro transformation, respectively, our findings are the 
first to establish a stringent requirement for canonical Wnt/β-catenin signaling in Hh 
pathway-driven neoplasia. 
In contrast to our findings, there are reports suggesting that Hh signaling can 
antagonize the canonical Wnt pathway in some settings.  This has been reported in colon, 
where Indian hedgehog appears to block Wnt signaling in mature colonocytes (van den 
Brink et al., 2004).  An antagonistic interaction between these pathways has also been 
reported in tongue, where blocking Hh signaling leads to enhanced Wnt signaling and 
taste papilla formation (Farndon et al., 1992).  Although the mechanisms through which 
these two key pathways interact remain largely unexplored, it is clear that the effects of 
Hh signaling on the Wnt pathway are highly dependent on cell and tissue context, and 
will therefore need to be determined empirically in each setting. 
Previous studies in normal skin have shown that in developing hair buds, 
canonical Wnt signaling precedes, and is required for, subsequent activation of Hh 
signaling (Andl et al., 2002; Gat et al., 1998; Huelsken et al., 2001; Lo Celso et al., 2004).  
Our data indicate that this temporal relationship is reversed in the setting of Hh-driven 
pathology in epidermis, where ectopic activation of Hh signaling leads to canonical Wnt 
signaling with resultant formation of de novo epithelial buds and follicular hamartomas.  
Several earlier reports have described links between the Hh and Wnt pathways in BCC, 
including upregulation of one or more Wnt genes (Mullor et al., 2001) and localization of 
β-catenin to the cytoplasm and/or nucleus (El-Bahrawy et al., 2003; Saldanha et al., 
2004; Yamazaki et al., 2001).  Furthermore, nuclear β-catenin localization has been 
reported in BCC-like tumors in mice with conditional homozygous inactivation of Ptch1 
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(Adolphe et al., 2006).  Interactions between the Hh and Wnt pathways have also been 
proposed to operate in pancreatic cancer (Pasca di Magliano, 2007) and cigarette smoke-
induced lung cancer (Manfredi et al., 2004).  Our results are in keeping with these 
observations, and provide the first direct evidence that canonical Wnt signaling is 
essential for a tumorigenic response to deregulated Hh signaling in skin.  Interestingly, a 
recent report described a role for β-catenin in cutaneous squamous cell carcinoma 
(Malanchi et al., 2008), which is biologically and pathogenetically distinct from BCC and 
not linked to aberrations in the Hh pathway, but it is not known whether signaling in 
squamous tumors is driven by Wnt ligands.  Since Wnt ligand expression is elevated in 
BCCs and β-catenin distribution is cytoplasmic and nuclear, our findings raise the 
possibility that canonical Wnt signaling may also be required for the development and/or 
expansion of full-blown BCC.  We have performed parallel experiments to those 
described here using Dkk1 in mice which develop nodular, BCC-like skin tumors, but 
Dkk1 was not effective in blocking canonical Wnt signaling in this setting (data not 
shown).  Alternative approaches will therefore be needed to assess the role of β-catenin 
function in the initiation and maintenance of frank BCC. 
Although M2SMO-induced epithelial buds expanded to form hamartomas, they 
failed to differentiate beyond a rudimentary stage of development, containing only two of 
the seven cell lineages seen in mature follicles.  This may be due at least in part to the 
fact that they failed to produce mesenchymal condensates and papillae required for 
proper follicle development.  The lack of condensates near ectopic buds was observed in 
dorsal (hairy) skin as well as hairless volar skin, arguing against the possibility that volar 
mesenchyme is selectively deficient in responsiveness to form this cell population. 
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It is also interesting that during M2SMO-induced epithelial bud neogenesis, bud-
specific marker P-cadherin was up-regulated in the de novo bud, but E-cadherin down-
regulation was not observed. E-cadherin downregulation has been reported to be critical 
for epithelial bud formation (Jamora et al., 2003).  This suggests that at least in the 
context of Hh-driven epithelial bud development, E-cadherin down-regulation is not a 
requirement.  
Furthermore, inconsistent results were seen in TOPGal;ΔK5-M2SMO 
bitransgenic skin, as well as in embryonic dorsal hair buds in TOPGal transgenic mice, 
suggesting that at least in certain contexts, TOPGal transgenic mice may not be a faithful 
reporter of TCF/Lef promoter activity/canonical Wnt pathway activation.   
Taken together, our findings suggest that blockade of canonical Wnt/β-catenin 
signaling may be a useful strategy for treatment of neoplasms currently considered to be 
caused by uncontrolled Hh signaling.  Because deregulated Hh signaling impacts on β-
catenin signaling primarily at the level of Wnt ligands, the range of potential therapeutic 
strategies is considerably greater than it is for colorectal and other cancers with 
mutational defects in APC or β-catenin, and would likely include antibodies or other 
recombinant proteins that antagonize the interaction of Wnt ligands with Frizzled and 
LRP receptors.  Future work will better clarify the utility of targeting proximal Wnt 
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Forced activation of canonical Wnt/β-catenin signaling is sufficient to drive 
advanced hair follicle differentiation in normal hairless volar and M2SMO skin∗ 
Introduction 
β-catenin is one of the key downstream effectors in the canonical Wnt signaling 
pathway, and the critical role of Wnt pathway in both early embryonic development and 
tumorigenesis has been well-established (Clevers, 2006).  As previously described in 
Chapter I, Wnt/β-catenin signaling plays a key role in early-stage hair bud initiation as 
well as late-stage advanced hair follicle lineage differentiation, and also in the 
development of hair follicle derived tumors (Fuchs, 2007; Reya and Clevers, 2005).  
Multiple studies have established the role of β-catenin in controlling epidermal lineage 
commitment in adult tissue.  Reddy et al. showed that a range of Wnts, their receptors, 
and antagonists are expressed in the epidermis, and Wnts 10a, 10b, and 5a are 
specifically upregulated in the developing hair placodes (Reddy et al., 2001).  Epidermal 
expression of N-terminally truncated, constitutively activated mutant form of β-catenin 
using keratin 14 (K14) promoter led to de novo hair follicle development from 
interfollicular epidermis and pre-existing hair follicles (Gat et al., 1998; Lo Celso et al., 
2004).  The K14 promoter, similar to K5 promoter, is active in all basal cells of 
                                                          
∗ Portion of this chapter represent data from a previously published manuscript: Zhang. Y., Andl. T., Yang 
S.H., et al. (2008). “Activation of β-catenin signaling programs embryonic epidermis to hair follicle fate.” 
Development 135, 2161-2172 (2008) doi:10.1242/dev.017459 
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interfollicular epidermis and along the length of the hair follicle outer root sheath (Vassar 
et al., 1989; Byrne et al., 1994; Wang et al., 1997).  The de novo hair follicles formed 
sebaceous glands and dermal papilla, normally only established during embryonic 
development, and also expressed Shh, Ptch, and markers of advanced hair follicle 
differentiation.  Interestingly, these investigators found that de novo hair follicle 
development was only seen in haired skin, such as skin from dorsal, tail, and dorsal foot 
region, but not in normally hairless regions such as the hairless volar skin (see Chapter I 
for orientation and pictures).  Also, two independent studies found that a brief, transient 
activation of canonical Wnt signaling by expressing truncated β-catenin mutant in 
telogen skin was sufficient to trigger new hair growth (anagen) (Lo Celso et al., 2004; 
Van Mater et al., 2003).  Silva-Vargas et al. further demonstrated that K14 promoter 
driven truncated β-catenin expression induces de novo hair follicle formation (Silva-
Vargas et al., 2005)  and these hair follicles contain clonogenic keratinocytes that express 
bulge-specific stem cell markers such as CD34 and keratin 15 (K15) (Morris et al., 2004; 
Trempus et al., 2003; Tumbar et al., 2004).  In addition, β-catenin-induced de novo 
follicles contained associated dermal papilla, provide a niche for melanocytes, and 
undergo cycles of growth and regression, but de novo follicle development did not occur 
in hairless volar skin of these mice as well (Silva-Vargas et al., 2005).  
Taken together, these studies clearly demonstrate that β-catenin can control 
epidermal lineage commitment in the adult tissue.  However, it is not clear why de novo 
hair follicle formation was not seen in hairless volar skin in these studies.  Could it be 
explained by the possible lack of multipotent hair follicle progenitor cells in the hairless 
volar skin that prevents β-catenin induced de novo hair follicle development?  
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Alternatively, are there additional inductive factors that are necessary to trigger the 
mutant β-catenin responses that are not present in the hairless volar skin?  Hairless volar 
skin does not contain dermal papillae, and since the dermal papillae play a key role in 
hair follicle morphogenesis and cycling, could the lack of dermal papillae and its 
inductive signals prevent de novo hair follicles to form in response to mutant β-catenin 
expression?  
The lack of mutant β-catenin-induced responses in hairless volar skin in above 
studies was surprising, given the robust M2SMO-induced ectopic epithelial bud and 
hamartoma development in hairless volar skin in M2SMO transgenic mice.  Furthermore, 
we were also intrigued by the fact that M2SMO-induced ectopic buds in M2SMO 
transgenic mice did not feature associated mesenchymal condensate/dermal papillae, 
which are required for normal hair follicle development.  Also, M2SMO-induced 
follicular hamartomas contained only two of seven hair follicle lineages, and did not 
express late stage follicle lineage markers, such as trichohyalin (specific for inner root 
sheath) or type I hair keratin (specific for hair shaft) .  Our results indicate that canonical 
Wnt signaling is activated in M2SMO-induced buds and hamartomas (Chapter II).  If 
canonical Wnt signaling is sufficient to drive late stage hair follicle differentiation, then 
how can one explain the lack of late-stage follicle differentiation in M2SMO-induced 
hamartomas?  Is M2SMO-driven activation of canonical Wnt signaling enough to 
activate the development of ectopic epithelial buds, but is it too low to drive 
differentiation of advanced-stage follicle lineages? 
To address these intriguing questions, I set out to test the effects of directly 
modulating Wnt/β-catenin activity in skin of M2SMO-expressing transgenic mice.  To 
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achieve this, a series of crosses using several transgenic mice were required: 1) Cre-
inducible M2SMO transgenic mice (K5-flxGFP-M2SMO) (Allen et al., 2003), which 
upon crossed with mice expressing a taxomifen-inducible form of Cre (CreERT2) in 
epidermis (K5-CreERT2) (Indra et al., 1999), develop de novo ectopic epithelial buds and 
hamartomas after birth because of low level recombinase activity in the absence of 4-
hydroxytamoxifen (4-OHT) (Allen et al., 2003); 2) Ctnnb1(Ex3)fl/fl mice, in which exon 3 
of β-catenin was flanked by loxP sequences (Harada et al., 1999), that results in the 
accumulation of unphosphorylated, stabilized β-catenin mutant in K5-expressing cells 
and their progeny when combined with K5-CreERT2 mice upon 4-OHT treatment; and 3) 
K5-CreERT2 (Indra et al., 1999) mice, which express a tamoxifen-inducible form of Cre 
(CreERT2) in epidermis.  When Ctnnb1(Ex3)fl/fl mice were combined with Cre-inducible 
M2SMO and K5-CreERT2 transgenic mice, the resulting K5-CreERT2;K5-flxGFP-
M2SMO;Ctnnb1(Ex3)fl/fl triple transgenic mice had developed ectopic buds and 
hamartomas in their skin prior to 4-OHT treatment, and upon 4-OHT treatment, stabilized 
β-catenin mutant accumulated in all K5-expressing cells, including the already 
established buds and hamartomas.  In addition, I also tested the effects of modulating 
Wnt/β-catenin activity on normal adult hairless volar skin by combining Ctnnb1(Ex3)fl/fl 
mice with K5-CreERT2 mice. 
Materials and Methods 
Generation of transgenic mice and transgene activation 
Generation of transgenic mice with constitutive expression of M2SMO in skin 
(ΔK5-M2SMO) has been described (Grachtchouk et al., 2003).  To generate epithelial-
specific Cre-inducible M2SMO mice, K5-flxGFP-M2SMO mice (Allen et al., 2003) were 
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crossed with K5-CreERT2 (Indra et al., 1999) mice.  Low level recombinase activity 
without 4-OHT in untreated double-transgenic M2SMO mice was described previously 
(Allen et al., 2003).  To generate 4-OHT inducible stabilized β-catenin mutant 
(designated βcat*), Ctnnb1(Ex3)fl/fl  (Harada et al., 1999) mice were crossed with K5-
CreERT2 mice to produce double transgenic progeny (K5-CreERT2;Ctnnb1(Ex3)fl/fl).  To 
generate triple transgenic K5-CreERT2;K5-flxGFP-M2SMO;Ctnnb1(Ex3)fl/fl mice 
(designated M2SMO+βcat*), K5-flxGFP-M2SMO mice were crossed with Ctnnb1(Ex3)fl/fl 
mice, and resulting double transgenic progeny were further crossed with K5-CreERT2 
mice.  To induce Cre recombinase expression in 7-8 week old adult βcat* and 
M2SMO+βcat* mice, dorsal back hair was clipped using Oster Golden A5 hair clipper 
(Oster, McMinnville, TN), and 50 uL of 4-OHT dissolved in 95% ethanol (10 mg/mL, 
Sigma-Aldrich, St. Louis, MO) was applied on dorsal back skin. 95% ethanol vehicle 
alone was used as control.  All mice were housed and maintained according to University 
of Michigan institutional guidelines, as stipulated by the University Committee on the 
Use and Care of Animals. 
 
Tissue harvesting, wholemount preparation and wholemount Oil Red O staining 
For hematoxylin and eosin (H&E) staining, mouse skin was fixed in neutral-
buffered formalin (NBF) overnight, transferred to 70% EtOH, processed, and embedded 
in paraffin.  Mouse skin was also embedded in O.C.T. Compound (Tissue-Tek, Torrance, 
CA) for frozen sections.  To prepare wholemounts for mouse tail skin, mice were 
euthanized and tail skin was removed and cut in pieces in ~1cm length.  Tail skin 
wholemount preparation was performed as described previously (Braun et al., 2003).  To 
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prepare wholemounts for mouse volar skin, mice were euthanized and ventral hindlimb 
skin was removed.  Volar skin was microdissected and wholemount preparation was 
performed essentially as described previously for tail skin (Braun et al., 2003).  After the 
wholemounts were prepared, Oil Red O staining was performed as described previously 
(Braun et al., 2003).  Transilluminated wholemount photomicrographs were captured 
with digital camera (Spot RT3.0, Diagnostic Instruments, Inc, Sterling Heights, MI) 
mounted on dissecting microscope.  
 
Semiquantitative RT-PCR 
Volar, tail, and postnatal day 8 dorsal skin were microdissected under dissecting 
microscope (Nikon, Japan), homogenized in Trizol (Invitrogen), and stored at -80°C until 
further processing.  RNA isolation, first strand cDNA synthesis, and RT-PCR were 
performed as described previously (Allen et al., 2003).  
 
Immunostaining and wholemount immunoflourescence staining 
The following primary antibodies were used for immunostaining:  K5 (Covance), 
1:2000; K17 (gift from P. Coulombe); 1:4000, β-catenin (Sigma), 1:1000; CDP (Santa 
Cruz), 1:100; AE13 (gift from H. Sun), 1:10; AE15 (gift from H. Sun), 1:50; K6hf (gift 
from L. Langbein), 1:1000.  For immunohistochemistry, tissues were fixed overnight in 
NBF, processed and paraffin-embedded, and 8 μm sagitally sections were prepared for 
staining.  Immunoreactivity of antigens was restored by immersing slides in boiling 0.01 
M citrate buffer, pH ~6, for 10 min. Blocking was performed using 1.5% NGF in PBS, 
and tissue sections were incubated with primary antibodies diluted in PBS containing 1% 
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bovine serum albumin, typically for 1-3 h at room temperature (21-23 ºC).  Subsequent 
immunostaining procedures were performed using peroxidase Vectastain ABC kit 
(Vector Laboratories, Inc., Burlingame, CA) and 3,3’-diaminobenzidine (DAB) as a 
substrate, according to the manufacturer’s protocol.  M.O.M Kit (Vector Laboratories, 
Inc., Burlingame, CA) was used for β-catenin immunostaining according to 
manufacturer’s protocol.  Sections were counter-stained with hematoxylin and mounted 
using Permount (Fisher Scientific).  For immunoflourscence, fluorescent secondary 
antibodies (Jackson Labs) were used at 1:75 dilution. Wholemount immunoflourescence 
staining was performed as described previously (Braun et al., 2003).  OCT compound-
embedded frozen sections were used for endogenous alkaline phosphatase staining.  
Endogenous alkaline phosphatase activity was visualized using Alkaline Phosphatase 




Stabilized β-catenin induced in adult epidermis causes formation of functional 
ectopic hair follicles in multiple regions of skin 
To test the effects of inducing mutation of β-catenin in adult epidermis, we used 
mice carrying a mutant β-catenin allele (Ctnnb1(Ex3)fl/+) (Harada et al., 1999), which 
yields a stabilized form of β-catenin (βcat*) following Cre-mediated recombination.  In 
the first set of experiments, Ctnnb1(Ex3)fl/+ mice were crossed with mice carrying a 4-
OHT-inducible K5-CreERT2 transgene (Indra et al., 1999) to generate bitransgenic mice 
(Figure 3-1).  Tail, dorsal, and dorsal foot skin from solvent-treated K5-
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CreERT2;Ctnnb1(Ex3)fl/+ mice was similar to control wild type skin, and did not contain 
any evidence of ectopic hair follicles or other skin appendages (Figure 3-1a-c).  In 
contrast, tail, dorsal, and dorsal foot skin from adult mice treated with 4-OHT to activate 
βcat* expression rapidly developed multiple, tightly packed de novo hair follicles within 
seven days (Figure 3-1d-f).  The de novo follicles developed from existing hair follicle 
outer root sheaths as well as interfollicular epidermis, and expressed hair follicle matrix 
marker CDP (Figure 3-1i, white arrowheads) and outer root sheath marker K17 (Figure 3-
1j).  In contrast to cell membranous β-catenin localization in control skin (Figure 3-1a’-
c’), βcat* skin revealed intense nuclear and cytoplasmic β-catenin localization, indicating 
robust activation of canonical Wnt signaling pathway.   
De novo follicle formation in 4OHT-induced K5-CreERT2;Ctnnb1(Ex3)fl/+ mice 
could also be seen via wholemount analysis of tail skin after epidermal-dermal separation 
(Figure 3-1g,h), where de novo follicles arising from existing tail hair follicles are visible 
















Figure 3-1.  β-catenin mediated development of de novo hair follicles in adult K5-
CreERT2;Ctnnb1(Ex3)fl/+ mice. (a-f) H&E sections of EtOH-treated (a-c) and 4OHT-
treated (d-f) tail, dorsal, and dorsal foot skin from K5-CreERT2;Ctnnb1(Ex3)fl/+ mice, 7 
days after treatment.  4OHT-treated tail, dorsal and dorsal foot skin contain de novo hair 
follicles arising from interfollicular epidermis as well as existing hair follicles. (a’-f’) 
Immunohistochemistry for β-catenin reveals ‘basket-weave’-like cell membranous 
localization in control (EtOH-treated) skin (a’-c’), while intense nuclear/cytoplasmic β-
catenin localization is seen in 4OHT-treated skin (d’-f’).  (g,h) Wholemount view of 
hematoxylin/Oil Red O-stained epidermis of tail skin after epidermal-dermal separation.  
De novo hair follicles arising from existing hair follicles are visible in 4OHT-treated tail 
skin (yellow arrowheads).  (i) Wholemount immunoflourescence for matrix marker CDP. 
Both existing hair follicle and de novo follicles (white arrowheads) show CDP expression.  
(j) Wholemount immunoflourecence staining for hair follicle marker K17 reveals K17-
positive de novo follicles arising from existing hair follicle. 
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Normal hairless volar skin is competent to form mature hair follicle lineages 
following expression of stabilized β-catenin (βcat*) 
Although Hh signaling activates several early markers of follicle development in 
hairless volar skin, advanced stages of follicle maturation are not achieved even after 
prolonged intervals (Allen et al., 2003; Grachtchouk et al., 2003).  To test whether volar 
skin is competent to respond to a potent signal for follicle development, we generated 
K5-CreERT2;Ctnnb1(Ex3)fl/+  double transgenic offspring, then applied either solvent or 
4-OHT on the dorsal skin starting at postnatal day 49 (Figure 3-2a).  Volar skin was then 
harvested and analyzed five days after 4-OHT treatment.  Volar skin from solvent-treated 
K5-CreERT2;Ctnnb1(Ex3)fl/+ mice was similar to control volar skin, and did not contain 
any evidence of hair follicles or other skin appendages (Figure 3-2b,d,f,h).  In contrast, 
volar skin from adult mice treated with 4-OHT to activate βcat* expression rapidly 
(within five days) developed multiple skin appendages (Figure 3-2c,d,g,i).  Some of these 
consisted only of dense aggregates of matrix-like cells, while others comprised matrix-
like cells associated either with hair shafts, sebaceous glands, or both (Figure 3-2e,g,i).  
Immunostaining and semiquantitative RT-PCR revealed expression of multiple hair 
follicle and sebaceous gland lineage markers, including the inner root sheath marker 
trichohyalin (detected using AE15 antibody) (O'Guin et al., 1992); hair follicle-specific 
keratin 6 (K6hf), a marker of the innermost layer of the outer root sheath (the companion 
layer) and medulla (Gailani et al., 1992); Lef-1, a hair matrix/pre-cortical marker; mouse 
hair keratin A1 (mHK-A1) (Kaytes et al., 1991) and Hacl-1, hair shaft-specific markers 
(Huh et al., 1994); K6irs, an inner root sheath specific marker (Thayer et al., 2003); and 
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the sebocyte marker Mc5r (Chen et al., 1997) (Figure 3-3e-i).  In addition, the dermal 
condensate/papilla marker, alkaline phosphatase, was induced in mesenchymal cells 
adjacent to the newly-formed follicles (Figure 3-3d).  Many of the epithelial cells in these 
follicles, as well as neighboring mesenchymal cells in the dermis, had intense nuclear β-
catenin expression detected by immunostaining (Figure 3-3b).  Thus, hairless volar skin 
remains competent to form mature hair follicles and sebaceous glands in adult mice 
following epidermal activation of a stabilized β-catenin mutant under the control of its 
endogenous promoter.   
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Figure 3-2.  β-catenin mediated development of de novo hair follicles and sebaceous 
glands in hairless volar skin. (a) Bitransgenic K5-CreERT2;Ctnnb1(Ex3)fl/+ mice and 
experimental design.  7 week old K5-CreERT2;Ctnnb1(Ex3)fl/+ mice were given either 
solvent or 4OHT to induce βcat* expression.  (b,c) Transilluminated wholemount view of 
hairless volar skin removed from ventral aspect of hind limb from EtOH-treated (b) and 
4OHT-treated (c) K5-CreERT2;Ctnnb1(Ex3)fl/+ mice, 5 days after treatment. In addition 
to skin folds also seen in controls (b), 4OHT-treated volar skin (c) contains multiple hair 
follicles which produce hair shafts (yellow arrowheads) (d-g) Wholemount view of 
hematoxylin/Oil Red O-stained epidermis after epidermal-dermal separation. De novo 
hair shafts and Oil Red O-positive sebaceous glands are visible in 4OHT-treated volar 
skin. (h,i) H&E-stained sections showing de novo hair follicles and sebaceous glands in 
4OHT-treated volar skin. Inset: Hair shaft in de novo hair follicle is visualized using 






Figure 3-3.  βcat*-induced de novo follicles express intensely nuclear and 
cytoplasmic β-catenin, alkaline phosphatase, and multiple late-stage follicle lineages.    
(a,b) Immunohistochemistry for β-catenin reveals ‘basket-weave’-like cell membranous 
localization in control (EtOH-treated) skin, while intense nuclear/cytoplasmic β-catenin 
localization is seen in 4OHT-treated skin. (c,d) Endogenous alkaline phostaphase, a 
marker for dermal papilla cells, is detected in 4OHT-treated volar skin. (e-h) 
Immunoflourescence for hair follicle lineage markers trichohyalin (detected with AE15 
antibody) and K6hf (Texas Red), and Keratin 5 (FITC), marker for the basal layer of 
epidermis and outer root sheath.  Trichohyalin and K6hf are only detected in hair follicles 
in 4OHT treated volar skin. (i) Semiquantitative RT-PCR demonstrating induction of hair 
follicle (mHA-K1, Hacl-1, and K6irs) and sebocyte lineage markers (Mc5r) in volar skin 
of 4OHT-treated K5-CreERT2;Ctnnb1(Ex3)fl/+ mice 5 days post-induction. Postnatal day 
8 control dorsal skin was used as positive control (hf). Note upregulation of the Wnt 
target gene and hair matrix marker Lef1 in 4OHT-treated volar skin. 
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βcat* expression results in preputial gland keratinization and differentiation 
Preputial gland is a large exocrine gland that is composed of two leaf-like 
structures located subcutaneously at the base of the penis.  Preputial glands are almost 
entirely composed of sebocyte-like cells and their progenitors, and normally do not 
express hair follicle or epidermal lineage markers.  During our analysis of 4-OHT treated 
K5-CreERT2;Ctnnb1(Ex3)fl/+ bitransgenic mice, we also noted significant hyperplasia of 
preputial glands in male K5-CreERT2;Ctnnb1(Ex3)fl/+  mice expressing βcat*.  Grossly, 
βcat*-expressed preputial glands were several-fold larger than controls, and appeared 
more opaque in color.  Histologically, normal preputial glands are almost entirely 
composed of sebocyte-like cells and their progenitors (Figure 3-4a), but βcat* preputial 
glands exhibited a marked loss of sebocyte population and instead featured large foci of 
accumulated keratinized material and morphological features of advanced stage hair 
follicle differentiation (Figure 3-4b).  β-catenin immunostaining revealed intense nuclear 
and cytoplasmic β-catenin localization in βcat*-expressing preputial gland (Figure 3-4d), 
indicating robust activation of canonical Wnt signaling pathway, but hardly any nuclear 
or cytoplasmic β-catenin localization was observed in control preputial gland (Figure 3-
4c).  Control preputial glands do not express hair follicle or epidermal lineage markers 
(Figure 3-4e,g), but βcat*-expressing preputial glands expressed multiple late stage hair 
follicle lineage markers, including the inner root sheath marker trichohyalin (detected 
using AE15 antibody); hair specific keratin (detected using AE13 antibody); and 





Figure 3-4.  βcat* induces preputial gland keratinization and differentiation.  (a) 
H&E-stained section of normal preputial gland.  Note normal preputial gland is 
composed almost entirely of sebocyte-like cells.  (b) H&E-stained section of βcat*-
expressing preputial gland. Note extensive keratinization with accumulation of 
keratinized material within the gland.  (c,d) β-catenin immunostaining reveals intense 
nuclear and cytoplasmic β-catenin localization in βcat*-expressing preputial gland, 
whereas cell membranous β-catenin localization is seen in control preputial gland.  (e,f) 
βcat*-expressing preputial gland expresses late stage follicle lineage marker 
trichohyaline (detected by AE15 antibody, FITC), and epidermal lineage marker K10 
(Texas Red).  Control preputial gland does not express trichohyalin or K10.  (g,h) βcat*-
expressing preputial gland expresses late stage follicle marker hair keratin (detected by 
AE13 antibody, FITC), and epidermal lineage marker K1 (Texas Red). Control preputial 
gland does not express hair keratin or K1.  
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M2SMO-induced ectopic buds and hamartomas in volar skin retain the capacity to 
produce late-stage follicle lineages with expression of stabilized β-catenin 
We then tested the effects of inducing βcat* expression in pre-existing follicular 
hamartomas in triple-transgenic (K5-CreERT2;Cre-inducible M2SMO; Ctnnb1(Ex3)fl/+) 
mice (Figure 3-5a).  This was feasible because the Cre-inducible M2SMO transgene 
undergoes limited recombination to produce follicular hamartomas in the absence of 4-
OHT treatment, in K5-CreERT2;Cre-inducible M2SMO bitransgenic mice (Allen et al., 
2003).  Therefore, when 4-OHT was applied to K5-CreERT2;Cre-inducible M2SMO; 
Ctnnb1(Ex3)fl/+ mice at postnatal day 49, these triple transgenic mice already had 
developed follicular hamartomas in their skin.  Expression of βcat* in M2SMO-
expressing skin starting at postnatal day 49 induced the appearance of multiple advanced-
stage hair follicle lineages rapidly within 7 days (Figure 3-5b-m).  Morphological 
changes resembling an expanded inner root sheath compartment and occasional hair 
shafts were evident in M2SMO+βcat* skin (Figure 3-5c), but not in skin expressing 
M2SMO alone (Figure 3-5b).  Epithelial cells in M2SMO+βcat* skin showed dark 
nuclear and cytoplasmic β-catenin localization (Figure 3-5e), with a staining intensity 
that appeared significantly higher than that seen in skin expressing M2SMO alone 
(Figure 3-5d).  M2SMO+βcat* skin also expressed the mesenchymal papilla marker 
alkaline phosphatase (Figure 3-5g), and multiple late stage epithelial follicle 
differentiation markers, including trichohyalin, hair shaft-specific keratin, and K6hf 
(Figure 3-5g,i,k,m), but skin from M2SMO mice did not (Figure 3-5f,h,j,l).  These data 
demonstrate that undifferentiated M2SMO induced hamartomas remain competent to 
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produce late stage hair follicle lineages following robust activation of canonical Wnt 




Figure 3-5. SMO*-induced hamartomas retain the capacity to produce late stage 
follicle lineages with expression of stabilized β-catenin.  
(a) Triple transgenic K5-CreERT2;Cre-inducible SMO*;Ctnnb1(Ex3)fl/+  mice and 
experimental design.  Due to leaky expression of Cre-inducible SMO* transgene without 
4OHT treatment, triple transgenic K5-CreERT2;Cre-inducible SMO*;Ctnnb1(Ex3)fl/+ 
mice produce follicular hamartomas prior to 4OHT treatment.  Induction of βcat* 
expression in 7 week old K5-CreERT2;Cre-inducible SMO*;Ctnnb1(Ex3)fl/+ mice was 
achieved by treating the mice with 4OHT (see text for more details). (b,c) H&E sections 
of volar skin from SMO* and SMO*+βcat* mice. Note morphological changes 
resembling an expanded inner root sheath compartment in SMO*+βcat* skin 
(arrowheads), compared to hamartomas in SMO* skin. (d,e) Immunostaining for β-
catenin reveals relatively much more intense nuclear/cytoplasmic β-catenin localization 
in SMO*+βcat* skin compared to SMO* alone. (f,g) Positive alkaline phosphatase 
activity in SMO*+βcat* skin, while SMO* alone does not stain for alkaline phosphatase. 
(h-m) Immunofluorescence staining for late stage follicle differentiation markers. 
SMO*+βcat* skin expresses AE15 (trichohyaline), AE13, and K6hf, while SMO* alone 




Forced expression of a stabilized β-catenin in epidermis led to robust and rapid 
formation of de novo hair follicles which expressed multiple follicle specific markers in 
tail, dorsal, and dorsal foot skin (Figure 3-1).  Furthermore, βcat* expression in epidermis 
led to the formation of alkaline phosphatase-expressing mesenchymal cells both in 
control and M2SMO-expressing volar skin (Figure 3-2 and 3-4).  In volar skin from 
M2SMO mice, βcat* induced the rapid appearance of late-stage follicle lineages and 
rudimentary hair shafts within hamartomas, showing that these undifferentiated tumors 
retain the potential to undergo advanced stages of terminal differentiation when supplied 
with an appropriate stimulus.  Since β-catenin immunostaining yields an intense signal in 
skin of M2SMO+βcat* mice, compared to M2SMO mice, it is possible that high-level β-
catenin activity in βcat*-expressing mice is required for activation of hair lineage 
markers.  Thus, the level of Wnt signaling in M2SMO mice may be sufficient to initiate 
epithelial bud development, but inadequate to stimulate terminal differentiation of hair 
lineages.  This would be in keeping with the intense expression of X-gal staining in lacZ-
based TCF/Lef reporter mice in hair precursor cells in mature follicles, compared to 
relatively low staining levels detected in hair buds (DasGupta and Fuchs, 1999), and the 
ability of high-level canonical Wnt signaling to drive development of follicle lineages 
even in glandular epithelia (Bierie et al., 2003; Miyoshi et al., 2002).  Despite consistent 
detection of nuclear and cytoplasmic β-catenin in epithelial buds and hamartomas in 
M2SMO-expressing skin, we have been unable to detect TCF reporter activity using the 
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TOPgal mouse reporter line (DasGupta and Fuchs, 1999), arguing that in certain settings, 
immunolocalization of β-catenin provides a more reliable read-out of signaling activity. 
As a control for experiments examining the consequences of βcat* induction in 
follicular hamartomas, we also examined the effects of postnatal βcat* activation in 
otherwise normal volar epidermis in adult mice.  Within 5 days, βcat*-expressing mice 
developed multiple de novo skin appendages, some of which appeared to be relatively 
normal-appearing follicles with sebaceous glands and hair shafts.  Particularly interesting 
was the concurrent appearance of other ‘types’ of skin appendages with seemingly 
different combinations of cell types: some of these follicular structures produced only 
hair shafts, others only a sebaceous gland, and still others exhibited little evidence of 
terminal differentiation, based on tissue morphology (Figure 3-2e,g).  What could explain 
this phenomenon?  Possible explanations for these findings include βcat* activation in 
epidermal progenitors with different developmental potential; activation of an inductive 
mesenchyme adjacent to only a subset of these lesions; or differential expression of 
required cofactors, e.g., Tcf4, in volar epidermis.  It still remains to be determined if 
mesenchymal condensates/dermal papillae are only seen in a subset of de novo 
‘appendages,’ which may help explain why hair shafts are only seen in some.  
Nonetheless, our findings underscore the plasticity of adult skin even from a region that 
is normally hairless, and although other investigators had not reported follicle 
development in hairless skin following Wnt pathway activation (Gat et al., 1998; Lo 
Celso et al., 2004), our study is the first to examine the consequences of expressing an 
activated β-catenin mutant from its endogenous promoter in adult mice.  Although earlier 
studies have demonstrated expression of truncated β-catenin mutant is sufficient to 
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induce de novo hair follicle development in skin (Gat et al., 1998; Lo Celso et al., 2004; 
Silva-Vargas et al., 2005), these skin-targeting studies studies have generally used basal 
cell keratin K14 promoter, which is either not expressed, or weakly expressed, in hair 
matrix and matrix progenitor cells.  In addition, it is also plausible that in previous studies, 
K14 promoter activity could have been downregulated by mutant β-catenin, in contrast to 
positive feedback regulation of epithelial β-catenin mRNA levels by βcat* (Liu et al., 
2007).  It is also possible that there may be subtle activity differences in the mutant β-
catenin protein with its first 87 N-terminal residues truncated and exon 3-deleted β-
catenin mutant protein used here.   
Aforementioned β-catenin mutant-induced do novo hair follicles in haired skin 
provided a niche for melanocytes, and the hair shafts were pigmented (Lo Celso et al., 
2004).  The βcat*-induced de novo follicles and associated hair shafts that formed in the 
hairless volar skin in our model did not contain pigment morphologically, although more 
rigorous biochemical assays to determine the presence of melanocytes have not been 
done.  If βcat*-induced follicles do not contain melanocytes or pigmented hair shafts, it 
will be interesting to determine why de novo follicles that form on hairless volar skin are 
incompetent to accumulate pigmented hair shafts.  
βcat* expression induced the formation of nearly normal-appearing hair follicles 
in hairless volar skin within 5 days.  Because the hairless volar skin is a 
morphogenetically naive epidermis that normally does not contain hair follicles or 
follicle-associated structures, it can be considered a ‘clean slate’ with no expression of 
hair follicle lineage markers.  One can therefore take advantage of this fact and perform 
mircroarray experiments on βcat*-induced skin at different timepoints (day 0, 1, 3, 5, etc) 
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to globally monitor gene expression profile changes during de novo hair follicle 
morphogenesis.  It will be an important finding to compare any differences in gene 
expression patterns during postnatal de novo hair follicle morphogenesis versus normal 
embryonic hair follicle development.  By employing the already developed epidermal-
dermal separation technique that works extremely well with hairless volar skin, the 
βcat*-induced volar skin can even be separated into epidermal-dermal components and 
the microarray analysis may be done separately to dissect out the molecular signatures.  
We also saw βcat*-induced keratinization and differentiation of preputial glands 
in 4-OHT treated male K5-CreERT2;Ctnnb1(Ex3)fl/+ mice (Figure 3-4).  Preputial glands 
are almost entirely composed of sebocyte-like cells and their progenitors, and normally 
do not express hair follicle or epidermal lineage markers.  However, βcat* expression 
drove development of expression of multiple late-stage follicle lineage markers in 
preputial glands of K5-CreERT2;Ctnnb1(Ex3)fl/+ mice.  These results are in keeping with 
previous studies which found that activated of canonical Wnt signaling leads to 
transdifferentiation and development of hair follicle lineages in glandular epithelia such 
as prostate and mammary epithelium (Bierie et al., 2003; Miyoshi et al., 2002).   
It will be interesting to examine the consequences of expressing βcat* in the 
suprabasal cells of the epidermis and test whether forced activation of canonical Wnt 
signaling will have an effect on the further differentiated suprabasal cells.  To achieve 
this, one can utilize K10-CreERT2 mice to generate K10-CreERT2;Ctnnb1(Ex3)fl/+  
bitransgenic mice, which will then allow for Cre recombination and accumulation of 
βcat* in the suprabasal cells of the epidermis upon 4-OHT treatment.  Could βcat* 
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expression in the differentiated suprabasal epithelial cell population induce de-
differentiation of these cells and force them to differentiate into follicle lineages?   
Previous studies showed that expression of constitutively active β-catenin mutant 
in mouse skin induces the development of hair follicle derived tumors such as 
pilomatricoma and trichofolliculoma, although these tumors did not develop until the 
transgenic mice reached several months of age (Gat et al., 1998; Lo Celso et al., 2004).  I 
also wanted to test whether βcat* expression would lead to tumor development in haired 
as well as hairless volar skin of 4-OHT treated K5-CreERT2;Ctnnb1(Ex3)fl/+  mice, but 
no tumor development was seen in K5-CreERT2;Ctnnb1(Ex3)fl/+  mice 45 days after 4-
OHT treatment.  It is possible that pilomatricoma or triochofolliculoma may develop in 
these mice if allowed to survive longer, but 4-OHT treated K5-CreERT2;Ctnnb1(Ex3)fl/+  
mice became sick and moribund a few weeks after 4-OHT treatment and had to be 
euthanized.  To circumvent this problem, it may be necessary to use a much diluted 
concentration of 4-OHT and apply a tiny volume onto a small area on the skin (1-2 uL) to 
induce a localized Cre-recombination and βcat* accumulation and avoid a systemic βcat* 
effect.  These mice should then survive for a normal life-span after 4-OHT treatment and 
can then be monitored for any tumor development.   
βcat*-induced de novo hair follicles that formed in hairless volar skin looked 
relatively normal with sebaceous glands and hair shafts, and they also expressed the stem 
cell marker K15 (data not shown) (Morris et al., 2004), suggesting the establishment of 
stem cell niche in βcat*-induced de novo follicles.  It would be interesting to determine 
whether these de novo follicles also undergo normal hair cycles of growth, regression and 
quiescence, but with the current K5-CreERT2;Ctnnb1(Ex3)fl/+ system this may not be 
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possible as the continuous accumulation of βcat* disrupts follicle morphology and 
function.  An alternative, inducible model of βcat* expression in skin where βcat* can be 
transiently expressed in the volar skin, and subsequently switched off, will be necessary 
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Epithelium-specific activation of Hh signaling is sufficient to reactivate growth of 
resting hair follicles 
Introduction 
Like other organs, developing hair follicles arise via a precisely orchestrated 
series of secreted signals traveling between epithelial hair follicle progenitors and an 
adjacent mesenchymal condensate, which together ultimately give rise to a mature hair-
producing follicle.  Multiple inductive signals are expressed and play a role during hair 
follicle morphogenesis, and in particular, Shh is produced and secreted by a group of 
epithelial cells in the developing hair bud.  Based on initial studies mapping the 
expression patterns of developing hair follicle (Oro et al., 1997; St Jacques et al., 1998; 
Chiang et al., 1999; Mill et al., 2003), the Hh pathway is activated in epithelial cells of 
the hair bulb and outer root sheath, as well as in the dermal papillae (Sato et al., 1999; 
Oro and Higgins, 2003).  Once formed, the postnatal hair follicle undergoes repeated 
cycles of growth, regression, and rest (Paus and Cotsarelis, 1999; Stenn and Paus, 2001), 
thus making it an unique and ideal model for studying fundamental questions involving 
cutaneous stem cell biology, organogenesis, and regeneration. The expression of Shh and 
Hh target genes in follicle epithelium is restricted to the active growth phase, anagen 
(Sato et al., 1999; Oro and Higgins, 2003).  However, the precise location of Hh-
activated cells in growing and resting hair follicles has not yet been established.  The 
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deepest portion of the growing anagen follicle contains highly proliferative matrix cells 
which give rise to multiple cell lineages in the inner root sheath and hair shaft.  During 
catagen, proliferation ceases, and there is massive apoptosis, leaving a relatively small 
number of non-proliferative epithelial cells surrounding the telogen hair shaft (Figure 1-
2).  It is within this residual epithelial cell compartment, often referred to as the ‘bulge’, 
that stem cells capable of giving rise to all cell lineages in the hair follicle, sebaceous 
gland, and epidermis, reside (Cotsarelis et al., 1990; Kobayashi et al., 1993; Oshima et al., 
2001).   
As mentioned in the previous chapters, it has been well-established that the 
canonical Wnt pathway can act as a switch to trigger new hair growth, and Wnt pathway 
activation in telogen mouse skin is sufficient to induce new hair growth cycle (Van Mater 
et al., 2003; Lo Celso et al., 2004).  Subsequently, Shh acts as a powerful stimulus to 
drive proliferation of the growing follicle epithelium during anagen.  However, 
adenoviral delivery of Shh (Sato et al., 1999) or topical application of a synthetic Hh 
agonist (Paladini et al., 2005) can also stimulate telogen follicles to enter anagen, 
suggesting that Hh signaling can also act as a switch for triggering follicle growth 
(perhaps indirectly via activation of canonical Wnt signaling, a hypothesis that will need 
to be explored in future studies).  It should be noted that each of these approaches 
delivered Hh pathway activators indiscriminantly to multiple cutaneous cell types, 
including the follicle epithelium and mesenchyme.  These studies therefore raise several 
fundamental questions:  does Shh act directly on hair follicle stem cells to reactivate 
growth and trigger a new anagen phase?  Is epithelial Hh signaling sufficient to initiate 
new follicle formation?  In this chapter, I addressed these questions using novel 
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conditional mouse models that allow precise spatial and temporal control of Hh signaling 
activity in skin.  One such mouse model is the tetracycline-inducible TRE-SmoA1 mouse 
(developed by fellow MSTP student Evan Michael in the Dlugosz laboratory).  When 
crossed with K5-rtTA (Diamond et al., 2000) mouse, resulting K5-rtTA;TRE-SmoA1 
bitransgenic mice express SmoA1, cell-autonomous activator of Hh signaling, 
specifically in the epithelium upon doxycycline administration.  Utilizing this inducible 
mouse model, I was able to address the question of whether epithelium-specific Hh 
activation is sufficient to trigger new follicle growth.   
Furthermore, it has been established that Hh signaling promotes growth of many 
tissues, and it has been proposed that Hh triggers proliferation by acting directly on stem 
cell populations to maintain normal homeostasis, or when aberrantly activated, in 
tumorigenesis [reviewed in (Ruiz i Altaba et al., 2002)].  However, there is limited 
functional data that support this theory in vertebrates and no study to date has 
conclusively demonstrated this.  By utilizing the keratin 15 (K15) promoter which 
selectively targets transgene expression specifically to stem cells in the bulge 
compartment of hair follicles in postnatal mice (Liu et al., 2003; Morris et al., 2004), I 
was able to test the effects of modulating Hh function selectively in this stem cell 
population in vivo, to test whether stem cell compartment-specific Hh activation is 
sufficient to induce new follicle growth in telogen hair follicles.  
The data described in this chapter and additional future work based on the data 
presented will enhance our understanding of how Hh signaling influences skin appendage 
biology and may ultimately have clinical impact affecting a large proportion of the 
population, given that disorders of the hair follicle and sebaceous glands are extremely 
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common.  Understanding the molecular basis for growth and maintenance of the follicle 
may yield new approaches to treating these conditions.  
 
 
Materials and Methods 
Transgenic mice and conditional transgene activation.   
To focally activate Hh signaling specifically in the epithelium, we crossed K5-
rtTA (Diamond et al., 2000) mice with TRE-SmoA1 (generated by Evan Michael) mice.  
Resulting K5-rtTA;TRE-SmoA1 double transgenic mice were screened and used for 
experiments.  To induce SmoA1 expression, doxycycline (20 mg/ml) was administered in 
drinking water with 5% sucrose, and in doxycycline-containing chow (Bio-serve, 
200mg/kg).  After three days, mice were maintained on doxycycline-containing chow but 
received normal drinking water.  Duration of doxycycline administration varied with each 
experiment, as described in results section below.  To generate triple transgenic mice 
with inducible expression of SmoA1 specifically in the stem cell compartment, R26X-
rtTA+GFP (Yu et al., 2005; Belteki et al., 2005) mice were crossed with TRE-SmoA1 
transgenic mice.  R26X-rtTA+GFP;TRE-SmoA1 bitransgenic mice were then crossed 
with K15-CrePR1 (Morris et al., 2004) to generate Cre- and doxy- regulated K15-
CrePR1;R26X-rtTA+GFP;TRE-SmoA1 triple transgenic mice.  To induce stem cell 
compartment specific expression of SmoA1 transgene, triple transgenic animals were 
clipped, and 200 uL of RU486 (200 ug/mL) was topically applied on dorsal skin at 
postnatal day 51 once daily for five days, and doxycycline was administered orally as 
described above.  All mice were housed and maintained according to University of 
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Michigan institutional guidelines, as stipulated by the University Committee on the Use 
and Care of Animals.  
 
Tissue harvesting.   
For hematoxylin and eosin (H&E) staining and immunohistochemistry, mouse 
skin samples were fixed in neutral-buffered formalin (NBF) overnight, transferred to 70% 
ethanol, processed, and embedded in paraffin.  Images were captured as described 
previously (Chapter II).  
 
Immunostaining.   
The following primary antibodies were used for immunostaining: Sox9 (rabbit 
polyclonal, 1:1,000, Chemicon); K17 (rabbit polyclonal, 1:4,000, gift from P. 
Coulombe); K6 (rabbit polyclonal, 1:500, Covance); HA (rat polyclonal, 1:100, Roche); 
K15 (mouse monoclonal, 1:250, Neomarkers); CD34 (1:50, rat polyclonal, BD 
Biosciences); β-catenin (mouse monoclonal, 1:1,000, Sigma); Ki67 (rabbit polyclonal, 
1:500, Vector Laboratories).  Immunohistochemistry was performed as described 
previously (Chapter II).   
 
Results 
Epithelial-specific Hh activation by SmoA1 in telogen skin is sufficient to reactivate 
growth of resting hair follicles 
First, we tested whether epithelial Hh activation in quiescent telogen skin is 
sufficient to trigger new follicle growth.  To test this hypothesis, I utilized doxycycline-
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inducible K5-rtTA;TRE-SmoA1 bitransgenic mice, where epithelium-specific expression 
of  SmoA1 transgene, a constitutively activated allele of the proximal Hh effector Smo 
that drives cell-autonomous activation of Hh signaling, could be induced by  
administration of doxycycline.  Postnatal hair cycling during the synchronized period is 
well characterized in C57/BL6 mice (Figure 4-1 and (Paus et al., 1999)), and the dorsal 
hair follicles enter prolonged second telogen phase at approximately postnatal day 40 and 
remain in telogen until about postnatal day 70.  Taking advantage of this fact, K5-
rtTA;TRE-SmoA1 mice and littermate controls were allowed to mature to postnatal day 
50, when the dorsal hair follicles had just entered a prolonged telogen phase.  At 
postnatal day 50, K5-rtTA;TRE-SmoA1 and control mice were given: A) doxycycline 
only; B) depilation only to induce anagen; or C) doxycycline and depilation to assess the 
effects of heightened Hh signaling on activated follicular cells that are undergoing active 
phases of growth and proliferation.  Doxycycline administration was continued for 12 
days, and the animals were sacrificed and skin harvested at postnatal day 62.   
Depilation using a depilatory agent is a well-established method to stimulate 
anagen induction.  As expected, depilation alone induced reactivation of follicle growth 
in both K5-rtTA;TRE-SmoA1 and control mice (Figure 4-2b,e).  In addition, we also saw 
morphological evidence of reactivated follicle growth in doxycycline-treated K5-
rtTA;TRE-SmoA1 mice, suggesting that the epithelium-specific activation of Hh signaling 
by SmoA1 expression was also sufficient to trigger anagen (Figure 4-2a).  We also 
treated control mice with doxycycline to assess whether doxycycline alone has an effect 
on hair follicle cycling; we observed no abnormal phenotype in doxycycline-treated 
control skin, and the hair follicles remained in telogen (Figure 4-2d).  Reactivated follicle 
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growth was also induced in K5-rtTA;TRE-SmoA1 and control mice that were treated with 








Figure 4-1. Cartoon illustrating experimental design and time-line for induction of 
SmoA1 expression in K5-rtTA;TRE-SmoA1 mice during prolonged resting phase.  
Hair follicle cycling is synchronized in the first few months of life in mice.  Taking 
advantage of this fact, K5-rtTA;TRE-SmoA1 mice and littermate controls were allowed to 
reach postnatal day 50 (when the dorsal hair follicles are in the prolonged telogen phase), 
and the mice were either A) given doxy only; B) depilated only; and C) given doxy and 
depilated.  Doxycycline was administered for 12 days, and the animals were sacrificed 










Figure 4-2. Epithelial Hh activation by SmoA1 is sufficient to trigger new hair 
growth, but with preferential expansion of outer rooth sheath (ORS) cells near the 
bulge, the stem cell compartment.  (a) H&E-stained sections of K5-rtTA;TRE-SmoA1 
mice that were given doxy only (“Doxy”). Hair follicles are in anagen, in contrast to 
control (d), but with an expansion of ORS compartment.  (b,e) H&E-stained sections of 
K5-rtTA;TRE-SmoA1 and control mice that were depilated. Note presence of anagen 
follicles in both. (c,f) H&E-stained sections of K5-rtTA;TRE-SmoA1 and control mice 
that were treated with doxycycline and depilated.  Anagen follicles are seen in both, but 
note expansion of ORS cells near the bulge, stem cell compartment.  (A’,B’) High-
powered magnification view of follicles in (c,f). Note expansion of ORS cells in A’ 
compared to B’. 
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Preferential expansion of outer root sheath cells near follicle bulge, the stem cell 
compartment, in SmoA1-induced growing hair follicles 
Interestingly, histological analysis revealed a preferential expansion of outer root 
sheath (ORS) cells in SmoA1-induced follicles just below the sebaceous gland, which 
corresponded to the area of the stem cell niche, the bulge.  The ORS expansion was 
observed in both doxycycline-treated, and doxycycline-treated and depilated K5-
rtTA;TRE-SmoA1 skin (Figure 4-2a,c).  The close proximity of the expanding ORS cells 
in SmoA1-induced follicles to the bulge might suggest that SmoA1 expression may 
induce an expansion of the follicular stem cells and/or their transit-amplifying progeny.  
Expansion of the ORS cells in SmoA1-induced follicles compared to control was easily 
appreciated (Figure 4-2A’,B’.  Immunophenotyping confirmed the expansion of ORS 
cells (Figure 4-3) in doxycycline-treated K5-rtTA;TRE-SmoA1 mice.  ORS-specific 
marker Sox9 immunostaining revealed a massive expansion of Sox9-positive ORS cells 












Figure 4-3. Preferential expansion of ORS compartment in SmoA1-induced follicles. 
(a) Immunofluorescence staining of control anagen follicles with ORS-specific marker 
Sox9. Sox9 staining reveals Sox9-positive ORS cells that are 1-2 cell layers thick.  (b) 
Immunofluorescence staining of doxycycline-treated K5-rtTA;TRE-SmoA1 follicles with 
Sox9.  Note massive expansion of Sox9-positive cells 
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SmoA1 transgene is expressed in both ORS and matrix compartments, but distinct 
cell populations show differing responsiveness to SmoA1 
Intrigued by the expansion of the ORS compartment in SmoA1-induced follicles, 
we then next sought to determine SmoA1 transgene expression pattern in the doxycycline 
treated K5-rtTA;TRE-SmoA1 skin.  Because of the presence of HA-epitope tag in the 
SmoA1 transgene construct, SmoA1 transgene expression could be easily detected by 
simple HA immunostaining.  No HA expression could be detected in mice that were not 
treated with doxycycline, confirming the lack of SmoA1 expression and tight regulation 
of transgene expression in uninduced K5-rtTA;TRE-SmoA1 bitransgenic mice (Figure 4-
4c).  In contrast, HA-positive cells were detected in the ORS compartment, interfollicular 
epidermis, and matrix compartment of doxycycline treated follicles of K5-rtTA;TRE-
SmoA1 mice.  Interestingly, HA-staining was not homogeneous and uniform in SmoA1-
induced follicles, but rather patchy with numerous non-HA positive cells mixed in 
together with HA-positive cells in the ORS compartment (Figure 4-4d).  In addition, 
intensely HA-positive cells were detected in the matrix compartment of doxycycline 
treated follicles (Figure 4-4j), suggesting that robust levels of SmoA1 transgene was 
expressed in the matrix compartment.  However, in contrast to the ORS compartment of 
SmoA1-induced follicles where prominent ORS expansion was apparent (Figure 4-4a,b), 
the matrix compartment morphologically looked similar to control (Figure 4-4g,h).  In 
addition, Hh target gene K17 expression and localization were indistinguishable in the 
matrix compartment of SmoA1-induced follicles compared to control (Figure 4-4k,l), 
suggesting that despite robust SmoA1 transgene expression, SmoA1 had no gross effect 
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Fig. 4-4. Differing responsiveness of distinct cell populations to SmoA1 transgene 
expression.  (a,b) H&E-stained sections of control (a) and doxycycline treated (b) 
follicles, showing expansion of ORS compartment in (b).  (c,d) HA immunostaining 
reveals patchy HA expression in ORS compartment of doxycycline treated follicles (d), 
while no HA expression is seen in control (c).  (e,f) ORS-specific marker K17 
immunostaining reveals expansion of the ORS compartment in SmoA1-induced follicles 
compared to control.  (g,h) H&E-stained sections of the matrix compartments of control 
(g) and SmoA1-induced (h) follicles.  Despite robust SmoA1 expression as assessed by 
HA immunostainig (j), matrix compartment of doxycycline treated follicle (h) 
morphologically looks normal and virtually indistinguishable to control (g).  (k,l) Hh 
target gene K17 staining reveals virtually identical K17 expression in control (k) and 
doxycycline treated (l) follicles. 
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Expression of stem cell markers K15 and CD34 is lost over time in follicles 
reactivated to grow by SmoA1 
Because the location of ORS expansion in SmoA1-induced follicles was in close 
proximity to the bulge, we were intrigued by the possibility that epithelium-specific Hh 
activation may lead to the expansion of the follicular stem cells.  To begin addressing this 
issue, I used the follicle stem cell markers K15 (Liu et al., 2003; Morris et al., 2004) and 
CD34 (Trempus et al., 2003) to see whether the expanded ORS contained an increased 
number of cells expressing K15 and/or CD34 expression.  K15 and CD34 expression and 
localization in the bulge region of control telogen follicles confirmed that these markers 
were specific for the follicle bulge (Figure 4-5a,c).  Interestingly, the expanded ORS cells 
of SmoA1-induced follicles did not express K15 or CD34 (Figure 4-5b,d).  Additional 
functional studies will be required to assess whether Hh signaling leads to an expansion 
of stem or progenitor cells, despite the apparent absence of stem cell markers in this 
interesting cell population.   
Next, instead of a 12 day doxycycline administration in K5-rtTA;TRE-SmoA1 
mice, they were given doxycycline for 3 days and skin harvested at day 3.  Previously, it 
was found that application of topical Hh agonist on dorsal skin did not induce an 
appreciable upregulation of Hh transcriptional activity for several days (Paladini et al., 
2005), suggesting that Hh pathway activation in telogen skin may be triggering anagen 
indirectly via a secondary signaling pathway.  Given my earlier data on Hh-Wnt 
interactions during Hh-driven ectopic epithelial bud development, I hypothesized that 
forced Hh activation in follicle epithelium may trigger new follicle growth indirectly via 
activation of canonical Wnt pathway.  K5-rtTA;TRE-SmoA1 mice in prolonged telogen 
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phase (postnatal day 50) were given doxycycline for 3 days, and then were sacrificed and 
skin harvested at day 3.  Morphologically, 3 day SmoA1-induced follicles featured 
expansion of the secondary hair germ at the base of follicles (Figure 4-6a,b).  HA 
immunostaining confirmed robust expression of SmoA1 transgene in SmoA1-induced 
follicles, especially at the base of follicles (Figure 4-6c,d).  Double immunostaining of 
SmoA1-induced follicles with Ki67 and HA revealed that the majority of HA-positive 
cells were also Ki67-positive, consistent with the possibility that SmoA1 may be driving 
the proliferation of follicle epithelial cells (Figure 4-6i,j). 
I then examined β-catenin localization in early SmoA1-induced follicles.  β-
catenin immunostaining revealed robust nuclear and cytoplasmic β-catenin localization at 
the base of SmoA1-induced follicles (Figure 4-6f), indicating activation of canonical Wnt 
signaling pathway, while no nuclear/cytoplasmic β-catenin localization was seen in 
control (Figure 4-6e).  This data suggests that epithelial Hh activation leads to canonical 
Wnt activation, and that Hh-mediated hair follicle growth may be mediated indirectly via 
activation of canonical Wnt activation.  However, functional study to definitively test this 
hypothesis is still required (see Discussion for additional comments).  Interestingly, 
intensely nuclear β-catenin localization was also seen in dermal papillae of SmoA1-
induced follicles (Figure 4-6f), although SmoA1 transgene was not expressed in dermal 
papilla cells as assessed by HA staining (Figure 4-6j), suggesting a mesenchymal 
response to secreted Wnt ligands.   
Furthermore, immunostaining with the stem cell marker K15 in 3 day SmoA1-
induced follicles revealed an expansion of K15-positive cells (Figure 4-6h) compared to 
control (Figure 4-6g), which was in contrast to the lack of K15 positive cells in 12 day 
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SmoA1-induced follicles (Figure 4-5b,d).  Based on these initial stem cell marker 
immunostaining results, it is possible that while the initial SmoA1 expression induces 
expansion of the follicular stem cell population, continued SmoA1 expression and 








Figure 4-5.  Stem cell markers K15 and CD34 are not expressed in expanded ORS 
cells of SmoA1-induced follicles. (a) K15 is expressed in the bulge region of control 
telogen follicle. Note patchy K15 expression also in the interfollicular epidermis. (b) K15 
is not expressed in expanded ORS cells of SmoA1-induced follicles. (c) CD34 is 
expressed in the bulge region of control telogen follicle.  (d) CD34 is not expressed in 










Figure 4-6.  3-day SmoA1 expression in telogen skin induces canonical Wnt pathway 
activation and expansion of K15 positive cells.  (a,b) H&E stained sections of dorsal 
skin from control (a) and K5-rtTA;TRE-SmoA1 mice treated with doxycycline for 3 days 
(b).  (c,d) As assessed by HA immunostaining, SmoA1 transgene is expressed in the hair 
follicles of doxycycline treated K5-rtTA;TRE-SmoA1 mice, but not in control (c).  (e,f) β-
catenin immunostaining reveals robust nuclear and cytoplasmic β-catenin localization in 
SmoA1-induced follicle at the base and in the dermal papilla (f), indicating activation of 
canonical Wnt pathway.  No nuclear/cytoplasmic β-catenin localization is seen in control 
follicle (e).  (g,h) Expansion of K15 positive cells are seen in SmoA1-induced follicle (h), 
compared to control (g).  (i,j) Double immunoflourescence staining using Ki67 and HA 
antibodies reveal numerous follicular cells co-expressing Ki67 and HA at the base of 
follicle, while no HA-positivity and occasional Ki67 positive cells in the secondary hair 





Activation of Hh Signaling in the stem cell compartment does not induce anagen 
Given the results above and the widely held notion that Hh signaling acts directly 
on stem cells during development and tumorigenesis [reviewed in (Altaba et al., 2002)], I 
hypothesized that Hh pathway activation specifically in quiescent hair follicle stem cells 
would be sufficient to reactivate hair follicle growth.  To test this hypothesis, I utilized 
K15-CrePR1 mice (Morris et al., 2004), which allows for specific targeting of transgene 
expression to stem cells within the bulge compartment of hair follicles in postnatal mice.  
In K15-CrePR1;Rosa26Reporter bitransgenic mice, topical treatment with the 
progesterone antagonist RU486 activates Cre function and results in recombination 
strikingly limited to the stem cell compartment of telogen hair follicles.  In addition, fate-
mapping studies using similarly-treated mice shows that progeny of these β-gal 
expressing cells can contribute to all epithelial cell types in the epidermis, hair follicle, 
and sebaceous gland, verifying that recombination/lacZ activation took place in 
multipotent progenitor cells (Morris et al., 2004).  To activate Hh pathway specifically in 
the stem cell compartment, I generated triple transgenic K15-CrePR1;R26X-
rtTA+GFP;TRE-SmoA1 mice, which combined the Cre- and doxycycline-regulated 
systems to achieve tight control of transgene expression in hair follicle stem cells (Yu et 
al., 2005; Belteki et al., 2005).  Triple transgenic mice and littermate controls in second 
prolonged telogen were treated with topical RU486 once daily for 5 days starting at post-
natal day 51, and were given doxycycline, clipped and monitored for hair growth (Figure 
4-7).  Similar to the experiment outlined in Figure 4-1, triple transgenic mice and controls 
were also depilated only, and treated with RU486 and doxycycline, and depilated to 
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assess the effect of heightened Hh signaling on activated follicle stem cells and their 
transient-amplifying cell progeny.   
As expected, new follicle growth was observed in control and triple transgenic 
mice that were depilated only (Figure 4-8b,e).  However, follicles in doxycycline-treated 
triple transgenic mice remained in telogen and new follicle growth was not observed 
(Figure 4-8a), suggesting that Hh activation by SmoA1 specifically in the stem cell 
compartment is not sufficient to trigger new hair growth.  In contrast, triple transgenic 
mice that received doxycycline and were depilated featured prominent expansion of ORS 
cells compared to control (Figure 4-8c,f).  HA immunostaining to assess SmoA1 
transgene expression revealed occasional HA-positive cells in doxycycline treated 
follicles (Figure 4-8g), while robust HA expression was seen in doxycycline-treated and 
depilated follicles (Figure 4-8i).  Immunostaining with ORS-specific marker Sox9 
confirmed expansion of Sox9-positive ORS cells in doxycycline-treated and depilated 










Figure 4-7.  Cartoon illustrating experimental design and time-line for induction of 
SmoA1 expression in K15-CrePR1;R26X-rtTA+GFP;TRE-SmoA1 mice during 
prolonged resting phase. K15-CrePR1;R26X-rtTA+GFP;TRE-SmoA1 mice were 
allowed to age to postnatal day 51, when dorsal hair follicles were in second prolonged 
telogen.  At postnatal day 51, triple transgenics and littermate controls were treated with 
topical RU486 once daily for 5 days.  After 5 days (postnatal day 56), triple transgenic 
mice and controls were : A) given doxycycline only; B) depilated only; and C) given 
doxycycline and depilated. Doxycycline was administered for 12 days, and the animals 




Figure 4-8. Activation of Hh Signaling in stem cell compartment does not induce 
anagen.  (a,d) H&E stained sections of dorsal skin from K15-CrePR1;R26X-
rtTA+GFP;TRE-SmoA1 mice (a) and controls (d) treated with doxycycline.  Note 
follicles are in telogen phase in K15-CrePR1;R26X-rtTA+GFP;TRE-SmoA1 skin, 
suggesting that SmoA1 expression specifically in the stem cell compartment is not 
sufficient to trigger new follicle growth.  (b,e) As expected, new follicle growth is seen in 
triple transgenic and control mice that are depilated.  (c,f) H&E stained sections of K15-
CrePR1;R26X-rtTA+GFP;TRE-SmoA1 mice and controls that were given doxycycline 
and were depilated.  Note ORS expansion and clear cell hyperplasia in (c) compared to 
(f).  (g) HA immunostaining reveals occasional HA positive follicles in doxycycline 
treated skin.  In contrast, expanded ORS cells in triple transgenic mice show robust but 
patchy HA expression (i).  (j,k,l) ORS specific marker Sox9 immunostaining reveals 
ORS expansion in K15-CrePR1;R26X-rtTA+GFP;TRE-SmoA1 mice (l) compared to 




Adenoviral delivery of Shh (Sato et al., 1999) as well as topical treatment with 
Hh-agonist (Paladini et al., 2005) in mouse skin is sufficient to trigger growth of 
quiescent telogen follicles in mice.  However, in both settings, multiple cell types 
including keratinocytes, fibroblasts, and other mesenchymal cells, including dermal 
papilla cells, may have been responding to Hh pathway activation, and it is not clear 
whether activation of follicle growth was due to direct stimulation of quiescent bulge 
stem cells, or a consequence of stimulating additional cell types which could then 
indirectly influence the stem cell compartment through a secondary signal(s).  Utilizing 
novel mouse models that allow precise spatial and temporal control of Hh signaling in 
skin, I tested whether epithelium-specific activation of Hh signaling is sufficient to 
trigger follicle growth in resting telogen skin.  My results with K5-rtTA;TRE-SmoA1 
bitransgenic mice show that epithelium-specific Hh activation is sufficient to trigger new 
follicle growth (Figure 4-2).   
Interestingly, 12-day SmoA1-induced anagen follicles also featured expansion of 
the ORS compartment near the bulge, the stem cell niche of the hair follicle (Figure 4-4b).  
Furthermore, 3-day SmoA1-induced follicles exhibited expansion of stem cell marker 
K15-positive cells in the reactivated hair follicle, which also expressed robust levels of 
SmoA1 transgene and increased Ki67 expression (Figure 4-6h).  In addition, a very brief 
doxycycline induction (12 – 24 hours) in K5-rtTA;TRE-SmoA1 mice resulted in new 
follicle growth without obvious expansion of the ORS compartment (data not shown).  
We therefore suspected SmoA1 may drive the expansion of follicular stem cells.  
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However, immunostaining with stem cell markers revealed lack of K15 and CD34 
expression in the expanded ORS cells of 12-day SmoA1 induced follicles.  Based on 
these observations, it is possible that while SmoA1 expression initially induces the 
expansion of follicular stem cells, sustained and continued Hh activation for 12 days may 
deplete the stem cell reservoir.  It should also be noted that the lack of positive K15 or 
CD34 staining does not absolutely preclude the fact that Hh signaling may influence the 
function and status of follicular stem cells.  To address this issue, more rigorous 
functional assays such as fluorescence activated cell sorting analysis and in vitro 
clonogenic assays to characterize the nature of the expanded cell population in SmoA1-
induced follicles will be needed, to determine whether activation of Hh signaling 
influences the function or number of follicle stem cells.  Furthermore, in a separate 
experiment, K5-rtTA;TRE-SmoA1 mice could be given doxycycline for 12 days to induce 
anagen, and subsequently discontinue doxycycline treatment to allow the follicles to 
complete a hair cycle and return to the quiescent telogen phase.  If the follicular stem 
cells are depleted in the K5-rtTA;TRE-SmoA1 mice, upon another depilatory challenge, 
these follicles will not be able to re-enter another growth phase as robustly as control 
follicles. 
In SmoA1-induced follicles, HA immunostaining revealed robust SmoA1 
transgene expression in the matrix compartment, but without obvious morphological 
abnormalities or Hh target gene K17 expression compared to control (Figure 4-4h,j,l).  
What can explain the differing responsiveness of distinct cell populations to SmoA1 
transgene expression?  The lack of responses in the matrix compartment may be due the 
fact that during periods of follicle growth, the matrix compartment already has a high 
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level of Hh activation.  Therefore, an additional stimulus by SmoA1 may not be inducing 
a phenotype because the matrix cells are already saturated and “maxed out”.   
Interestingly, HA immunostaining in SmoA1-induced follicles also exhibited 
patchy HA expression.  Co-immunolocalization of HA (for transgene expression) and Hh 
target genes (such as Gli1, Ptch1, and K17) and/or proliferation markers (such as Ki67 
and PCNA) will reveal whether the HA-negative epithelial cells that surround HA-
positive cells also have Hh pathway activation and a proliferative advantage or other 
functional alteration.  
It was shown that a topical application of a synthetic Hh agonist on mouse skin is 
sufficient to trigger growth of telogen follicles (Paladini et al., 2005), but Hh pathway 
transcriptional activation did not occur for 3-4 days after topical Hh agonist treatment, a 
considerable delay which could implicate a secondary signal with subsequent activation 
of endogenous Hh signaling during the expected time-frame in early anagen.  
Furthermore, numerous studies are pointing to the canonical Wnt signaling as the key 
stimulus needed to trigger postnatal anagen onset (Van Mater et al., 2003; Lo Celso et al., 
2004).  These results raise the possibility that Hh agonist treatment itself is not directly 
triggering new follicle growth but rather the Hh agonist may be inducing anagen by 
stimulating a particular cell type in the skin that in turn activates another signaling 
pathway, such as canonical Wnt signaling pathway.  This hypothesis is plausible, given 
1) my previous data showing that Hh-driven ectopic epithelial bud development occurs 
indirectly by activation of canonical Wnt signaling pathway; 2) detection of intense 
nuclear and cytoplasmic β-catenin (indication of canonical Wnt activation) in the follicles 
3 days after SmoA1 induction; and 3) previous studies that support the notion that 
162 
canonical Wnt plays a key role in triggering new follicle growth (Van Mater et al., 2003; 
Lo Celso et al., 2004).  I have tried to test this hypothesis by acquiring the synthetic Hh 
agonist from Curis, Inc and first confirming that it can trigger new follicle growth in 
telogen mouse skin.  A single topical application of Hh agonist was sufficient to trigger 
anagen in all mice tested (data not shown).  However, Hh agonist treatment on K5-
rtTA;TRE-Dkk1 bitransgenic mice, which upon doxycycline administration express Dkk1 
in K5-expressing cells to block the canonical Wnt pathway, still resulted in the induction 
of new follicle growth on dorsal skin (data not shown).  Given that Dkk1 expression was 
not effective in blocking M2SMO-induced bud and hamartoma phenotype in dorsal skin 
(Chapter II), it is plausible that K5-rtTA;TRE-Dkk1 is not an ideal system to test whether 
blocking the canonical Wnt pathway would inhibit Hh agonist induced anagen.  Another 
mouse model to block canonical Wnt pathway, such as one that expresses soluble Wnt 
decoy receptor comprising the Frizzled8 cysteine-rich domain (CRD) fused to the human 
Fc domain (F8CRDhFc) (DeAlmeida et al., 2007), may be a better system to address this 
hypothesis and could be generated.  
Immediately following the Hh agonist application on skin and several days 
thereafter, what cell types in the skin are responding to the Hh agonist?  This is an 
important question that remains to be answered.  In our laboratory, we have multiple Hh 
pathway reporter mice, such as Gli1-lacZ (Bai et al., 2002) and Ptch1-lacZ (Goodrich et 
al., 1997) mice, in which upon X-gal staining lacZ gene product β-galactosidase can be 
visualized as a marker of Hh pathway in vivo.  Topical application of Hh agonist directly 
on Gli1-lacZ and/or Ptch1-lacZ telogen dorsal skin and identifying the specific cell types 
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that are responding to Hh agonist by wholemount X-gal staining or in sections will be 
required to identify target cells responding to this drug..   
We also tested if Hh activation selectively in the follicle stem cells is sufficient to 
trigger new follicle growth.  To address this question, I took advantage of K15-CrePR1 
mice, which allows for targeting of transgene expression to stem cells within the bulge 
compartment of hair follicles in post-natal mice (Liu et al., 2003; Morris et al., 2004), 
providing a powerful tool for modulating gene function in this stem cell population in 
vivo.  By generating Cre- and doxycycline- inducible K15-CrePR1;R26X-
rtTA+GFP;TRE-SmoA1 triple transgenic mice, I was able to specifically activate Hh 
signaling in the stem cell niche.  Activation of Hh signaling specifically in the stem cell 
compartment did not result in induction of anagen, suggesting that direct Hh activation on 
hair follicle stem cells with SmoA1 is not sufficient to initiate new follicle formation.  In 
contrast, outer root sheath hyperplasia was observed in follicles that were treated with 
doxycycline and depilated, suggesting that SmoA1 expression had an effect on the 
progeny of activated stem cells in the bulge, including transient amplifying cells that give 
rise to all lineages of the hair follicle.  
It should be noted, however, that the lack of anagen induction by Hh activation in 
stem cells may be due to a technical issue, where insufficient Cre recombination and 
subsequent low level SmoA1 transgene expression in the bulge may be the reason for the 
lack of new follicle growth.  Modifying the experimental protocol may improve and yield 
higher Cre recombinase activity.  In addition, only a subset of follicles in doxycyline 
treated triple transgenic mice showed HA expression (Figure 4-8g), suggesting inefficient 
Cre recombinase activity and low level SmoA1 expression in these follicles.  However, 
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since a single paraffin section only exposes a small surface area of the follicle, it is 
possible that not all HA-positive epithelial cells are detected using conventional 
immunostaining methods.  A wholemount HA immunostaining technique will circumvent 
this problem.   
Taken together, data presented in this chapter suggest that epithelium-specific 
activation of Hh signaling by cell-autonomous Hh activator SmoA1 is sufficient to trigger 
new follicle growth in telogen skin.  Combined with the K15-CrePR1;R26X-
rtTA+GFP;TRE-SmoA1 triple transgenic data, it may be postulated that Hh signaling in 
skin does not act directly on the stem cells in the hair follicle, but instead acts on their 
transient amplifying progeny.  Additional future work will be needed to assess the 
biological potential of the expanded cell population in SmoA1-expressing cells, and 
determine whether anagen induction in Hh-activated follicle epithelium reflects a direct 
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Chapter V 
Heightened Hh signaling in epidermis stimulates ectopic pigment accumulation and 
melanogenesis 
Introduction 
M2SMO-expressing mice consistently exhibited areas of increased pigmentation 
in multiple regions of the skin, including the tail, paws, ventral skin and ears.  Increased 
pigmentation in other mouse models of Hh-activated skin tumors has been described 
(Grachtchouk et al., 2000; Sheng et al., 2002; Grachtchouk et al., 2003; Hutchin et al., 
2005; Svard et al., 2006), and this is in keeping with the fact that a subset of human 
BCCs (but not other common epithelial tumors) may also be pigmented (Bleehen, 1975).  
In this chapter, I examined the Hh-induced ectopic pigment accumulation at the 
molecular level to gain a further understanding into the potential link between aberrant 
Hh signaling and ‘unscheduled’ melanogenesis.  Understanding Hh-associated 
melanogenesis will help explain why a subset of human BCCs are pigmented, and may 
yield novel insight into the regulation of melanogenesis in general.  
Melanocytes are highly specialized melanin-producing cells of the hair and skin 
that originate from the neural crest and migrate to the epidermis and hair follicles during 
embryonic development (Erickson and Reedy, 1998; Dorsky et al., 2000a).  Once formed, 
melanocytes play a crucial role in skin by absorbing ultraviolet radiation and offering 
photoprotection and thermoregulation.  Neural crest development is dependent on several 
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signal transduction pathways, including members of the canonical Wnt pathway (Dorsky 
et al., 2000b; Wilson et al., 2001; Garcia-Castro et al., 2002), bone morphogenetic protein 
families (Wilson et al., 2001), and fibroblast growth factor (Trainor et al., 2002).  Neural 
crest cells are pluripotent cells that migrate via two distinct pathways during 
embryogenesis: a ventral path between the neural tube and somites for cells that will 
differentiate into neurons and glial cells of the peripheral nervous system, and a 
dorsolateral path between the ectoderm and dermomyotome of the somites for cells that 
will differentiate into melanocytes (Erickson and Reedy, 1998; Dorsky et al., 2000a).  
Melanoblasts, the precursors of melanocytes, migrate, proliferate, and differentiate en 
route to their destinations in the basal layer of epidermis and hair follicles.  In mice, 
melanoblasts differentiate from pluripotent neural crest cells at about embryonic day 8.5, 
and by embryonic day 14.5 melanocytes exit from the overlying dermis and populate the 
epidermis and developing hair follicles (Mackenzie et al., 1997).    
Multiple signaling pathways and transcription factors are known to play critical 
roles during melanocyte development and migration, including the canonical Wnt/β-
catenin signaling pathway (Christiansen et al., 2000).  It has been reported that 
endogenous Dkk1 secreted by fibroblasts in the dermis elicits the hypopigmented 
phenotype of palmoplantar skin in humans due to suppression of melanocyte function and 
growth via the regulation of two important signaling factors, microphthalmia-associated 
transcription factor (MITF) and β-catenin (Yamaguchi et al., 2008; Yamaguchi et al., 
2007b; Yamaguchi et al., 2004).  In addition, overexpression of β-catenin in zebrafish 
promotes melanoblast formation and reduction of neuron and glia formation (Dorsky et 
al., 1998).  In addition, MITF (Steingrimsson et al., 2004) is also known to play a critical 
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role in melanocyte development.  MITF expression is activated early on while neural 
crest cells are differentiating into melanoblasts, and is absolutely required for the survival 
of migrating melanoblasts (Steingrimsson et al., 2004).  Furthermore, sustained 
expression of MITF throughout the life of an organism seems to be critical for the 
survival of melanocytes: mice which carry the hypomorphic mutant allele Mitfvit  have 
normal melanocyte development at early stages, but accelerated age-dependent graying 
of coat color occurs due to premature postnatal melanocyte loss (Lerner et al., 1986).  c-
Kit, a tyrosine kinase receptor, and its ligand Stem Cell Factor (SCF) also play  important 
roles in permitting melanoblast survival and proliferation (Steel et al., 1992; Mackenzie 
et al., 1997; Jordan and Jackson, 2000).  Transgenic Scf expression in skin using the 
keratin 14 (K14) promoter was sufficient to support melanocyte homing to the epidermis 
in mice, which otherwise has few epidermal melanocytes in fur-bearing regions 
(Kunisada et al., 1998).  In addition, it was found that the use of imatinib mesylate 
(Gleevec), a Bcr-Abl tyrosine kinase inhibitor that also inhibits c-Kit tyrosine kinase, can 
result in the loss of melanocytes in human skin (Legros et al., 2005).  Other molecules 
that are also believed to play a role in melanocyte migration and function include 
Endothelin 1 (ET1) and Endothelin 3 (ET3), hepatocyte growth factor (HGF) and basic 
fibroblast growth factor (b-FGF) (Imokawa, 2004).   
Once the melanoblast migration and expansion are complete, within the postnatal 
hair follicle exists two discrete melanocytic populations: melanocyte stem cells that 
reside in the bulge, and their differentiated progeny which take residence in the bulb of 
the follicle to give rise to pigmented hair shafts.  Under physiological conditions, 
melanogenesis is stimulated in association with Hh-driven proliferation of follicle 
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epithelium.  Shortly after activation of a new hair follicle growth phase, unpigmented 
melanoblasts residing within the follicle bulge are stimulated to divide and migrate into 
the newly-formed hair bulb, where they differentiate and transfer pigment to the 
developing hair shaft (Nishimura et al., 2002).  However, many questions still remain to 
be answered:  What are the signals that modulate melanocyte stem cells’ awakening from 
and return to quiescence?  To what degree are the melanocyte stem cells dependent on 
the bulge, and what are the signals that modulate melanocyte cell death during hair 
follicle regression?  
While multiple signaling pathways and transcription factors have been implicated 
in melanocyte development and melanocyte-derived pigment defect pathology, the link 
between aberrant Hh signaling and melanogenesis has not been clearly established.  
Interestingly, transgenic mouse models with epithelium-specific activation of Hh 
signaling, such ΔK5-M2SMO (Grachtchouk et al., 2003) and doxycycline-inducible K5-
tTA;TRE-SmoA1 mice, consistently exhibit increased pigmentation in various regions of 
skin.  Furthermore, full blown BCCs that develop in K5-Gli2 (Grachtchouk et al., 2000) 
and K5-rtTA;TRE-Gli2 (Hutchin et al., 2005) mice that are bred on agouti and black 
founders also exhibit increased pigment.  In addition, clinicians have long noted that a 
subset of human BCCs, tumors that are driven by aberrant Hh signaling, also contains 
pigment (Bleehen, 1975), thus further suggesting that oncogenic Hh signaling may be 
influencing on melanogenesis.  How is oncogenic Hh signaling in keratinocytes giving 
rise to increased pigmentation?  One possible explanation, given the critical role of 
canonical Wnt signaling in melanogenesis, is that heightened Hh signaling may be 
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indirectly stimulating melanogenesis and pigment accumulation by stimulating Wnt 
ligand expression and activating canonical Wnt signaling.   
A recent paper revealed a novel surprising genoprotective role of tumor 
suppressor p53 in the regulation of the suntan response (Cui et al., 2007).  In response to 
ultraviolet-induced genotoxic stress, p53 becomes activated in skin keratinocytes and 
stimulates transcription from the pro-opiomelanocortin (POMC) gene promoter.  The 
POMC precursor polypeptide is then processed into several bioactive products including 
alpha-melanocyte stimulating hormone (α-MSH), which through a paracrine effect on 
epidermal melanocytes (mediated by the α-MSH receptor melanocortin-1 receptor 
(MC1R) and MITF), leads to melanin production and redistribution among skin cells 
(Cui et al., 2007).  Intriguingly, these investigators also found that only those human 
BCCs that retain wild-type p53 are pigmented, while BCCs harboring p53 mutations are 
not pigmented.  If this is true, then would the same finding apply to those human BCCs 
that feature foci of hyper-pigmentation within tumor nests without pigment 
accumulation?  Furthermore, would ectopic pigment accumulation in M2SMO expressing 
skin or Gli2-driven BCCs also require normal p53 function?  This could be tested with 
crosses of M2SMO- or Gli2- over-expressing mice onto a p53-/-  background.   
In this chapter, I describe the preliminary data that show ectopic Hh activation in 
mouse skin using the keratin 5 (K5) promoter results in a striking accumulation of 
grossly visible pigment, and furthermore, this increase in pigment is accompanied by a 
striking increase in melanoblast and/or melanocyte number as assessed using Dct-lacZ 
reporter mice, and expression of multiple transcripts encoding melanocyte markers.  In 
addition, gene expression for several secreted factors previously implicated in 
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melanogenesis are also upregulated.  Inhibition of canonical Wnt signaling by co-
overexpression of the potent Wnt inhibitor Dkk1 in M2SMO skin blocked pigment 
accumulation (Chapter 2 and Fig. 2-11b), suggesting that non cell-autonomous effects of 
Hh-activated keratinocytes on the melanocyte lineage are dependent on canonical Wnt 
signals.  The work described here provides the foundation for future studies exploring the 
molecular mechanism of aberrant melanogenesis in the setting of deregulated Hh 
signaling in skin and other pathological conditions.  
 
Materials and Methods 
Generation of transgenic mice 
Generation of transgenic mice with constitutive expression of M2SMO in skin 
(ΔK5-M2SMO) mice has been described (Grachtchouk et al., 2003).  Generation of 
transgenic melanoblast reporter mice by inserting a lacZ transgene under the control of 
Trp2 promoter (Dct-lacZ) has been described (Mackenzie et al., 1997).  Dct-lacZ mice 
were crossed with ΔK5-M2SMO mice to generate Dct-lacZ;ΔK5-M2SMO bitransgenic 
mice.  All mice were housed and maintained according to University of Michigan 
institutional guidelines, as stipulated by the University Committee on the Use and Care of 
Animals.   
 
Tissue harvesting, wholemount preparation and wholemount X-gal staining 
For hematoxylin and eosin (H&E) staining, mouse skin was fixed in neutral-
buffered formalin (NBF) overnight, transferred to 70% EtOH, processed, and embedded 
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in paraffin.  To prepare wholemounts for mouse volar skin, mice were euthanized and 
ventral hindlimb skin was removed.  Volar skin was microdissected and wholemount 
preparation was performed essentially as described previously for tail skin (Braun et al., 
2003).  For wholemount X-gal staining, separated epidermal and dermal sheets were 
fixed in fresh 4% paraformaldehyde/PBS (pH 7.0-7.5) for 1 hour at 4 °C.  Following 3 
washes, for 15 minutes each in wash buffer (100 mM sodium phosphate (pH 7.3), 2 mM 
MgCl2, 0.01% sodium deoxycholate, and 0.02% NP-40), tissues were stained in freshly 
prepared staining solution (wash buffer plus 5mM potassium ferricyanide, 5mM 
potassium ferocyanide, and 1 mg/mL X-gal solution from 25 mg/mL stock in 
dimethylformamide stored at -20 °C) for overnight at 37 °C.  Tissues were post-fixed 
overnight in NBF and stored in 70% EtOH.  Transilluminated wholemount 
photomicrographs were captured with digital camera (Spot RT3.0, Diagnostic 
Instruments) mounted on dissecting microscope (Leica MZFL3), using Spot Software 
Version 4.6 (Diagnostic Instruments).    
 
Semiquantitative RT-PCR 
Volar and postnatal day 8 dorsal skin were microdissected under dissecting 
microscope (Nikon, Japan), homogenized in Trizol (Invitrogen), and stored at -80 °C 
until further processing.  RNA isolation, first strand cDNA synthesis, and RT-PCR were 





Heightened Hh signaling in epidermis stimulates melanogenesis 
‘Inappropriate’ pigment accumulation has been reported in human BCCs, tumors 
that are driven by aberrant Hh signaling (Bleehen, 1975).  Similarly, mouse BCCs and 
other skin tumors driven by Gli2 or Gli2ΔN2 overexpression also contain abundant 
pigment (Grachtchouk et al., 2000; Sheng et al., 2002; Hutchin et al., 2005).  Skin from 
M2SMO-expressing transgenic mice also consistently exhibited increased pigmentation 
compared to control skin [(Figure 5-1), and (Grachtchouk et al., 2003)].  Dramatic 
ectopic pigmentation accumulation was easily appreciated in transilluminated 
wholemount M2SMO volar skin compared to control (Figure 5-1a,b), and also in H&E-
stained sections (Figure 5-1c,d).  H&E sections revealed the vast majority of ectopic 
pigment accumulation had occurred in the dermis of M2SMO volar skin (Figure 5-1d).   
To determine whether this phenotype was associated with an increased number of 
melanoblasts and/or melanocytes rather than just grossly increased accumulation of 
melanin, we crossed M2SMO mice with Dct-lacZ reporter mice (Mackenzie et al., 1997).  
Dct-lacZ mice are useful reporters since dopachrome tautomerase (Dct), also called 
tyrosinase-related protein 2 (Trp2), is a reliable marker of the melanocytic lineage, 
expressed in melanocyte progenitors, melanoblasts residing in adult skin, and terminally 
differentiated melanocytes (Tsukamoto et al., 1992; Bouchard et al., 1994; Mackenzie et 
al., 1997; Virador et al., 2001).  Following dermal-epidermal separation and wholemount 
examination, epidermis from X-gal stained Dct-lacZ;M2SMO volar skin exhibited 
numerous β-galactosidase expressing cells compared to Dct-lacZ volar skin, where 
almost no positive cells were visible (Figure 5-2a,b).  Surprisingly, although the majority 
of X-gal positive cells in Dct-lacZ;M2SMO skin were in the epidermis, most of the 
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increased pigment was again detected in the dermis (Figure 5-2b,d,f).  Sections of 
wholemount stained Dct-lacZ;M2SMO volar skin showed numerous X-gal positive cells 
scattered among the suprabasal epithelial cells in hamartomas (Figure 5-2f), but not 
among the basal cell layer where they are normally distributed in regions of epidermis 
containing melanocytes.  This overall distribution pattern of melanocytic cells is 
reminiscent of what has been reported during late-stage development in embryonic hair-
bearing skin (Nishimura et al., 1999), in keeping with the notion that follicular 
hamartomas represent an expansion of primitive, follicle-like epithelium.  
Semiquantitative RT-PCR of volar skin from M2SMO-expressing mice revealed 
induction of multiple melanocyte lineage markers, including Mitf, a major lineage 
determinant which activates expression of several genes involved in melanogenesis (Levy 
et al., 2006).  These genes include Tyr, Tyrp1, Dct/Tyrp2, Pmel17, and Ped, none of 
which are detected in control volar skin (Figure 5-2g).  In addition, multiple transcripts of 
secreted factors involved in melanogenesis, including Endothelin 1 (ET1), Endothelin 3 
(ET3), kit ligand/stem cell factor (SCF), and basic fibroblast growth factor (b-FGF) were 
also upregulated in early bud-stage as well as late hamartoma-stage M2SMO volar skin 
(Figure 5-2g).  mRNA levels for SCF appeared to be expressed relatively higher in 
hamartoma-stage compared to bud-stage M2SMO volar skin, although quantitative PCR 
studies are needed to confirm this impression.  If true, it would suggest that SCF is 
unique among the genes implicated in melanogenesis that we examined, since it is 






Figure 5-1.  Increased pigment accumulation in M2SMO hairless volar skin.  (a) 
Transilluminated wholemount image of control hairless volar skin at postnatal day 30.  
Hair shafts on lower right corner are from the normal adjacent hair bearing region on the 
ventral hindlimb.  (b) Transilluminated wholemount image of M2SMO hairless volar 
skin at postnatal day 30.  Note extensive hamartoma development and associated pigment 
accumulation, featured by disorganized cords and bands of epithelial thickening and dark 
pigmentation surrounding them.  (c) H&E-stained section of control volar skin.  Note the 
absence of hair follicles or follicle-associated structures, and minimal pigment 
accumulation in the dermis.  (d) H&E-stained section of M2SMO volar skin.  Note 
extensive hamartoma development and accompanying pigment accumulation in the 







Figure 5-2.  Increased pigmentation in M2SMO skin: Hedgehog signaling induces 
increased melanogenesis.  (a,b) Wholemount X-gal stained epidermis of Dct-LacZ and 
Dct-LacZ;M2SMO volar skin. Numerous X-gal positive cells are visible in Dct-
LacZ;M2SMO volar skin. (c,d) Wholemount X-gal stained dermis of Dct-LacZ and Dct-
LacZ;M2SMO volar skin. Dark pigmentation in dermis is visible in Dct-LacZ;M2SMO 
skin.  (e,f) X-gal stained sections with Nuclear Fast Red counterstain of Dct-LacZ and 
Dct-LacZ;M2SMO volar skin. Note X-gal positive cells in M2SMO-induced hamartomas 
that are scattered throughout the hyperplastic epithelium but not dermis, while no X-gal 
positive cells are visible in Dct-LacZ volar skin.  (g) Semiquantitative RT-PCR was 
performed on RNA isolated from control volar skin, M2SMO volar skin and positive 
control (postnatal day 8 back skin, hf).  Transcripts for multiple melanocytic markers are 
upregulated in M2SMO volar skin, including Mi, Tyrosinase, TRP1, Dct, Pmel 17, and 
PED.  Transcripts for genes involved in melanogenesis, including Endothelin 1 (ET1), 
Endothelin 3 (ET3), kit ligand/stem cell factor (SCF), and basic fibroblast growth factor 
(b-FGF) are also upregulated in both early bud-stage (M2SMO Bud) and late 
hamartoma-stage (M2SMO BFH) skin.   
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Summary 
M2SMO-expressing skin consistently exhibited increased pigmentation compared 
to control skin, as previously reported in other mouse models with elevated Hh signaling 
in skin and in a subset of human BCCs (Bleehen, 1975).  The majority of accumulated 
pigment was localized in the dermis of M2SMO-expressing skin.  M2SMO mice were 
then crossed with Dct-lacZ reporter mice (Mackenzie et al., 1997) to determine whether 
increased pigment accumulation was associated with an increased number of 
melanoblasts and/or melanocytes.  Wholemount X-gal staining revealed an increased 
number of β-galactosidase expressing cells in the epidermis of Dct-lacZ;M2SMO volar 
skin compared to Dct-lacZ volar skin alone, supporting the notion that pigment 
accumulation in M2SMO mice is associated with an increase in the number of 
melanoblasts and/or melanocytes.  While melanocytes are normally found in the basal 
layer of the epidermis (Yamaguchi et al., 2007a), X-gal positive cells in the epidermis of 
Dct-lacZ;M2SMO volar skin were scattered among the suprabasal epithelial cells in 
hamartomas.   
It will be important to determine in the future the molecular mechanism for 
increased number of melanocytes in M2SMO-expressing skin.  How does heightened Hh 
signaling stimulate unscheduled melanogenesis in postnatal skin?  Is it possible that 
epithelial Hh activation leads to the activation of Dct-lacZ negative melanocyte stem cells 
in the epidermis or dermis of volar skin?  Alternatively, circulating melanocyte 
progenitors may also be recruited and migrate in.  Immunostaining with antibodies 
specific for MITF and Trp2 in the volar skin of doxycycline-inducible K5-rtTA;TRE-
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SmoA1 bitransgenic animals before and after SmoA1 expression will be necessary to 
address this issue. 
Melanogenesis is regulated through the concerted action of multiple secreted 
signaling molecules, including Wnts [reviewed in (Lin and Fisher, 2007)].  Specifically, 
Wnt3a leads to increased numbers of neural crest-derived melanocyte progenitors as well 
as terminally-differentiated melanocytes (Takeda et al., 2000; Dunn et al., 2005), raising 
the possibility that the elevated expression of Wnt3a and/or other Wnts is contributing to 
the increased number of Dct-positive cells in M2SMO-expressing skin.  Other secreted 
factors involved in melanogenesis in various settings include ET1, ET3, HGF, b-FGF, 
SCF, and α-MSH, derived from the Proopiomelanocortin (Pomc) transcript (Diamond et 
al., 2000; Chu et al., 2004; Weidinger et al., 2005; Cui et al., 2007).  Remarkably, 
semiquantitative RT-PCR revealed induction of SCF, ET1, and ET3, but not HGF or 
Pomc in volar skin of M2SMO-expressing mice (Figure 5-2g, and data not shown).  Of 
these, only SCF appeared to be expressed at higher levels in skin containing hamartomas 
than in skin from younger mice containing epithelial buds (Figure 5-2g).  Thus multiple 
secreted factors that are coordinately induced may work in concert to bring about the 
dramatic increase in pigmentation seen in M2SMO-expressing skin. 
In addition to inhibiting epithelial changes associated with deregulated Hh 
signaling in skin, blockade of Wnt signaling in M2SMO+Dkk1 mice also grossly 
suppressed skin hyperpigmentation (Figure 2-13).  These in vivo results suggest that non 
cell-autonomous effects of M2SMO-expressing epithelium on the melanocyte lineage are 
also likely to be mediated by canonical Wnt signals, but additional studies will be needed 
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to determine whether this reflects a direct effect of Wnt ligand(s) on melanocytes, or a 
secreted secondary factor(s).   
 Although my data implicate epithelial Hh signaling in ectopic melanogenesis in 
M2SMO-expressing mice and BCC, a recent paper by Cui et al. reported a central role 
for epithelial p53 function, via production of Pomc mRNA and MSH expression (Cui et 
al., 2007),  in the suntan response of melanocytes to ultraviolet light.  Moreover, data 
were presented in this report also implicating normal p53 function in pathological 
pigmentation in human BCCs, since human BCCs that are pigmented retain wild-type 
p53 while those BCCs harboring p53 mutations are not pigmented (Cui et al., 2007).  
Further studies are needed to directly test whether p53 function is implicated for 
melanogenesis associated with Hh pathway-driven epithelial tumorigenesis in M2SMO-
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Summary and Future Directions 
Hh→Wnt crosstalk in Hh-driven skin pathology  
The Hh and canonical Wnt signaling pathways play essential regulatory roles in 
both development and adult life, and when deregulated, contribute to the tumorigenesis of 
many tissues and organs.  In skin, Wnt signals are necessary and sufficient for the initial 
formation of hair buds (Gat et al., 1998; Huelsken et al., 2001; Andl et al., 2002; Lo 
Celso et al., 2004), and in the differentiation of committed epithelial progenitors to form 
late-stage hair follicle lineages to give rise to the seven distinct concentric layers of 
terminally differentiating cells in the mature hair follicle (DasGupta and Fuchs, 1999).  In 
addition, Wnt signals provide the initial trigger to reactivate follicle growth during the 
regenerative phase of postnatal hair cycles (Van Mater et al., 2003; Huelsken et al., 2001; 
Lo Celso et al., 2004).  Uncontrolled activation of canonical Wnt signaling, however, 
promotes the development of several hair follicle-derived tumors such as pilomatricoma 
and trichofolliculoma (Gat et al., 1998; Chan et al., 1999; Lo Celso et al., 2004).  In skin, 
Hh signaling is essential for the proliferation of follicle epithelium needed to assemble a 
mature hair follicle during embryogenesis and postnatal hair cycling (St Jacques et al., 
1998; Chiang et al., 1999; Wang et al., 2000).  Physiologic Hh signaling in skin is tightly 
regulated, and deregulated, aberrant activation of Hh signaling results in the development 
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of skin tumors such as BCC and basaloid follicular hamartoma (Grachtchouk et al., 2003; 
ya-Grosjean and Couve-Privat, 2005).  
BCC is the most common type of cancer in light-skinned individuals with more 
than a million new cases in the US each year, and although it rarely metastasizes, BCC 
can cause significant morbidity due to local invasion (Tang et al., 2007).  BCC is 
classified histologically according to morphology, and includes nodular, micronodular, 
infiltrative and superficial forms (Sexton et al., 1990).  In superficial BCC, epithelial 
buds of proliferating basal cells grow down from the epidermis into the superficial dermis, 
maintaining their attachment to the basal cell layer.  Intriguingly, pathologists have long 
noted the morphological similarity between focal epidermal downgrowths in BCC and 
embryonic hair germs (Montgomery, 1935; Lever, 1948; Kumakiri and Hashimoto, 1978).  
However, the molecular explanation for this morphological similarity between two 
structures driven by two distinct signaling pathways has been lacking.  This observation 
raised the possibility that pathologic Hh signaling can A) directly stimulate epidermis to 
form de novo hair bud-like structures and skin neoplasms; or B) stimulate Wnt signaling 
to indirectly bring about these pathologic responses to deregulated Hh signaling in skin.  
While some prior studies have identified coordinate changes in the Hh and canonical Wnt 
pathways in BCCs and other neoplasms (Pasca di et al., 2007; Taipale and Beachy, 2001; 
Mullor et al., 2001; Yamazaki et al., 2001; El-Bahrawy et al., 2003; Saldanha et al., 2004; 
Li et al., 2007), direct evidence establishing the functional significance of Wnt signaling 
in Hh pathway-driven pathology in vivo was lacking. 
The primary goal of my thesis project was to gain further molecular insights into 
the functions of the Hh and Wnt embryonic signaling pathways in cell fate decisions and 
186 
cancer, using the skin as a model system. The hair follicle is one of few organs that 
undergoes cyclic transformations for its entire life, from periods of regeneration and rapid 
growth (anagen), where key aspects of its embryonic development are recapitulated, to 
periods of massive regression via apoptotic mechanisms (catagen), followed by periods 
of rest and quiescence (telogen) [reviewed in (Stenn and Paus, 2001; Paus and Cotsarelis, 
1999) and (Figure 1-2)].  These unique and remarkable features of the hair follicle, in 
addition to its relative abundance and easy accessibility, make it an attractive model 
system to study many fundamental biological processes. 
Based on the morphological similarity between Hh-driven ectopic epithelial buds 
and embryonic hair buds, I hypothesized that the cross-talk between Hh and Wnt 
pathways plays important roles during Hh-driven skin tumorigenesis.  Using transgenic 
mice that express an oncogene M2SMO (Xie et al., 1998) as a model system, I tested 
whether pathological Hh signaling in skin leads to the formation of hair-bud like 
structures indirectly, via canonical Wnt signaling, the physiological stimulus for hair bud 
formation in embryos.  I showed upregulation of multiple canonical Wnt genes, nuclear 
and cytoplasmic redistribution of β-catenin, and upregulation of endogenous Wnt target 
genes Axin2 and Sp5 in M2SMO-expressing mouse skin.  Moreover, using a 
doxycycline-regulated transgenic mouse expressing the canonical Wnt inhibitor Dkk1, I 
showed that ectopic bud formation and expansion to form follicular hamartomas require 
canonical Wnt signaling activity.  My findings 1) uncover a previously unknown 
requirement for ligand-driven, canonical Wnt signaling for Hh-driven tumorigenesis; 2) 
provide a molecular explanation for the morphological and biochemical similarity 
between early BCC and embryonic hair germs; 3) explain how ‘follicular’ tumors can 
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arise from interfollicular epidermis; and 4) identify Wnt ligands as a novel 
pharmacological target for prevention and/or treatment of a subset of Hh-driven 
neoplasms in skin.  
My findings also challenge the pre-existing dogma that canonical Wnt signaling 
always precedes, and is required for, subsequent Hh activation in skin (Gat et al., 1998; 
Huelsken et al., 2001; Andl et al., 2002; Lo Celso et al., 2004). Our data indicate that this 
temporal relationship is reversed in the setting of Hh-driven pathology in epidermis, 
where ectopic activation of Hh signaling leads to canonical Wnt signaling with resultant 
formation of de novo epithelial buds and follicular hamartomas.  In light of our findings 
in the setting of pathologically-activated Hh signaling in skin, it will be interesting to 
determine whether the Hh pathway contributes to Wnt signaling under physiological 
conditions, as has been proposed in other organs [e.g., (Hu et al., 2005; Madison et al., 
2005)].  Interactions between the Hh and canonical Wnt pathways have also been 
proposed in pancreatic cancer (Pasca di et al., 2007) and cigarette smoke-induced lung 
cancer (Manfredi et al., 2004).  Given the results presented herein, it will be important to 
test the functional role of canonical Wnt signaling in other tumors and cancers that are 
driven by aberrant Hh signaling.  
Semiquantitative RT-PCR of M2SMO-expressing skin revealed upregulation of 
multiple Wnt ligand transcripts, including Wnt3, 4,5a, 7b, 10a, and 10b.  Mullor et al. 
also reported expression of multiple Wnts in Xenopus animal cap explants injected with 
Gli2 and Gli3 mRNA, as well as upregulation of multiple Wnt ligands in human BCC 
(Mullor et al., 2001).  These observations raise several interesting questions: What is the 
biological significance of upregulation of multiple Wnt ligands?  Is every induced Wnt 
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ligand playing a different role, or is a coordinated multi-Wnt ligand induction required to 
mediate Hh-induced responses?  What are the temporal and spatial (epithelial versus 
mesenchymal) expression patterns of induced Wnt ligands in M2SMO-expressing skin?  
Does Hh activation trigger coordinate expression of multiple Wnt ligands, or are some 
Wnt ligands turned on secondarily, and if so, which Wnt ligands are turned on first?  To 
address these questions, one could employ doxycycline-inducible K5-rtTA;TRE-SmoA1 
mice, which readily develop ectopic epithelial buds following postnatal activation of 
SmoA1 expression (data not shown)..  Volar skin from doxycycline-induced K5-
rtTA;TRE-SmoA1 mice can be collected at multiple time points, from uninduced, and 12, 
24, 48, 72 hours after doxycyline induction.  A comprehensive panel of RT-PCR and in 
situ hybridization studies would reveal the temporal and spatial expression of Wnt ligand 
genes induced by SmoA1.  A strong advantage of working with the volar skin system in 
this setting should be emphasized.  Since the volar skin can be considered a 
morphogenetically naive “clean slate” that normally does not contain any hair follicles or 
other skin appendages, it provides a sensitive and convenient tool to detect changes in 
morphology or gene expression.  Interestingly, it has been shown that relatively higher 
expression of endogenous Dkk1 secreted by dermal fibroblasts in human palmoplantar 
skin gives it the relatively hypopigmented phenotype as well as increased thickness 
compared to other regions of the body (Yamaguchi et al., 2004, Yamaguchi et al., 2008), 
suggesting that site-specific differential expression of secreted factors could explain the 
phenotypes observed in different regions of the skin.  Furthermore, follicle density during 
embryogenesis is governed by competition between placode-stimulating (epidermis-
restricting) and placode-restricting (epidermis-stimulating) factors [reviewed in (Fuchs 
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2007)].  Given these results, it is therefore also conceivable that the volar skin could be in 
an 'inhibited state' where placode-restricting signals, such as BMP signaling (Mou et al., 
2006, Kobielak et al., 2003, Andl et al., 2004), or epidermal growth factor receptor 
(EGFR) signaling (Atit et al., 2003) are preferentially expressed to actively suppress hair 
follicle morphogenesis in this region.  Conversely, it is also possible that the volar skin 
lacks the expression of BMP-inhibitor noggin (Botchkarev et al., 1999) or the 
FGF10/FGF7 receptor FGFRIIIb (Petiot et al., 2003) that are needed for hair follicle 
development and growth.  These results may suggest that the volar skin could be an 
‘active’ site for multiple signaling pathway interactions, rather than a strictly 
morphogenetically naive “clean slate” epidermis, and the morphological and gene 
expression changes brought about by the Hh activation in this region of skin may be also 
influenced by interactions with these additional signaling pathways that are known to 
play a role in hair follicle morphogenesis.  
 While the RT-PCR and in situ experiments outlined above will reveal the 
temporal and spatial expression patterns of Wnt ligands induced by Hh activation, these 
studies will not necessarily determine which Wnt ligand(s) among those induced by 
SmoA1 is the functionally critical player in activating the downstream canonical Wnt 
pathway machinery to initiate Hh-induced ectopic epithelial bud development.  
Answering this question would likely require a functional assay to block each Wnt ligand 
induced by SmoA1, assuming that the biological effects mediated by the induced Wnt 
ligands are driven solely by a single ligand, not via concerted efforts among multiple Wnt 
ligands working together.  However, given my results that showed that a global Wnt 
inhibition using the Wnt inhibitor Dkk1 resulted in a dramatic blockade of M2SMO-
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induced phenotype, the lack of this knowledge may not preclude the pre-clinical use of a 
global Wnt inhibitor (such as a decoy Wnt ligand receptor that will bind to multiple Wnt 
ligands) to test for inhibition of Hh-induced tumor development, at least initially.  Future 
studies that will delineate the exact molecular mechanism of which Wnt ligands are 
activated upon Hh activation may allow for a much more selective and advanced drug 
designs that will target the specific key Wnt ligands to block Hh-induced tumorigenesis. 
It will be also important to determine the exact molecular mechanisms of how 
activated Hh signaling induces the expression of Wnt ligands.  Could the activated Gli 
transcription factors be binding directly onto the promoter regions of genes encoding 
various Wnt ligands, or could there be a yet-to-be identified secondary signal that 
mediates Hh-induced Wnt ligand expression?  Several strategies could be employed to 
answer this question, one of which is via Chromatin Immunoprecipitation (ChIP) assay to 
determine the potential direct Gli-Wnt ligand promoter binding interactions.  In an 
alternative approach, one could also start by screening for canonical Gli binding sites on 
different Wnt ligand promoters, and performing reporter assays with wild-type versus 
mutant promoter constructs co-transfected with SmoA1 or Gli expression plasmids.   
It will also be interesting to determine whether M2SMO-driven ectopic epithelial 
bud development is accompanied by the formation of ‘new’ follicle stem cells.  It has 
been proposed that Hh signaling promotes proliferation directly on stem cell populations 
during tumorigenesis (Altaba et al., 2002).  Furthermore, expression of stabilized mutant 
β-catenin in postnatal skin was sufficient to induce de novo hair follicles that contained 
clonogenic keratinocytes that express bulge-specific stem cell markers such as CD34 and 
K15 (Silva-Vargas et al., 2005), and I have found that βcat*-induced de novo follicles 
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that arose from hairless volar skin also expressed the stem cell marker K15 (data not 
shown).   These results, along with the finding that M2SMO induces canonical Wnt and 
β-catenin activation, might suggest that M2SMO-driven ectopic bud development may 
lead to establishment of a follicle stem cell niche.  However, functional assays will be 
required to more rigorously assess the stem cell potential of cells from M2SMO-induced 
epithelial buds and hamartomas.  
In M2SMO+Dkk1 skin, M2SMO is expressed in the epithelium only and results 
in cell-autonomous activation of Hh signaling.  In contrast, Dkk1 expression is likely to 
influence both the epithelium and mesenchyme, since Dkk1 is a secreted molecule 
(Bafico et al., 2001; Mao et al., 2001).  Since a precise temporal control of Dkk1 
expression in ΔK5-M2SMO;K5-rtTA;TRE-Dkk1 triple transgenic mice can be achieved 
using doxycycline, a number of additional experiments could be performed to address 
several interesting questions.  Hutchin et al. found that while shutting off the Gli2 
transgene in established BCCs in K5-tTA;TRE-Gli2 mice induced regression of these 
tumors, the regressed tumors never completely disappeared, and grew back often at an 
accelerated rate once Gli2 transgene expression was restored (Hutchin et al., 2005).  In 
the M2SMO+Dkk1 system, if Dkk1 expression is induced early on to inhibit M2SMO-
induced bud and hamartoma development, and then terminated after a period of time, will 
the M2SMO-induced tumors appear?  If hamartomas arise after removal of Dkk1 
expression, this finding would have a therapeutic implication and suggest that a 
therapeutic blockade of canonical Wnt signaling may be required indefinitely to inhibit 
the growth of Hh-induced hamartomas.   
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On the other hand, what would happen to established Hh-driven hamartomas if 
the canonical Wnt signaling is shut off once they are already formed?  Would inhibition 
of canonical Wnt signaling induce regression of the hamartomas, and if so, what will be 
the mechanism? Or will the hamartomas merely stop growing and expanding, but yet still 
persist and not regress?  This question may be addressed by inducing Dkk1 expression in 
ΔK5-M2SMO;K5-rtTA;TRE-Dkk1 mice at postnatal day 30 or later, when the M2SMO-
induced hamartomas have been well-established in skin.  Based on my results that show 
that only the outer-most peripheral cells of established hamartomas show nuclear and 
cytoplasmic β-catenin localization, as well as Ki67 and Cyclin D1 expression, I expect 
that the induction of Dkk1 in established hamartomas would not make the hamartomas 
regress, but rather stop them from expanding further by shutting off the canonical Wnt 
signaling in the outer-most cells of hamartomas.  This issue also has therapeutic 
implications, since a potential canonical Wnt-inhibiting drug to block Hh-driven 
hamartoma development in humans would have to be initiated extremely early.  Since 
hamartomas and skin cancers in humans are typically not detected or diagnosed until they 
are grossly visible, this may pose a challenge for practical applicability of Wnt-inhibiting 
drug to treat Hh-induced skin lesions.   
Constitutive Hh signaling also underlies BCC development (ya-Grosjean and 
Couve-Privat, 2005), and several earlier reports have described links between the Hh and 
Wnt pathways in BCC, including upregulation of multiple Wnt genes (Mullor et al., 
2001) and localization of β-catenin to the cytoplasm and/or nucleus in human BCCs 
(Yamazaki et al., 2001; El-Bahrawy et al., 2003; Saldanha et al., 2004).  In addition, we 
have observed nuclear and cytoplasmic β-catenin localization, expression of stabilized/ 
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unphosphorylated β-catenin, and upregulation of endogenous Wnt target gene Axin2 in 
Gli2-driven mouse BCCs (data not shown), raising the possibility that canonical Wnt 
signaling may also be required for the development and/or expansion of full-blown BCC.  
To test this hypothesis we have performed experiments in which Dkk1 expression is 
induced in mice that develop nodular, BCC-like skin tumors mostly in dorsal skin, but 
Dkk1 was not effective in blocking canonical Wnt signaling in this setting (data not 
shown).   
An alternative approach to test the functional role of canonical Wnt signaling in 
Hh-driven BCC development and maintenance may be to generate and utilize a 
transgenic mouse model which expresses a soluble Wnt decoy receptor comprising the 
Frizzled8 cysteine-rich domain (CRD) fused to the human Fc domain (F8CRDhFc) 
(DeAlmeida et al., 2007).  The potent anti-tumor efficacy of F8CRDhFc has been shown 
using the mouse mammary tumor virus Wnt1 tumor model.  F8CRDhFc seem to be 
capable of binding to and inhibiting functions of multiple Wnt ligands (personal 
communication).  In vitro experiments using F8CRDhFc showed a robust inhibition of 
autocrine Wnt signaling in teratoma cell lines PA-1, NTera-2, Tera-2, and NCCIT, and 
systemic administration of F8CRDhFc significantly inhibited the growth of tumor 
xenografts derived from PA-1 and NTera-2 cell lines (DeAlmeida et al., 2007).  Once 
transgenic mice that conditionally express F8CRDhFc in skin are generated, they can 
then be crossed with BCC-producing mice to test the role of canonical Wnt/β-catenin 
signaling in BCC initiation, expansion, and maintenance.  The use of F8CRDhFc, which 
blocks the canonical Wnt signaling by directly binding to the Wnt ligands, may be a 
better approach to examine the functional role of canonical Wnt signaling in BCC 
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development and maintenance than with K5-rtTA;TRE-Dkk1 model, since there may be a 
relative deficiency of Kremens 1/2 (Mao et al., 2002), which facilitate Dkk1’s ability to 
block canonical Wnt signaling, or Dkk1 transgene may be insufficiently expressed in 
dorsal skin.  In addition, transgenic F8CRDhFc-expressing mice will also be useful to 
cross with M2SMO-expressing mice to corroborate our M2SMO+Dkk1 data, since Dkk1 
blocks canonical Wnt signaling at the level downstream of Wnt ligand expression (Niehrs, 
2006), and the direct binding of Wnt ligands by F8CRDhFc would also be expected to be 
effective in blocking M2SMO-induced phenotype in ΔK5-M2SMO mice.   
To independently test and confirm the functional role of canonical Wnt/β-catenin 
signaling in M2SMO-induced ectopic bud and hamartoma development, a substantial 
amount of effort was also dedicated to breed M2SMO-expressing mice onto β-catenin 
knockout background by crossing ΔK5-M2SMO mice with Cre-inducible conditional β-
catenin knockout mice (Brault et al., 2001) and Msx2-Cre mice (Sun et al., 2000), which 
drives a patchy Cre-recombination in skin during embryogenesis.  Unfortunately, no 
conclusive data could be achieved from ΔK5-M2SMO;Msx2-Cre;β-catenin-/- mice 
experiments, as the newborn ΔK5-M2SMO;Msx2-Cre;β-catenin-/- mice analyzed showed 
no phenotypic differences compared to ΔK5-M2SMO mice .  ΔK5-M2SMO;Msx2-Cre;β-
catenin-/- mice were born with severely deformed limbs (data not shown) and often did 
not survive for more than 24 hours, as the Msx2 promoter is also active in the apical 
ectodermal ridge (Sun et al., 2000).  This forced us to examine newborn mice or E19.5 
embryos, but this complicated our analysis further since the skin phenotype in ΔK5-
M2SMO mice is not readily apparent until a few days after birth (personal observation 
and (Grachtchouk et al., 2003)).  In addition, generating M2SMO-expressing mice with 
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skin-specific deletion of β-catenin required quadruple-alleled transgenic mice with the 
probability of obtaining the correct genotype in only 1 out of every 16 offspring.  
 
β-catenin drives advanced stages of hair follicle differentiation   
Although M2SMO-induced epithelial buds expanded to form hamartomas, they 
failed to differentiate beyond a rudimentary stage of development, containing only two of 
the seven cell lineages seen in mature follicles.  This may be due at least in part to the 
fact that they failed to produce mesenchymal condensates and papillae required for 
proper follicle development.  The lack of condensates near ectopic buds was observed in 
dorsal (hairy) skin as well as hairless volar skin, arguing against the possibility that volar 
mesenchyme is selectively deficient in responsiveness to form this cell population. 
In volar skin from M2SMO mice, βcat* induced the rapid appearance of late-
stage follicle lineages and rudimentary hair shafts within hamartomas, showing that these 
undifferentiated tumors retain the potential to undergo advanced stages of terminal 
differentiation when supplied with an appropriate stimulus.  Since β-catenin 
immunostaining yields an intense signal in skin of M2SMO+βcat* mice, relatively 
compared to M2SMO mice, it is possible that high-level β-catenin activity in βcat*-
expressing mice is required for activation of hair lineage markers.  Thus, the level of Wnt 
signaling in M2SMO mice may be sufficient to initiate epithelial bud development, but 
inadequate to stimulate terminal differentiation of hair lineages. 
We also examined the effects of postnatal βcat* activation in otherwise normal 
volar epidermis in adult mice.  Within 5 days, βcat*-expressing mice developed multiple 
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de novo skin appendages, some of which appeared to be relatively normal-appearing 
follicles with sebaceous glands and hair shafts.  Our findings underscore the plasticity of 
adult skin even from a region that is normally hairless, and although other investigators 
had not reported follicle development in hairless skin following Wnt pathway activation 
(Gat et al., 1998; Lo Celso et al., 2004), the consequences of expressing an activated β-
catenin mutant from its endogenous promoter in adult mice has not yet been described.   
Analysis of transgenic mice that express Shh in skin (K14-Shh) revealed that early 
BCC-like lesions showed morphological evidence of dermal papilla and positive alkaline 
phosphatase activity, dermal papilla-specific marker (Oro et al., 1997).  This finding 
suggests that Hh activation at the level of Shh ligand is sufficient to induce the formation 
of BCC-like lesions with associated dermal condensates.  Recently, Cre-inducible Shh-
overexpressing mice were developed in the Dlugosz laboratory, and I generated K5-
CreERT2;Cre-inducible Shh bitransgenic mice to test whether overexpression of Shh in 
postnatal skin would result in the induction of epithelial buds with associated dermal 
condensates.  Epithelium-specific Shh overexpression in hairless volar skin led to the 
development of de novo epithelial buds, and Shh-induced de novo buds expressed early 
hair bud-lineage markers Sox9, K17, and CDP (data not shown).  However, these buds 
did not show morphological evidence of associated dermal papilla, suggesting that 
induction of Shh expression in postnatal skin is unable to induce the formation of dermal 
papillae (data not shown).    
 
Epithelial Hh signaling reactivates growth of resting hair follicles   
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Adenoviral delivery of Shh (Sato et al., 1999), as well as topical treatment with 
Hh-agonist (Paladini et al., 2005) in mouse skin is sufficient to trigger growth of telogen 
follicles in mice.  However, in both settings, multiple cell types including keratinocytes, 
fibroblasts, and mesenchymal cells including dermal papilla cells were subject to Hh 
pathway activation, and it is not clear whether activation of follicle growth was due to 
direct stimulation of quiescent bulge stem cells, or a consequence of stimulating 
additional cell types which could then indirectly influence the stem cell compartment 
through a secondary signal.  Utilizing novel mouse models that allow precise spatial and 
temporal control of Hh signaling in skin, I tested whether epithelium-specific activation 
of Hh signaling is sufficient to trigger new follicle growth in telogen skin.  The results 
with K5-rtTA;TRE-SmoA1 bitransgenic mice showed that epithelium-specific Hh 
activation is sufficient to induce new follicle growth in telogen skin.  Next, we also tested 
if direct Hh activation in the follicle stem cells is sufficient to trigger new follicle growth.  
To address this question, I took advantage of K15-CrePR1 mice, which allows for 
selective targeting of transgene expression to stem cells within the bulge compartment of 
hair follicles in post-natal mice (Liu et al., 2003; Morris et al., 2004).  By generating Cre- 
and doxycycline- inducible K15-CrePR1;R26X-rtTA+GFP;TRE-SmoA1 triple transgenic 
mice, I was able to specifically activate Hh signaling in the stem cell niche and test 
whether bulge-specific Hh activation is sufficient to induce new follicle growth.  My 
results showed that the activation of Hh signaling specifically in the stem cell 
compartment did not result in induction of anagen, suggesting that direct Hh activation on 
hair follicle stem cells with SmoA1 is not sufficient to initiate new follicle formation.  
Similar to the follicles in doxycycline-treated K5-rtTA;TRE-SmoA1 bitransgenic mice, 
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expansion of outer root sheath cells was also observed in K15-CrePR1;R26X-
rtTA+GFP;TRE-SmoA1 follicles that were depilated and treated with doxycycline, 
suggesting that SmoA1 expression had an effect on the progeny of activated stem cells in 
the bulge, including transient amplifying cells that give rise to all lineages of the hair 
follicle.  
Given the availability of Hh reporter mice such as Gli1-lacZ mice (Bai et al., 
2002) that allow a precise in vivo visualization of Hh activation in skin, we can also 
examine which cell types in the skin are responding to Hh-agonist treatment to bring 
about the new follicle growth.  Treatment of the Hh-agonist on Gli1-lacZ mice and 
examining the X-gal stained skin at several early time points (0, 6, 12, 24, 48, 72 hours 
post Hh-agonist treatment) will delineate the cells types that are responding to the Hh-
agonist to induce new follicle growth. 
A topical application of a synthetic Hh agonist on mouse skin is sufficient to 
trigger new growth in telogen follicles (Paladini et al., 2005), but Hh pathway 
transcriptional activation did not occur for 3-4 days after topical Hh agonist treatment.  
This result raises the possibility that Hh agonist treatment itself is not directly triggering 
new follicle growth but rather the Hh agonist may be inducing anagen by stimulating a 
particular cell type in the skin that in turn activates another signaling pathway, such as 
canonical Wnt signaling pathway.  This hypothesis sounds plausible, given 1) my 
previous data that suggest that Hh-driven ectopic epithelial bud development occurs 
indirectly by activation of canonical Wnt signaling pathway; 2) detection of intense 
nuclear and cytoplasmic β-catenin (indication of canonical Wnt activation) in the follicles 
3 days after SmoA1 induction in K5-rtTA;TRE-SmoA1 mice; and 3) previous studies that 
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support the notion that canonical Wnt plays a key role in triggering new follicle growth 
(Van Mater et al., 2003; Lo Celso et al., 2004).  However, Hh agonist-treated K5-
rtTA;TRE-Dkk1 bitransgenic mice still resulted in the induction of new follicle growth 
despite Dkk1 expression (data not shown).  Interestingly, depilation-induced anagen was 
also not blocked in doxycycline-induced K5-rtTA;TRE-Dkk1 bitransgenic mice, 
indicating that an alternative model to block canonical Wnt signaling in dorsal skin may 
be required.  Furthermore, given that Dkk1 expression was not effective in blocking 
M2SMO-induced bud and hamartoma phenotype in dorsal skin (Chapter II), it is 
plausible that K5-rtTA;TRE-Dkk1 is not an ideal system to test the functional role of 
canonical Wnt signaling in Hh-induced hair follicle growth.  Another conditional mouse 
model to block the canonical Wnt pathway, such as one that expresses soluble Wnt decoy 
receptor F8CRDhFc (DeAlmeida et al., 2007), may be a better system to address this 
hypothesis.  
 
Pathologic Hh signaling and melanogenesis  
M2SMO-expressing skin consistently exhibited increased pigmentation compared 
to control skin, as previously reported in other mouse models with elevated Hh signaling 
in skin and in a subset of human BCCs (Bleehen, 1975).  Wholemount X-gal staining 
revealed an increased number of β-galactosidase expressing cells in the epidermis of Dct-
lacZ;M2SMO volar skin compared to Dct-lacZ volar skin alone, supporting the notion 
that pigment accumulation in M2SMO mice is associated with concurrent increase in the 
number of melanocytes and/or melanocyte progenitors.  In addition, semiquantitative RT-
PCR revealed induction of multiple melanocyte markers and multiple genes implicated in 
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melanogenesis, including SCF, ET1, and ET3, but not HGF or Pomc, in volar skin of 
M2SMO-expressing mice.  Of these, only SCF appeared to be expressed at higher levels 
in skin containing hamartomas than in skin from younger mice containing epithelial buds 
(Figure 5-2g).  Thus multiple secreted factors that are coordinately induced may work in 
concert to bring about the dramatic increase in pigmentation seen in M2SMO-expressing 
skin.   
In addition to inhibiting epithelial changes associated with deregulated Hh 
signaling in skin, blockade of Wnt signaling in M2SMO+Dkk1 mice also grossly 
suppressed skin hyperpigmentation (Figure 2-13).  These in vivo results suggest that non 
cell-autonomous effects of M2SMO-expressing epithelium on the melanocyte lineage are 
also likely to be mediated by canonical Wnt signals, working either directly on 
melanocytes, or indirectly through secondary signals such as Scf.   
Interestingly, a recent paper reported a surprising role of tumor suppressor p53 in 
mediating the suntan responses to ultraviolet light, and reported that human BCCs that 
are pigmented retain wild-type p53, while those BCCs harboring p53 mutations are not 
pigmented (Cui et al., 2007). To functionally test whether Hh-induced melanogenesis 
may occur in the absence of p53 using genetic mouse models, M2SMO-expressing mice 
may be bred onto p53 knockout background and the skin examined for the status of 
ectopic pigment accumulation.   
Taken together, the key findings presented herein raise the possibility that 
blockade of canonical Wnt/β-catenin signaling may be a useful strategy for treatment of 
at least some neoplasms currently considered to be caused by uncontrolled Hh signaling.  
Because deregulated Hh signaling impacts on β-catenin signaling primarily at the level of 
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Wnt ligands, the range of potential therapeutic strategies is considerably greater than it is 
for colorectal and other cancers with mutational defects in APC or β-catenin, and would 
likely include antibodies or other recombinant proteins that antagonize the interaction of 
Wnt ligands with Frizzled and LRP receptors.  Future work will better clarify the utility 
of targeting proximal Wnt pathway components for the prevention or treatment of Hh-
dependent neoplasms and other disorders.  By examining the complex interactions 
between Hh and Wnt pathways during pathogenesis of skin tumors driven by ectopic Hh 
signaling, my thesis work uncovers a novel requirement for canonical Wnt signaling 
downstream of pathologic Hh signaling in skin, and opens exciting new avenues for 
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